JNK1
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0MZ66 | S444 | Sugiyama | SHTN1 KIAA1598 | RPVNQTARPKTKPESSKGCEsAVDELKGILGtLNKSTSSRs |
| A0MZ66 | S494 | Sugiyama | SHTN1 KIAA1598 | EtELERILRRRKVtAEADsssPtGILAtsEsKsMPVLGsVs |
| A5A3E0 | S1068 | Sugiyama | POTEF A26C1B | SLSTFQQMWISKQEyDEsGPsIVHRKCL_____________ |
| A5A3E0 | T789 | Sugiyama | POTEF A26C1B | YPMEHGIITNWDDMEKIWHHtFyNELRVAPEEHPVLLTEAT |
| A5A3E0 | T949 | Sugiyama | POTEF A26C1B | TVAsSSSLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| A5A3E0 | Y1062 | Sugiyama | POTEF A26C1B | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCL_______ |
| A5A3E0 | Y791 | Sugiyama | POTEF A26C1B | MEHGIITNWDDMEKIWHHtFyNELRVAPEEHPVLLTEATLN |
| A5A3E0 | Y940 | Sugiyama | POTEF A26C1B | ALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPEA |
| A6NKT7 | T1475 | Sugiyama | RGPD3 RGP3 | DSFKKIFDEAKTAQEKDsLItPHVsRsstPREsPCGKIAVA |
| O00151 | S130 | Sugiyama | PDLIM1 CLIM1 CLP36 | PQEVLHIGsAHNRsAMPFtAsPAsSTTARVItNQyNNPAGL |
| O00161 | S110 | Sugiyama | SNAP23 | TKNFEsGKAYKttWGDGGENsPCNVVSKQPGPVTNGQLQQP |
| O00165 | S153 | Sugiyama | HAX1 HS1BP1 | PDSHQPRIFGGVLESDARSEsPQPAPDWGsQRPFHRFDDVW |
| O00232 | S335 | Sugiyama | PSMD12 | MRWSTLVEDYGMELRKGsLEsPAtDVFGsTEEGEKRWKDLK |
| O00267 | T806 | Sugiyama | SUPT5H SPT5 SPT5H | MYGsQtPLQDGsRtPHyGsQtPLHDGsRtPAQsGAWDPNNP |
| O00418 | S396 | iPTMNet | EEF2K | LsENSGDENMSDVTFDsLPSsPsSATPHSQKLDHLHWPVFS |
| O00429 | S126 | Sugiyama | DNM1L DLP1 DRP1 | EIRQEIENETERISGNNKGVsPEPIHLKIFSPNVVNLTLVD |
| O00499 | T323 | Sugiyama | BIN1 AMPHL | sPAAtPEIRVNHEPEPAGGAtPGAtLPKsPsQLRKGPPVPP |
| O14497 | S363 | Sugiyama | ARID1A BAF250 BAF250A C1orf4 OSA1 SMARCF1 | AAAAAAASGGAQQRsHHAPMsPGssGGGGQPLARtPQPssP |
| O14497 | S698 | Sugiyama | ARID1A BAF250 BAF250A C1orf4 OSA1 SMARCF1 | QSPFSPHTSPHLPGIRGPsPsPVGsPAsVAQSRsGPLsPAA |
| O14497 | S702 | Sugiyama | ARID1A BAF250 BAF250A C1orf4 OSA1 SMARCF1 | SPHTSPHLPGIRGPsPsPVGsPAsVAQSRsGPLsPAAVPGN |
| O14545 | T323 | Sugiyama | TRAFD1 FLN29 | ELLIDHQTSCNPSRALPsLNtGsssPRGVEEPDVIFQNFLQ |
| O14639 | S431 | Sugiyama | ABLIM1 ABLIM KIAA0059 LIMAB1 | TSGYDDKQERQsLGEsPRtLsPtPsAEGyQDVRDRMIHRst |
| O14715 | T1474 | Sugiyama | RGPD8 RANBP2ALPHA RANBP2L1 RANBP2L3 | DSFKKIFDEAKTAQEKDsLItPHVsRsstPREsPCGKIAVA |
| O14745 | S280 | Sugiyama | NHERF1 NHERF SLC9A3R1 | tNGEIQKENsREALAEAALEsPRPALVRsAssDtsEELNsQ |
| O14910 | S130 | Sugiyama | LIN7A MALS1 VELI1 | ELPKTDEGLGFNVMGGKEQNsPIyIsRIIPGGVAERHGGLK |
| O14979 | S241 | Sugiyama | HNRNPDL HNRPDL JKTBP | KRAKALKGKEPPKKVFVGGLsPDtsEEQIKEYFGAFGEIEN |
| O43242 | S430 | Sugiyama | PSMD3 | ISLSySRIsLADIAQKLQLDsPEDAEFIVAKAIRDGVIEAs |
| O43379 | S1070 | Sugiyama | WDR62 C19orf14 | LPQtPEQEKFLRHHFETLtEsPCRALGDVEASEAEDHFFNP |
| O43379 | T1053 | SIGNOR|PSP | WDR62 C19orf14 | TEDELSLPEGPSVPsssLPQtPEQEKFLRHHFETLtEsPCR |
| O43521 | S104 | SIGNOR|ELM|EPSD | BCL2L11 BIM | RRSsLLSRsssGYFsFDTDRsPAPMSCDKSTQtPsPPCQAF |
| O43521 | S118 | SIGNOR|ELM | BCL2L11 BIM | sFDTDRsPAPMSCDKSTQtPsPPCQAFNHYLSAMASMRQAE |
| O43521 | S69 | SIGNOR|EPSD | BCL2L11 BIM | GGEGDSCPHGsPQGPLAPPAsPGPFATRsPLFIFMRRSsLL |
| O43521 | S77 | SIGNOR | BCL2L11 BIM | HGsPQGPLAPPAsPGPFATRsPLFIFMRRSsLLSRsssGYF |
| O43521 | T116 | SIGNOR|ELM | BCL2L11 BIM | YFsFDTDRsPAPMSCDKSTQtPsPPCQAFNHYLSAMASMRQ |
| O43524 | S574 | EPSD|PSP | FOXO3 FKHRL1 FOXO3A | VsNMGLSESSSLGSAKHQQQsPVSQSMQTLSDSLsGSSLYS |
| O43561 | T184 | SIGNOR | LAT | VLPDSTPATSTAAPSAPALStPGIRDSAFSMESIDDyVNVP |
| O43765 | S77 | Sugiyama | SGTA SGT SGT1 | TLPEIFEAAATGKEMPQDLRsPARtPPsEEDsAEAERLKTE |
| O43765 | T81 | Sugiyama | SGTA SGT SGT1 | IFEAAATGKEMPQDLRsPARtPPsEEDsAEAERLKTEGNEQ |
| O43852 | S261 | Sugiyama | CALU | RDKNRDGKMDKEEtKDWILPsDyDHAEAEARHLVyEsDQNK |
| O43852 | T65 | Sugiyama | CALU | FDyDHDAFLGAEEAKtFDQLtPEEsKERLGKIVSKIDGDKD |
| O43852 | Y263 | Sugiyama | CALU | KNRDGKMDKEEtKDWILPsDyDHAEAEARHLVyEsDQNKDG |
| O60282 | S176 | SIGNOR | KIF5C KIAA0531 NKHC2 | VHEDKNRVPYVKGCTERFVSsPEEVMDVIDEGKANRHVAVT |
| O60291 | S457 | Sugiyama | MGRN1 KIAA0544 RNF156 | LDSSRQKGRPQSKAPDstLRsPssPIHEEDEEKLsEDVDAP |
| O60291 | S460 | Sugiyama | MGRN1 KIAA0544 RNF156 | SRQKGRPQSKAPDstLRsPssPIHEEDEEKLsEDVDAPPPL |
| O60333 | T647 | Sugiyama | KIF1B KIAA0591 KIAA1448 | GKNHVFRFNHPEQARAEREKtPsAEtPsEPVDWTFAQRELL |
| O60333 | T652 | Sugiyama | KIF1B KIAA0591 KIAA1448 | FRFNHPEQARAEREKtPsAEtPsEPVDWTFAQRELLEKQGI |
| O60361 | S107 | Sugiyama | NME2P1 | GtIRGDFCIQVGRNIIHGsDsVKsAEKEISLRFKPEELVDY |
| O60361 | S110 | Sugiyama | NME2P1 | RGDFCIQVGRNIIHGsDsVKsAEKEISLRFKPEELVDYKSC |
| O60361 | Y136 | Sugiyama | NME2P1 | SLRFKPEELVDYKSCAHDWVyE___________________ |
| O60568 | S367 | Sugiyama | PLOD3 | WPQLQDHFSAVKLVGPEEALsPGEARDMAMDLCRQDPECEF |
| O60701 | T185 | Sugiyama | UGDH | EGTAIKDLKNPDRVLIGGDEtPEGQRAVQALCAVYEHWVPR |
| O75116 | S425 | Sugiyama | ROCK2 KIAA0619 | GNQLPFIGFTYYRENLLLsDsPSCRETDSIQSRKNEESQEI |
| O75179 | S2041 | Sugiyama | ANKRD17 GTAR KIAA0697 | NTAPTNATYPMPTAKEHyPVssPssPsPPAQPGGVsRNsPL |
| O75179 | Y2038 | Sugiyama | ANKRD17 GTAR KIAA0697 | SNNNTAPTNATYPMPTAKEHyPVssPssPsPPAQPGGVsRN |
| O75369 | S2325 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | PAsFAIRLNGAKGKIDAKVHsPsGAVEECHVsELEPDKYAV |
| O75376 | S158 | Sugiyama | NCOR1 KIAA1047 | RASADAKKDPAFGGKHEAPssPIsGQPCGDDQNAsPsKLSK |
| O75391 | S158 | Sugiyama | SPAG7 | LKELAQRQEEEAAQQGPVVVsPAsDyKDKYSHLIGKGAAKD |
| O75533 | S488 | Sugiyama | SF3B1 SAP155 | KPDDIQYFDKLLVDVDEstLsPEEQKERKIMKLLLKIKNGT |
| O75533 | T207 | Sugiyama | SF3B1 SAP155 | AAAsQPPsKRKRRWDQtADQtPGAtPKKLssWDQAEtPGHt |
| O75533 | T223 | Sugiyama | SF3B1 SAP155 | tADQtPGAtPKKLssWDQAEtPGHtPsLRWDEtPGRAKGsE |
| O75533 | T227 | Sugiyama | SF3B1 SAP155 | tPGAtPKKLssWDQAEtPGHtPsLRWDEtPGRAKGsEtPGA |
| O75822 | T109 | Sugiyama | EIF3J EIF3S1 PRO0391 | KKRQEEIKKRLEEPEEPKVLtPEEQLADKLRLKKLQEEsDL |
| O94842 | S174 | Sugiyama | TOX4 C14orf92 KIAA0737 | GLSLGGGTILPPAQSPEDRLsttPsPtssLHEDGVEDFRRQ |
| O94842 | S178 | Sugiyama | TOX4 C14orf92 KIAA0737 | GGGTILPPAQSPEDRLsttPsPtssLHEDGVEDFRRQLPSQ |
| O94842 | T176 | Sugiyama | TOX4 C14orf92 KIAA0737 | SLGGGTILPPAQSPEDRLsttPsPtssLHEDGVEDFRRQLP |
| O94868 | S693 | Sugiyama | FCHSD2 KIAA0769 SH3MD3 | RssLYFPRsPsANEKsLHAEsPGFsQAsRHtPETSYGKLRP |
| O94979 | S188 | Sugiyama | SEC31A KIAA0905 SEC31L1 HSPC275 HSPC334 | PEDISCIAWNRQVQHILAsAsPsGRATVWDLRKNEPIIKVS |
| O95140 | S27 | SIGNOR | MFN2 CPRP1 KIAA0214 | RCNsIVtVKKNKRHMAEVNAsPLKHFVTAKKKINGIFEQLG |
| O95149 | S348 | Sugiyama | SNUPN RNUT1 SPN1 | AsENGHyELEHLstPKLKGssHsPDHPGCLMEN________ |
| O95359 | T2514 | Sugiyama | TACC2 | DYPQPSDLSTFVNETKFssPtEELDyRNsYEIEyMEKIGss |
| O95433 | Y223 | Sugiyama | AHSA1 C14orf3 HSPC322 | KIPTCKITLKETFLTSPEELyRVFTTQELVQAFTHAPATLE |
| O95644 | S172 | EPSD|PSP | NFATC1 NFAT2 NFATC | PstATLSLPsLEAYRDPsCLsPAssLSSRSCNSEAsSYESN |
| O95757 | S599 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | sIDLPIQssLCRQLGQDLLNsyIENEGKMIMQDKLEKERND |
| O95757 | Y600 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | IDLPIQssLCRQLGQDLLNsyIENEGKMIMQDKLEKERNDA |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00367 | T409 | Sugiyama | GLUD1 GLUD | TKSNAPRVKAKIIAEGANGPttPEADKIFLERNIMVIPDLY |
| P00558 | S390 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | IIGGGDtAtCCAKWNtEDKVsHVstGGGAsLELLEGKVLPG |
| P00558 | S399 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | CCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDALsNI__ |
| P00558 | T376 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | MDEVVKAtsRGCItIIGGGDtAtCCAKWNtEDKVsHVstGG |
| P00558 | T378 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | EVVKAtsRGCItIIGGGDtAtCCAKWNtEDKVsHVstGGGA |
| P00558 | T394 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | GDtAtCCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDAL |
| P01106 | S77 | iPTMNet|PSP | MYC BHLHE39 | PPAPSEDIWKKFELLPtPPLsPsRRsGLCsPSyVAVTPFsL |
| P01106 | S86 | iPTMNet|PSP | MYC BHLHE39 | KKFELLPtPPLsPsRRsGLCsPSyVAVTPFsLRGDNDGGGG |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | T344 | Sugiyama | ALDOA ALDA | AQEEYVKRALANsLACQGKytPsGQAGAAAsEsLFVsNHAy |
| P04075 | T49 | Sugiyama | ALDOA ALDA | GILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtADDR |
| P04083 | S170 | Sugiyama | ANXA1 ANX1 LPC1 | RDINRVYREELKRDLAKDItsDtsGDFRNALLsLAKGDRsE |
| P04083 | S34 | Sugiyama | ANXA1 ANX1 LPC1 | IENEEQEyVQtVKssKGGPGsAVsPyPtFNPssDVAALHKA |
| P04083 | S37 | Sugiyama | ANXA1 ANX1 LPC1 | EEQEyVQtVKssKGGPGsAVsPyPtFNPssDVAALHKAIMV |
| P04150 | S226 | SIGNOR|ELM|iPTMNet|EPSD|PSP | NR3C1 GRL | KETNEsPWRSDLLIDENCLLsPLAGEDDSFLLEGNSNEDCK |
| P04181 | T39 | Sugiyama | OAT | HSSVASATSVATKKtVQGPPtSDDIFEREyKyGAHNyHPLP |
| P04406 | T211 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | PsGKLWRDGRGALQNIIPAstGAAKAVGKVIPELNGKLtGM |
| P04406 | T246 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKVVKQAS |
| P04406 | Y320 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GIALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsKE_____ |
| P04637 | S20 | SIGNOR|EPSD|PSP | TP53 P53 | _MEEPQsDPsVEPPLsQEtFsDLWKLLPENNVLsPLPsQAM |
| P04637 | T81 | SIGNOR|iPTMNet|EPSD|PSP | TP53 P53 | DEAPRMPEAAPPVAPAPAAPtPAAPAPAPSWPLSSSVPSQK |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05067 | T743 | SIGNOR | APP A4 AD1 | LKKKQYtsIHHGVVEVDAAVtPEERHLSKMQQNGyENPtyK |
| P05187 | S177 | Sugiyama | ALPP PLAP | RAKKAGKSVGVVTTTRVQHAsPAGtyAHtVNRNWysDADVP |
| P05198 | T279 | Sugiyama | EIF2S1 EIF2A | KEKIEEKRGVFNVQMEPKVVtDtDEtELARQMERLERENAE |
| P05386 | S101 | Sugiyama | RPLP1 RRP1 | APstAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD_______ |
| P05386 | S104 | Sugiyama | RPLP1 RRP1 | tAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S102 | Sugiyama | RPLP2 D11S2243E RPP2 | PAAGsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD_______ |
| P05387 | S105 | Sugiyama | RPLP2 D11S2243E RPP2 | GsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S17 | Sugiyama | RPLP2 D11S2243E RPP2 | ____MRyVAsyLLAALGGNssPsAKDIKKILDsVGIEADDD |
| P05387 | S29 | Sugiyama | RPLP2 D11S2243E RPP2 | LAALGGNssPsAKDIKKILDsVGIEADDDRLNKVIsELNGK |
| P05412 | S63 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | JUN | ADPVGSLKPHLRAKNsDLLtsPDVGLLKLAsPELERLIIQS |
| P05412 | S73 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | JUN | LRAKNsDLLtsPDVGLLKLAsPELERLIIQSSNGHItttPt |
| P05412 | T91 | EPSD|PSP | JUN | LAsPELERLIIQSSNGHItttPtPtQFLCPKNVTDEQEGFA |
| P05412 | T93 | EPSD|PSP | JUN | sPELERLIIQSSNGHItttPtPtQFLCPKNVTDEQEGFAEG |
| P05787 | S432 | EPSD|PSP | KRT8 CYK8 | HtKTTSGYAGGLSSAYGGLtsPGLSYSLGSSFGSGAGSSSF |
| P05787 | S74 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | KRT8 CYK8 | YGGASGMGGITAVtVNQSLLsPLVLEVDPNIQAVRTQEKEQ |
| P06733 | S263 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GMDVAASEFFRsGKyDLDFKsPDDPsRyIsPDQLADLyKsF |
| P06733 | S272 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | FRsGKyDLDFKsPDDPsRyIsPDQLADLyKsFIKDyPVVsI |
| P06733 | S37 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | NPtVEVDLFtsKGLFRAAVPsGAstGIyEALELRDNDKtRY |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P06733 | T41 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | EVDLFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKG |
| P06733 | Y280 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | DFKsPDDPsRyIsPDQLADLyKsFIKDyPVVsIEDPFDQDD |
| P06733 | Y44 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | LFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKGVSK |
| P06744 | S455 | Sugiyama | GPI | ALMRGKSTEEARKELQAAGKsPEDLERLLPHKVFEGNRPTN |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07205 | S390 | Sugiyama | PGK2 PGKB | VIGGGDTATCCAKWNtEDKVsHVstGGGAsLELLEGKILPG |
| P07205 | S399 | Sugiyama | PGK2 PGKB | CCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEALSNM__ |
| P07205 | T394 | Sugiyama | PGK2 PGKB | GDTATCCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEAL |
| P07237 | S449 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | ANEVEAVKVHsFPtLKFFPAsADRtVIDyNGERtLDGFKKF |
| P07237 | T453 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | EAVKVHsFPtLKFFPAsADRtVIDyNGERtLDGFKKFLESG |
| P07437 | S75 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | tGGKyVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| P07437 | T72 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | NEAtGGKyVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVF |
| P07437 | Y50 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | IDPTGtyHGDsDLQLDRIsVyyNEAtGGKyVPRAILVDLEP |
| P07741 | S30 | Sugiyama | APRT | EQRIRsFPDFPTPGVVFRDIsPVLKDPASFRAAIGLLARHL |
| P07814 | S1350 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | YRRRLLsVNIRVRADLRDNysPGWKFNHWELKGVPIRLEVG |
| P07814 | S739 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | TKVEATKNETSAPFKERPtPsLNNNCttsEDsLVLyNRVAV |
| P07814 | S886 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | EKTGKEyIPGQPPLsQssDssPtRNsEPAGLEtPEAKVLFD |
| P07814 | T294 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | ETIMKYAEKLIQEGKAyVDDtPAEQMKAEREQRIDSKHRKN |
| P07814 | T737 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | EKTKVEATKNETSAPFKERPtPsLNNNCttsEDsLVLyNRV |
| P07814 | T898 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | PLsQssDssPtRNsEPAGLEtPEAKVLFDKVAsQGEVVRKL |
| P07858 | S216 | Sugiyama | CTSB CPSB | PPCTGEGDTPKCSKICEPGysPtyKQDKHYGYNSYSVSNSE |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07900 | S391 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | MDNCEELIPEYLNFIRGVVDsEDLPLNIsREMLQQsKILKV |
| P07900 | S50 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | MSLIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKL |
| P07900 | T305 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IDQEELNKtKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLA |
| P08047 | T278 | GPS6|SIGNOR|EPSD|PSP | SP1 TSFP1 | VALNGNITLLPVNSVSAATLtPSSQAVTISSSGSQESGSQP |
| P08047 | T739 | SIGNOR|EPSD|PSP | SP1 TSFP1 | LsVGtLPLDsGAGsEGSGtAtPSALITTNMVAMEAICPEGI |
| P08195 | S598 | Sugiyama | SLC3A2 MDU1 | LQASDLPASASLPAKADLLLstQPGREEGsPLELERLKLEP |
| P08195 | S607 | Sugiyama | SLC3A2 MDU1 | ASLPAKADLLLstQPGREEGsPLELERLKLEPHEGLLLRFP |
| P08195 | T599 | Sugiyama | SLC3A2 MDU1 | QASDLPASASLPAKADLLLstQPGREEGsPLELERLKLEPH |
| P08238 | S383 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MDSCDELIPEYLNFIRGVVDsEDLPLNIsREMLQQsKILKV |
| P08238 | S417 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | QsKILKVIRKNIVKKCLELFsELAEDKENyKKFyEAFSKNL |
| P08238 | S45 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MSLIINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKL |
| P08238 | S468 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | RRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItG |
| P08238 | S497 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KEtQKsIyyItGEsKEQVANsAFVERVRKRGFEVVyMtEPI |
| P08238 | T297 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IDQEELNKtKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLA |
| P08238 | T467 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | NRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyIt |
| P08238 | T85 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LDsGKELKIDIIPNPQERtLtLVDtGIGMtKADLINNLGtI |
| P08238 | T89 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KELKIDIIPNPQERtLtLVDtGIGMtKADLINNLGtIAKSG |
| P08708 | S89 | Sugiyama | RPS17 RPS17L | ISIKLQEEERERRDNyVPEVsALDQEIIEVDPDtKEMLKLL |
| P08865 | T97 | Sugiyama | RPSA LAMBR LAMR1 | IssRNtGQRAVLKFAAAtGAtPIAGRFtPGTFTNQIQAAFR |
| P09104 | S37 | Sugiyama | ENO2 | NPtVEVDLyTAKGLFRAAVPsGAstGIyEALELRDGDKQRY |
| P09104 | T41 | Sugiyama | ENO2 | EVDLyTAKGLFRAAVPsGAstGIyEALELRDGDKQRYLGKG |
| P09104 | Y44 | Sugiyama | ENO2 | LyTAKGLFRAAVPsGAstGIyEALELRDGDKQRYLGKGVLK |
| P09382 | S63 | Sugiyama | LGALS1 | CLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVFPFQPG |
| P09382 | T58 | Sugiyama | LGALS1 | DsNNLCLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVF |
| P09923 | S174 | Sugiyama | ALPI | RAKQAGKSVGVVTTTRVQHAsPAGtyAHtVNRNWysDADMP |
| P0CG38 | S1068 | Sugiyama | POTEI | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG38 | T789 | Sugiyama | POTEI | YPMEHGIITNWDDMEKIWHHtFyNELRVAPEEHPILLTEAP |
| P0CG38 | Y1062 | Sugiyama | POTEI | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P0CG38 | Y791 | Sugiyama | POTEI | MEHGIITNWDDMEKIWHHtFyNELRVAPEEHPILLTEAPLN |
| P0CG39 | S1031 | Sugiyama | POTEJ | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG39 | T752 | Sugiyama | POTEJ | YPMEHGIITNWDDMEKIWHHtFyNELRVAPEEHPILLTEAP |
| P0CG39 | Y1025 | Sugiyama | POTEJ | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P0CG39 | Y754 | Sugiyama | POTEJ | MEHGIITNWDDMEKIWHHtFyNELRVAPEEHPILLTEAPLN |
| P0DJD0 | T1459 | Sugiyama | RGPD1 RANBP2L6 RGP1 | DSFKKIFDEAKTAQEKDsLItPHVsRsstPREsPCGKIAVA |
| P0DPH7 | S48 | Sugiyama | TUBA3C TUBA2 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P0DPH7 | T51 | Sugiyama | TUBA3C TUBA2 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| P10070 | T1546 | PSP | GLI2 THP | SGALSPSLLHSLSQNSSRLTtPRNSLTLPSIPAGISNMAVG |
| P10275 | S651 | EPSD|PSP | AR DHTR NR3C4 | KLKKLGNLKLQEEGEAsSttsPTEETTQKLTVSHIEGYECQ |
| P10276 | S445 | EPSD|PSP | RARA NR1B1 | GQPGGGGRDGGGLAPPPGsCsPsLsPSSNRSSPATHsP___ |
| P10276 | S461 | EPSD|PSP | RARA NR1B1 | PGsCsPsLsPSSNRSSPATHsP___________________ |
| P10276 | T181 | EPSD|PSP | RARA NR1B1 | DRNKKKKEVPKPECSESYTLtPEVGELIEKVRKAHQETFPA |
| P10415 | S70 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | BCL2 | SSQPGHtPHPAASRDPVARtsPLQtPAAPGAAAGPALsPVP |
| P10415 | S87 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | BCL2 | ARtsPLQtPAAPGAAAGPALsPVPPVVHLTLRQAGDDFSRR |
| P10415 | T69 | GPS6|SIGNOR|iPTMNet|EPSD|PSP | BCL2 | FSSQPGHtPHPAASRDPVARtsPLQtPAAPGAAAGPALsPV |
| P10809 | S453 | Sugiyama | HSPD1 HSP60 | EEGIVLGGGCALLRCIPALDsLtPANEDQKIGIEIIKRTLK |
| P10809 | S70 | Sugiyama | HSPD1 HSP60 | AVAVTMGPKGRtVIIEQsWGsPKVTKDGVtVAKsIDLKDKY |
| P10809 | T455 | Sugiyama | HSPD1 HSP60 | GIVLGGGCALLRCIPALDsLtPANEDQKIGIEIIKRTLKIP |
| P11142 | T163 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VVtVPAyFNDsQRQAtKDAGtIAGLNVLRIINEPtAAAIAy |
| P11142 | T226 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVNHFIAEFK |
| P11142 | T38 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P11142 | T45 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPtN |
| P11142 | Y41 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P11532 | S3613 | Sugiyama | DMD | LRQLLEQPQAEAKVNGttVssPstsLQRsDssQPMLLRVVG |
| P11802 | T172 | EPSD|PSP | CDK4 | GTVKLADFGLARIYSYQMALtPVVVTLWYRAPEVLLQSTYA |
| P12270 | S2155 | Sugiyama | TPR | PstPtLVVPHRtDGFAEAIHsPQVAGVPRFRFGPPEDMPQT |
| P13489 | S290 | Sugiyama | RNH1 PRI RNH | AKGCGDLCRVLRAKESLKELsLAGNELGDEGARLLCETLLE |
| P13667 | S379 | Sugiyama | PDIA4 ERP70 ERP72 | QPEKFQSKYEPRSHMMDVQGstQDsAIKDFVLKyALPLVGH |
| P13804 | S192 | Sugiyama | ETFA | sFDAAATsGGsASsEKAsStsPVEIsEWLDQKLTKSDRPEL |
| P13807 | S723 | Sugiyama | GYS1 GYS | TSGSKRNsVDtAtsssLstPsEPLsPtssLGEERN______ |
| P13807 | S727 | Sugiyama | GYS1 GYS | KRNsVDtAtsssLstPsEPLsPtssLGEERN__________ |
| P13807 | T721 | Sugiyama | GYS1 GYS | sSTSGSKRNsVDtAtsssLstPsEPLsPtssLGEERN____ |
| P13929 | S37 | Sugiyama | ENO3 | NPtVEVDLHtAKGRFRAAVPsGAstGIyEALELRDGDKGRY |
| P13929 | T41 | Sugiyama | ENO3 | EVDLHtAKGRFRAAVPsGAstGIyEALELRDGDKGRYLGKG |
| P13929 | Y44 | Sugiyama | ENO3 | LHtAKGRFRAAVPsGAstGIyEALELRDGDKGRYLGKGVLK |
| P14314 | S442 | Sugiyama | PRKCSH G19P1 | EYVYRLCPFKLVSQKPKLGGsPtsLGtWGsWIGPDHDKFSA |
| P14314 | S445 | Sugiyama | PRKCSH G19P1 | YRLCPFKLVSQKPKLGGsPtsLGtWGsWIGPDHDKFSAMKy |
| P14314 | T469 | Sugiyama | PRKCSH G19P1 | WGsWIGPDHDKFSAMKyEQGtGCWQGPNRstTVRLLCGKEt |
| P14314 | T492 | Sugiyama | PRKCSH G19P1 | WQGPNRstTVRLLCGKEtMVtStTEPSRCEYLMELMTPAAC |
| P14550 | S211 | Sugiyama | AKR1A1 ALDR1 ALR | LAQNELIAHCQARGLEVTAysPLGSSDRAWRDPDEPVLLEE |
| P14618 | S202 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | SLQVKQKGADFLVtEVENGGsLGsKKGVNLPGAAVDLPAVs |
| P14618 | S37 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | QLHAAMADTFLEHMCRLDIDsPPItARNtGIICtIGPAsRs |
| P14618 | T195 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | yVDDGLISLQVKQKGADFLVtEVENGGsLGsKKGVNLPGAA |
| P14618 | T365 | SIGNOR|PSP | PKM OIP3 PK2 PK3 PKM2 | GsDVANAVLDGADCIMLSGEtAKGDyPLEAVRMQHLIAREA |
| P14625 | S106 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | MKLIINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENAL |
| P14625 | S523 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | RtRLAKLLRFQssHHPtDItsLDQyVERMKEKQDKIyFMAG |
| P14625 | S552 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | KEKQDKIyFMAGsSRKEAEssPFVERLLKKGyEVIyLTEPV |
| P14649 | S87 | Sugiyama | MYL6B MLC1SA | EEFKEAFELFDRVGDGKILysQCGDVMRALGQNPtNAEVLK |
| P14866 | S101 | Sugiyama | HNRNPL HNRPL P/OKcl.14 | GAAGGGGGGENyDDPHKtPAsPVVHIRGLIDGVVEADLVEA |
| P14868 | S369 | Sugiyama | DARS1 DARS PIG40 | CEALAMLREAGVEMGDEDDLstPNEKLLGHLVKEKyDTDFy |
| P15311 | S535 | Sugiyama | EZR VIL2 | EKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHN |
| P15311 | T533 | Sugiyama | EZR VIL2 | NEEKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDII |
| P15336 | S90 | EPSD|PSP | ATF2 CREB2 CREBP1 | PtPtRFLKNCEEVGLFNELAsPFENEFKKASEDDIKKMPLD |
| P15336 | T69 | SIGNOR|EPSD|PSP|Sugiyama | ATF2 CREB2 CREBP1 | HEMtLKFGPARNDsVIVADQtPtPtRFLKNCEEVGLFNELA |
| P15336 | T71 | GPS6|SIGNOR|EPSD|PSP|Sugiyama | ATF2 CREB2 CREBP1 | MtLKFGPARNDsVIVADQtPtPtRFLKNCEEVGLFNELAsP |
| P15374 | S130 | Sugiyama | UCHL3 | KMHFESGSTLKKFLEEsVsMsPEERARyLENyDAIRVtHEt |
| P16104 | S140 | SIGNOR | H2AX H2AFX | KtsAtVGPKAPSGGKKAtQAsQEy_________________ |
| P16278 | S434 | Sugiyama | GLB1 ELNR1 | GFVLYRTTLPQDCSNPAPLssPLNGVHDRAyVAVDGIPQGV |
| P16949 | S38 | SIGNOR|Sugiyama | STMN1 C1orf215 LAP18 OP18 | QAFELILsPRsKEsVPEFPLsPPKKKDLsLEEIQKKLEAAE |
| P17066 | T228 | Sugiyama | HSPA6 HSP70B' | DVSVLSIDAGVFEVKAtAGDtHLGGEDFDNRLVNHFMEEFR |
| P17275 | T102 | SIGNOR|iPTMNet|EPSD|PSP | JUNB | LASSELERLIVPNSNGVITttPtPPGQyFYPRGGGsGGGAG |
| P17275 | T104 | SIGNOR|iPTMNet|EPSD|PSP | JUNB | SSELERLIVPNSNGVITttPtPPGQyFYPRGGGsGGGAGGA |
| P17535 | S100 | SIGNOR|EPSD|PSP | JUND | SAAPPDGLLAsPDLGLLKLAsPELERLIIQSNGLVtttPTS |
| P17544 | T51 | Sugiyama | ATF7 ATFA | HEMTLKFGPARtDsVIIADQtPtPtRFLKNCEEVGLFNELA |
| P17544 | T53 | Sugiyama | ATF7 ATFA | MTLKFGPARtDsVIIADQtPtPtRFLKNCEEVGLFNELASS |
| P17706 | S298 | Sugiyama | PTPN2 PTPT | CIKGDSSIQKRWKELsKEDLsPAFDHsPNKIMtEKYNGNRI |
| P17812 | S575 | Sugiyama | CTPS1 CTPS | LQKGCRLsPRDtysDRsGsssPDsEItELKFPsINHD____ |
| P17936 | S97 | Sugiyama | IGFBP3 IBP3 | EGQPCGIYTERCGSGLRCQPsPDEARPLQALLDGRGLCVNA |
| P17980 | S376 | Sugiyama | PSMC3 TBP1 | MPNEEARARIMQIHSRKMNVsPDVNyEELARCTDDFNGAQC |
| P17987 | S551 | Sugiyama | TCP1 CCT1 CCTA | IKLHPESKDDKHGsyEDAVHsGALND_______________ |
| P18669 | S152 | Sugiyama | PGAM1 PGAMA CDABP0006 | FysNIsKDRRyADLtEDQLPsCEsLKDtIARALPFWNEEIV |
| P18669 | S31 | Sugiyama | PGAM1 PGAMA CDABP0006 | HGEsAWNLENRFsGWyDADLsPAGHEEAKRGGQALRDAGyE |
| P18669 | T146 | Sugiyama | PGAM1 PGAMA CDABP0006 | MEPDHPFysNIsKDRRyADLtEDQLPsCEsLKDtIARALPF |
| P18754 | S90 | Sugiyama | RCC1 CHC1 | VQAEAGGMHTVCLSKsGQVysFGCNDEGALGRDtsVEGSEM |
| P19419 | S383 | GPS6|SIGNOR | ELK1 | tPVLLtPSSLPPSIHFWSTLsPIAPRsPAKLSFQFPSSGSA |
| P19419 | S389 | SIGNOR | ELK1 | PSSLPPSIHFWSTLsPIAPRsPAKLSFQFPSSGSAQVHIPS |
| P19793 | S260 | SIGNOR|EPSD|PSP | RXRA NR2B1 | LAVEPKTETyVEANMGLNPssPNDPVtNICQAADKQLFTLV |
| P20290 | T182 | Sugiyama | BTF3 NACB OK/SW-cl.8 | LRRLAEALPKQsVDGKAPLAtGEDDDDEVPDLVENFDEAsK |
| P20618 | S151 | Sugiyama | PSMB1 PSC5 | PYYVYNIIGGLDEEGKGAVysFDPVGsyQRDsFKAGGSASA |
| P20618 | Y150 | Sugiyama | PSMB1 PSC5 | FPYYVYNIIGGLDEEGKGAVysFDPVGsyQRDsFKAGGSAS |
| P21333 | S1084 | Sugiyama | FLNA FLN FLN1 | PTKPSKVKAFGPGLQGGsAGsPARFtIDTKGAGTGGLGLTV |
| P21333 | S1459 | Sugiyama | FLNA FLN FLN1 | KVPVHDVTDASKVKCsGPGLsPGMVRANLPQsFQVDTSKAG |
| P21333 | S2319 | Sugiyama | FLNA FLN FLN1 | VQEPGDyEVsVKFNEEHIPDsPFVVPVAsPsGDARRLtVss |
| P21333 | S2327 | Sugiyama | FLNA FLN FLN1 | VsVKFNEEHIPDsPFVVPVAsPsGDARRLtVssLQEsGLKV |
| P21333 | S2329 | Sugiyama | FLNA FLN FLN1 | VKFNEEHIPDsPFVVPVAsPsGDARRLtVssLQEsGLKVNQ |
| P22059 | T332 | Sugiyama | OSBP OSBP1 | AKQHNHLERAFRGAtVLPANtPGNVGsGKDQCCSGKGDMsD |
| P22059 | T762 | Sugiyama | OSBP OSBP1 | KQRLSRKKREAEAMKATEDGtPYDPyKALWFERKKDPVTKE |
| P22234 | S27 | Sugiyama | PAICS ADE2 AIRC PAIS | LNIGKKLYEGKtKEVyELLDsPGKVLLQsKDQItAGNAARK |
| P22314 | T233 | Sugiyama | UBA1 A1S9T UBE1 | GEQPLSAMVSMVTKDNPGVVtCLDEARHGFESGDFVSFSEV |
| P22392 | S122 | Sugiyama | NME2 NM23B | GtIRGDFCIQVGRNIIHGsDsVKsAEKEISLWFKPEELVDy |
| P22392 | S125 | Sugiyama | NME2 NM23B | RGDFCIQVGRNIIHGsDsVKsAEKEISLWFKPEELVDyKSC |
| P22392 | Y151 | Sugiyama | NME2 NM23B | SLWFKPEELVDyKSCAHDWVyE___________________ |
| P22626 | S259 | Sugiyama | HNRNPA2B1 HNRPA2B1 | GFGDGyNGyGGGPGGGNFGGsPGyGGGRGGYGGGGPGYGNQ |
| P22736 | S95 | SIGNOR|EPSD|PSP | NR4A1 GFRP1 HMR NAK1 | VQPCSSASSSASSTSSSSATsPASASFKFEDFQVYGCYPGP |
| P23246 | T687 | Sugiyama | SFPQ PSF | FGQGGAGPVGGQGPRGMGPGtPAGyGRGREEYEGPNKKPRF |
| P23396 | T242 | Sugiyama | RPS3 OK/SW-cl.26 | PIsEQKGGKPEPPAMPQPVPtA___________________ |
| P23528 | Y140 | Sugiyama | CFL1 CFL | SKDAIKKKLtGIKHELQANCyEEVKDRCTLAEKLGGsAVIs |
| P23921 | S559 | Sugiyama | RRM1 RR1 | ALEASCDLAKEQGPyEtyEGsPVsKGILQYDMWNVTPTDLW |
| P24534 | S8 | Sugiyama | EEF1B2 EEF1B EF1B | _____________MGFGDLKsPAGLQVLNDyLADKSYIEGY |
| P24752 | S218 | Sugiyama | ACAT1 ACAT MAT | ENTAKKLNIARNEQDAyAINsytRSKAAWEAGKFGNEVIPV |
| P24928 | S1913 | Sugiyama | POLR2A POLR2 | PtysPtsPVytPtsPKysPtsPtysPtsPKysPtsPtysPt |
| P24928 | S1917 | Sugiyama | POLR2A POLR2 | PtsPVytPtsPKysPtsPtysPtsPKysPtsPtysPtsPKG |
| P24928 | T1912 | Sugiyama | POLR2A POLR2 | sPtysPtsPVytPtsPKysPtsPtysPtsPKysPtsPtysP |
| P25786 | S14 | Sugiyama | PSMA1 HC2 NU PROS30 PSC2 | _______MFRNQyDNDVtVWsPQGRIHQIEYAMEAVKQGSA |
| P26038 | T465 | Sugiyama | MSN | WQQKAQMVQEDLEKTRAELKtAMstPHVAEPAENEQDEQDE |
| P26038 | T469 | Sugiyama | MSN | AQMVQEDLEKTRAELKtAMstPHVAEPAENEQDEQDENGAE |
| P26373 | T148 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PRKPSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARV |
| P26373 | T151 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARVItE |
| P26640 | S301 | Sugiyama | VARS1 G7A VARS VARS2 | DLPtPPGEKKDVSGPMPDsysPRYVEAAWYPWWEQQGFFKP |
| P27816 | S507 | Sugiyama | MAP4 | APAKDVAPSTVKEVGLLKDMsPLsEtEMALGKDVtPPPEtE |
| P28066 | S179 | Sugiyama | PSMA5 | sGtFVQCDARAIGsAsEGAQssLQEVyHKSMTLKEAIKSSL |
| P28074 | S175 | Sugiyama | PSMB5 LMPX MB1 X | SMGTMICGWDKRGPGLyyVDsEGNRISGATFSVGSGSVYAY |
| P28324 | S381 | GPS6 | ELK4 SAP1 | tPIILtPSPLLSSIHFWSTLsPVAPLsPARLQGANTLFQFP |
| P28324 | S387 | GPS6 | ELK4 SAP1 | PSPLLSSIHFWSTLsPVAPLsPARLQGANTLFQFPSVLNSH |
| P28324 | S425 | GPS6 | ELK4 SAP1 | NSHGPFTLSGLDGPStPGPFsPDLQKT______________ |
| P28324 | T361 | GPS6 | ELK4 SAP1 | LGILSPSLPTASLTPAFFSQtPIILtPSPLLSSIHFWSTLs |
| P28324 | T366 | GPS6 | ELK4 SAP1 | PSLPTASLTPAFFSQtPIILtPSPLLSSIHFWSTLsPVAPL |
| P28324 | T420 | GPS6 | ELK4 SAP1 | FPSVLNSHGPFTLSGLDGPStPGPFsPDLQKT_________ |
| P28715 | S384 | Sugiyama | ERCC5 ERCM2 XPG XPGC | ENRRQARGRNAPAAVDEGsIsPRtLSAIKRALDDDEDVKVC |
| P29401 | S105 | Sugiyama | TKT | VWAEAGFLAEAELLNLRKIssDLDGHPVPKQAFtDVATGsL |
| P29401 | S295 | Sugiyama | TKT | ysQIQsKKKILAtPPQEDAPsVDIANIRMPsLPsyKVGDKI |
| P29401 | T287 | Sugiyama | TKT | AEQIIQEIysQIQsKKKILAtPPQEDAPsVDIANIRMPsLP |
| P29474 | S114 | PSP | NOS3 | CTPRRCLGSLVFPRKLQGRPsPGPPAPEQLLSQARDFINQY |
| P29692 | S133 | Sugiyama | EEF1D EF1D | NVLEKssPGHRAtAPQtQHVsPMRQVEPPAKKPAtPAEDDE |
| P29692 | S162 | Sugiyama | EEF1D EF1D | AKKPAtPAEDDEDDDIDLFGsDNEEEDKEAAQLREERLRQY |
| P29692 | S64 | Sugiyama | EEF1D EF1D | sVILRDIARARENIQKsLAGssGPGAssGtsGDHGELVVRI |
| P29692 | T147 | Sugiyama | EEF1D EF1D | PQtQHVsPMRQVEPPAKKPAtPAEDDEDDDIDLFGsDNEEE |
| P29966 | S101 | Sugiyama | MARCKS MACS PRKCSL | sPsAAEKGEPAAAAAPEAGAsPVEKEAPAEGEAAEPGsPtA |
| P29966 | S27 | Sugiyama | MARCKS MACS PRKCSL | KTAAKGEAAAERPGEAAVAssPsKANGQENGHVKVNGDAsP |
| P29966 | S46 | EPSD|PSP | MARCKS MACS PRKCSL | ssPsKANGQENGHVKVNGDAsPAAAEsGAKEELQANGsAPA |
| P30041 | T177 | Sugiyama | PRDX6 AOP2 KIAA0106 | FDEILRVVISLQLTAEKRVAtPVDWKDGDsVMVLPtIPEEE |
| P30043 | S82 | Sugiyama | BLVRB FLR SCAN | DKTVAGQDAVIVLLGTRNDLsPTTVMSEGARNIVAAMKAHG |
| P30050 | S138 | Sugiyama | RPL12 | HRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDINsG |
| P30050 | S157 | Sugiyama | RPL12 | QsVGCNVDGRHPHDIIDDINsGAVECPAs____________ |
| P30050 | S165 | Sugiyama | RPL12 | GRHPHDIIDDINsGAVECPAs____________________ |
| P30050 | S26 | Sugiyama | RPL12 | DPNEIKVVYLRCtGGEVGAtsALAPKIGPLGLsPKKVGDDI |
| P30086 | T42 | Sugiyama | PEBP1 PBP PEBP | QHPLHVTYAGAAVDELGKVLtPtQVKNRPtsIsWDGLDsGK |
| P30086 | T69 | Sugiyama | PEBP1 PBP PEBP | RPtsIsWDGLDsGKLytLVLtDPDAPsRKDPKYREWHHFLV |
| P30086 | Y64 | Sugiyama | PEBP1 PBP PEBP | tQVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPKYREW |
| P30101 | S443 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | LsKDPNIVIAKMDAtANDVPsPyEVRGFPtIyFsPANKKLN |
| P30101 | Y115 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | yGVsGyPtLKIFRDGEEAGAyDGPRtADGIVsHLKKQAGPA |
| P30305 | S101 | SIGNOR | CDC25B CDC25HU2 | SRSRLTHLsLsRRASESSLSsEsSESSDAGLCMDSPSPMDP |
| P30305 | S103 | SIGNOR | CDC25B CDC25HU2 | SRLTHLsLsRRASESSLSsEsSESSDAGLCMDSPSPMDPHM |
| P30307 | S168 | SIGNOR|EPSD|PSP | CDC25C | SANKENDNGNLVDSEMKYLGsPITTVPKLDKNPNLGEDQAE |
| P31749 | T450 | SIGNOR | AKT1 PKB RAC | TSETDTRYFDEEFtAQMItItPPDQDDSMECVDSERRPHFP |
| P31943 | S104 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | EVFKSNNVEMDWVLKHtGPNsPDtANDGFVRLRGLPFGCSK |
| P31943 | T100 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | HRyVEVFKSNNVEMDWVLKHtGPNsPDtANDGFVRLRGLPF |
| P31946 | S186 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | YWHAB | HPIRLGLALNFSVFYYEILNsPEKACSLAKTAFDEAIAELD |
| P31947 | S186 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | SFN HME1 | NPIRLGLALNFSVFHYEIANsPEEAISLAKTtFDEAMADLH |
| P31948 | S481 | Sugiyama | STIP1 | CKEAADGYQRCMMAQyNRHDsPEDVKRRAMADPEVQQIMSD |
| P32322 | S294 | Sugiyama | PYCR1 | QEQVSPAAIKKTILDKVKLDsPAGtALsPsGHTKLLPRSLA |
| P32322 | S301 | Sugiyama | PYCR1 | AIKKTILDKVKLDsPAGtALsPsGHTKLLPRSLAPAGKD__ |
| P32322 | T298 | Sugiyama | PYCR1 | SPAAIKKTILDKVKLDsPAGtALsPsGHTKLLPRSLAPAGK |
| P33176 | S175 | Sugiyama | KIF5B KNS KNS1 | VHEDKNRVPYVKGCTERFVCsPDEVMDtIDEGKSNRHVAVT |
| P33991 | S131 | Sugiyama | MCM4 CDC21 | PVRQRPDLGsAQKGLQVDLQsDGAAAEDIVAsEQsLGQKLV |
| P33992 | S315 | Sugiyama | MCM5 CDC46 | RVLGIQVDTDGSGRSFAGAVsPQEEEEFRRLAALPNVYEVI |
| P33992 | S398 | Sugiyama | MCM5 CDC46 | LMLGDPGTAKSQLLKFVEKCsPIGVytsGKGSSAAGLtAsV |
| P34896 | T405 | Sugiyama | SHMT1 | NKNTCPGDRSALRPSGLRLGtPALTSRGLLEKDFQKVAHFI |
| P34897 | S417 | Sugiyama | SHMT2 | ERVLELVSITANKNTCPGDRsAItPGGLRLGAPALtSRQFR |
| P34897 | T420 | Sugiyama | SHMT2 | LELVSITANKNTCPGDRsAItPGGLRLGAPALtSRQFREDD |
| P34931 | T228 | Sugiyama | HSPA1L | DVSILTIDDGIFEVKAtAGDtHLGGEDFDNRLVsHFVEEFK |
| P34931 | T40 | Sugiyama | HSPA1L | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P34931 | T47 | Sugiyama | HSPA1L | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPQN |
| P34931 | Y43 | Sugiyama | HSPA1L | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P35222 | S33 | EPSD|PSP | CTNNB1 CTNNB OK/SW-cl.35 PRO2286 | AMEPDRKAAVsHWQQQsyLDsGIHsGATtTAPsLsGKGNPE |
| P35222 | S37 | SIGNOR|EPSD|PSP | CTNNB1 CTNNB OK/SW-cl.35 PRO2286 | DRKAAVsHWQQQsyLDsGIHsGATtTAPsLsGKGNPEEEDV |
| P35222 | T41 | SIGNOR|EPSD|PSP | CTNNB1 CTNNB OK/SW-cl.35 PRO2286 | AVsHWQQQsyLDsGIHsGATtTAPsLsGKGNPEEEDVDTsQ |
| P35269 | T389 | Sugiyama | GTF2F1 RAP74 | PPKRERKPsGGSSRGNsRPGtPsAEGGstsstLRAAASKLE |
| P35568 | S307 | GPS6|SIGNOR | IRS1 | HHLNNPPPSQVGLTRRsRtEsItAtsPAsMVGGKPGsFRVR |
| P35568 | S312 | SIGNOR|iPTMNet|EPSD|PSP | IRS1 | PPPSQVGLTRRsRtEsItAtsPAsMVGGKPGsFRVRAssDG |
| P35568 | S315 | SIGNOR | IRS1 | SQVGLTRRsRtEsItAtsPAsMVGGKPGsFRVRAssDGEGt |
| P35568 | S616 | SIGNOR | IRS1 | GGHHRPDsstLHtDDGyMPMsPGVAPVPSGRKGsGDyMPMs |
| P35568 | S636 | SIGNOR | IRS1 | sPGVAPVPSGRKGsGDyMPMsPKsVSAPQQIINPIRRHPQR |
| P35606 | T828 | Sugiyama | COPB2 | EEWVKETHADLWPAKQyPLVtPNEERNVMEEGKDFQPSRst |
| P35658 | S430 | Sugiyama | NUP214 CAIN CAN KIAA0023 | VKSLIKTPERLsLEGERQPKsPGstPTTPTSSQAPQKLDAS |
| P35658 | S433 | Sugiyama | NUP214 CAIN CAN KIAA0023 | LIKTPERLsLEGERQPKsPGstPTTPTSSQAPQKLDASAAA |
| P35658 | T434 | Sugiyama | NUP214 CAIN CAN KIAA0023 | IKTPERLsLEGERQPKsPGstPTTPTSSQAPQKLDASAAAA |
| P35813 | S216 | Sugiyama | PPM1A PPPM1A | ALGDFDYKCVHGKGPTEQLVsPEPEVHDIERSEEDDQFIIL |
| P35998 | T193 | Sugiyama | PSMC2 MSS1 | TYSDVGGCKEQIEKLREVVEtPLLHPERFVNLGIEPPKGVL |
| P36956 | S117 | EPSD|PSP | SREBF1 BHLHD1 SREBP1 | LSPPQPAPTPLKMYPSMPAFsPGPGIKEESVPLSILQTPTP |
| P37231 | S112 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | PPARG NR1C3 | DYKYDLKLQEyQSAIKVEPAsPPYYSEKTQLYNKPHEEPSN |
| P38646 | T86 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | CVAVMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAK |
| P38646 | T87 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VAVMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKR |
| P38646 | T94 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | QAKVLENAEGARttPsVVAFtADGERLVGMPAKRQAVtNPN |
| P38936 | S130 | SIGNOR|iPTMNet|EPSD|PSP | CDKN1A CAP20 CDKN1 CIP1 MDA6 PIC1 SDI1 WAF1 | HVDLsLSCTLVPRsGEQAEGsPGGPGDSQGRKRRQtsMTDF |
| P38936 | S98 | EPSD|PSP | CDKN1A CAP20 CDKN1 CIP1 MDA6 PIC1 SDI1 WAF1 | LPtGPRRGRDELGGGRRPGtsPALLQGTAEEDHVDLsLSCT |
| P38936 | T57 | SIGNOR|iPTMNet|EPSD|PSP | CDKN1A CAP20 CDKN1 CIP1 MDA6 PIC1 SDI1 WAF1 | LMAGCIQEARERWNFDFVtEtPLEGDFAWERVRGLGLPKLy |
| P40222 | S514 | Sugiyama | TXLNA TXLN | GsLtDsGPERRPEGPGAQAPssPRVtEAPCyPGAPSTEASG |
| P40763 | S727 | SIGNOR|EPSD|PSP | STAT3 APRF | KTKFICVtPttCsNtIDLPMsPRTLDSLMQFGNNGEGAEPS |
| P41091 | T109 | Sugiyama | EIF2S3 EIF2G | YKLDDPSCPRPECyRSCGsstPDEFPtDIPGtKGNFKLVRH |
| P41970 | S357 | ELM|iPTMNet | ELK3 NET SAP2 | NGLLLTPSPLLSSIHFWSSLsPVAPLsPARLQGPSTLFQFP |
| P42166 | T160 | Sugiyama | TMPO LAP2 | KLYEKKLLKLREQGtEsRsstPLPtIsssAENtRQNGsNDs |
| P42167 | T160 | Sugiyama | TMPO LAP2 | KLYEKKLLKLREQGTESRsstPLPTISsSAENTRQNGSNDS |
| P42224 | Y701 | SIGNOR | STAT1 | YSRPKEAPEPMELDGPKGtGyIKtELIsVsEVHPSRLQttD |
| P42226 | S707 | SIGNOR|EPSD|PSP | STAT6 | DMVPQVYPPHSHSIPPYQGLsPEESVNVLSAFQEPHLQMPP |
| P43121 | T107 | Sugiyama | MCAM MUC18 | EYEQRLsLQDRGAtLALtQVtPQDERIFLCQGKRPRSQEYR |
| P45983 | S179 | Sugiyama | MAPK8 JNK1 PRKM8 SAPK1 SAPK1C | VKSDCTLKILDFGLARTAGtsFMMtPyVVtRyYRAPEVILG |
| P45983 | S270 | Sugiyama | MAPK8 JNK1 PRKM8 SAPK1 SAPK1C | KKLQPTVRTYVENRPKyAGysFEKLFPDVLFPADsEHNKLK |
| P45983 | S284 | Sugiyama | MAPK8 JNK1 PRKM8 SAPK1 SAPK1C | PKyAGysFEKLFPDVLFPADsEHNKLKASQARDLLSKMLVI |
| P45983 | T178 | Sugiyama | MAPK8 JNK1 PRKM8 SAPK1 SAPK1C | VVKSDCTLKILDFGLARTAGtsFMMtPyVVtRyYRAPEVIL |
| P45983 | T183 | Sugiyama | MAPK8 JNK1 PRKM8 SAPK1 SAPK1C | CTLKILDFGLARTAGtsFMMtPyVVtRyYRAPEVILGMGYK |
| P45983 | T188 | Sugiyama | MAPK8 JNK1 PRKM8 SAPK1 SAPK1C | LDFGLARTAGtsFMMtPyVVtRyYRAPEVILGMGYKENVDL |
| P45983 | T243 | Sugiyama | MAPK8 JNK1 PRKM8 SAPK1 SAPK1C | ILFPGRDYIDQWNKVIEQLGtPCPEFMKKLQPTVRTYVENR |
| P45983 | Y185 | Sugiyama | MAPK8 JNK1 PRKM8 SAPK1 SAPK1C | LKILDFGLARTAGtsFMMtPyVVtRyYRAPEVILGMGYKEN |
| P45983 | Y266 | Sugiyama | MAPK8 JNK1 PRKM8 SAPK1 SAPK1C | PEFMKKLQPTVRTYVENRPKyAGysFEKLFPDVLFPADsEH |
| P45983 | Y269 | Sugiyama | MAPK8 JNK1 PRKM8 SAPK1 SAPK1C | MKKLQPTVRTYVENRPKyAGysFEKLFPDVLFPADsEHNKL |
| P46777 | S172 | Sugiyama | RPL5 MSTP030 | RTTTGNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNA |
| P46777 | S176 | Sugiyama | RPL5 MSTP030 | GNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNAEVHR |
| P46783 | S146 | Sugiyama | RPS10 | TYRRSAVPPGADKKAEAGAGsAtEFQFRGGFGRGRGQPPQ_ |
| P46937 | S138 | GPS6|SIGNOR | YAP1 YAP65 | LtPQHVRAHssPAsLQLGAVsPGtLtPtGVVsGPAAtPTAQ |
| P46937 | S367 | GPS6|SIGNOR|Sugiyama | YAP1 YAP65 | ALRSQLPtLEQDGGtQNPVssPGMsQELRTMttNssDPFLN |
| P46937 | S400 | SIGNOR | YAP1 YAP65 | NssDPFLNsGtyHsRDEstDsGLsMssysVPRtPDDFLNsV |
| P46937 | T110 | Sugiyama | YAP1 YAP65 | KLPDsFFKPPEPKsHsRQAstDAGtAGALtPQHVRAHssPA |
| P46937 | T119 | GPS6|SIGNOR|Sugiyama | YAP1 YAP65 | PEPKsHsRQAstDAGtAGALtPQHVRAHssPAsLQLGAVsP |
| P46937 | T154 | GPS6|SIGNOR|PSP | YAP1 YAP65 | LGAVsPGtLtPtGVVsGPAAtPTAQHLRQssFEIPDDVPLP |
| P46937 | T412 | GPS6|EPSD | YAP1 YAP65 | HsRDEstDsGLsMssysVPRtPDDFLNsVDEMDTGDTINQS |
| P47756 | S207 | Sugiyama | CAPZB | MNLGGsLtRQMEKDEtVsDCsPHIANIGRLVEDMENKIRst |
| P47914 | S142 | Sugiyama | RPL29 | KAKAKAKAKDQTKAQAAAPAsVPAQAPKRtQAPtKAsE___ |
| P48506 | S215 | Sugiyama | GCLC GLCL GLCLC | HRRGEKVVINVPIFKDKNtPsPFIETFTEDDEASRASKPDH |
| P48506 | T213 | Sugiyama | GCLC GLCL GLCLC | IRHRRGEKVVINVPIFKDKNtPsPFIETFTEDDEASRASKP |
| P48741 | T228 | Sugiyama | HSPA7 HSP70B | DVSVLSIDAGVFEVKAtAGDtHLGGEDFDNRLVNHFMEEFR |
| P49023 | S106 | Sugiyama | PXN | PVyGssAKtssVsNPQDsVGsPCsRVGEEEHVysFPNKQKs |
| P49023 | S178 | SIGNOR|iPTMNet|EPSD|PSP | PXN | NPPGFPADEANSSPPLPGALsPLyGVPETNSPLGGKAGPLT |
| P49023 | S303 | Sugiyama | PXN | QRADGERCWAAGWPRDGGRssPGGQDEGGFMAQGKtGsssP |
| P49321 | T390 | Sugiyama | NASP | EAPVLPKDGAVNGPsVVGDQtPIEPQtsIERLtEtKDGsGL |
| P49448 | T409 | Sugiyama | GLUD2 GLUDP1 | TKSNAPRVKAKIIAEGANGPttPEADKIFLERNILVIPDLY |
| P49643 | T470 | Sugiyama | PRIM2 PRIM2A | ESQRILNGGKDIKKEPIQPEtPQPKPsVQKTKDASSALASL |
| P49721 | S76 | Sugiyama | PSMB2 | FAEYIQKNVQLYKMRNGYELsPTAAANFTRRNLADCLRSRT |
| P49753 | S360 | Sugiyama | ACOT2 PTE2 PTE2A | NRNRIKVTKDGyADIVDVLNsPLEGPDQKSFIPVERAESTF |
| P49757 | S634 | Sugiyama | NUMB C14orf41 | DPFEAQWAALENKSKQRtNPsPtNPFSSDLQKTFEIEL___ |
| P49792 | S1400 | Sugiyama | RANBP2 NUP358 | PSNKELVGPPLAEtVFtPKtsPENVQDRFALVtPKKEGHWD |
| P49792 | T1396 | Sugiyama | RANBP2 NUP358 | QNLNPSNKELVGPPLAEtVFtPKtsPENVQDRFALVtPKKE |
| P49792 | T1761 | Sugiyama | RANBP2 NUP358 | ATKCIACQCPSKQNQtTAIstPAssEIsKAPKsGFEGMFIR |
| P49792 | T2450 | Sugiyama | RANBP2 NUP358 | DSFKKIFDEAKTAQEKDsLItPHVsRsstPREsPCGKIAVA |
| P49841 | T43 | Sugiyama | GSK3B | FGsMKVSRDKDGSKVTTVVAtPGQGPDRPQEVSyTDTKVIG |
| P49915 | S332 | Sugiyama | GMPS | IsDEDRtPRKRISKTLNMttsPEEKRKIIGDTFVKIANEVI |
| P50454 | S139 | Sugiyama | SERPINH1 CBP1 CBP2 HSP47 SERPINH2 PIG14 | SNSTARNVTWKLGsRLyGPssVsFADDFVRssKQHYNCEHS |
| P50454 | S141 | Sugiyama | SERPINH1 CBP1 CBP2 HSP47 SERPINH2 PIG14 | STARNVTWKLGsRLyGPssVsFADDFVRssKQHYNCEHSKI |
| P51812 | S715 | Sugiyama | RPS6KA3 ISPK1 MAPKAPK1B RSK2 | APHLVKGAMAAtysALNRNQsPVLEPVGRsTLAQRRGIKKI |
| P51991 | S358 | Sugiyama | HNRNPA3 HNRPA3 | QQQSNYGPMKGGsFGGRssGsPyGGGyGsGGGsGGyGsRRF |
| P52272 | S701 | Sugiyama | HNRNPM HNRPM NAGR1 | yADIKMENGKSKGCGVVKFEsPEVAERACRMMNGMKLSGRE |
| P52565 | T160 | Sugiyama | ARHGDIA GDIA1 | DKtDyMVGsYGPRAEEyEFLtPVEEAPKGMLARGsYsIKSR |
| P52948 | S623 | Sugiyama | NUP98 ADAR2 | KNLNNsNLFsPVNRDsENLAsPsEyPENGERFsFLSKPVDE |
| P53396 | S481 | Sugiyama | ACLY | ADEVAPAKKAKPAMPQDsVPsPRSLQGKSTTLFSRHTKAIV |
| P53779 | S217 | Sugiyama | MAPK10 JNK3 JNK3A PRKM10 SAPK1B | VKSDCTLKILDFGLARTAGtsFMMtPyVVtRyYRAPEVILG |
| P53779 | T216 | Sugiyama | MAPK10 JNK3 JNK3A PRKM10 SAPK1B | VVKSDCTLKILDFGLARTAGtsFMMtPyVVtRyYRAPEVIL |
| P53779 | T221 | Sugiyama | MAPK10 JNK3 JNK3A PRKM10 SAPK1B | CTLKILDFGLARTAGtsFMMtPyVVtRyYRAPEVILGMGYK |
| P53779 | T226 | Sugiyama | MAPK10 JNK3 JNK3A PRKM10 SAPK1B | LDFGLARTAGtsFMMtPyVVtRyYRAPEVILGMGYKENVDI |
| P53779 | T281 | Sugiyama | MAPK10 JNK3 JNK3A PRKM10 SAPK1B | ILFPGRDYIDQWNKVIEQLGtPCPEFMKKLQPTVRNYVENR |
| P53779 | Y223 | Sugiyama | MAPK10 JNK3 JNK3A PRKM10 SAPK1B | LKILDFGLARTAGtsFMMtPyVVtRyYRAPEVILGMGYKEN |
| P54105 | T223 | Sugiyama | CLNS1A CLCI ICLN | AGVRtEDsIRDyEDGMEVDttPtVAGQFEDADVDH______ |
| P54259 | S739 | GPS6|SIGNOR|EPSD|PSP | ATN1 D12S755E DRPLA | PPLSATQIKQEPAEEyEtPEsPVPPARsPsPPPKVVDVPSH |
| P54652 | T229 | Sugiyama | HSPA2 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVSHLAEEFK |
| P54652 | T39 | Sugiyama | HSPA2 | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P54652 | T46 | Sugiyama | HSPA2 | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPTN |
| P54652 | Y42 | Sugiyama | HSPA2 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P54727 | T155 | Sugiyama | RAD23B | SEPAPASAAKQEKPAEKPAEtPVAtsPtAtDstsGDssRSN |
| P54727 | T162 | Sugiyama | RAD23B | AAKQEKPAEKPAEtPVAtsPtAtDstsGDssRSNLFEDATS |
| P55036 | S115 | Sugiyama | PSMD4 MCB1 | LALKHRQGKNHKMRIIAFVGsPVEDNEKDLVKLAKRLKKEK |
| P55060 | T341 | Sugiyama | CSE1L CAS XPO2 | LASVCERPHYKNLFEDQNtLtsICEKVIVPNMEFRAADEEA |
| P55072 | T76 | Sugiyama | VCP HEL-220 HEL-S-70 | TVLLKGKKRREAVCIVLSDDtCSDEKIRMNRVVRNNLRVRL |
| P55209 | T62 | Sugiyama | NAP1L1 NRP | MMQNPQILAALQERLDGLVEtPtGyIEsLPRVVKRRVNALK |
| P55795 | S104 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | EVFKSNsVEMDWVLKHtGPNsPDtANDGFVRLRGLPFGCSK |
| P55795 | T100 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | HRyVEVFKSNsVEMDWVLKHtGPNsPDtANDGFVRLRGLPF |
| P55809 | S509 | Sugiyama | OXCT1 OXCT SCOT | LWEGLTVDDVQKSTGCDFAVsPKLMPMQQIAN_________ |
| P55957 | T59 | EPSD|PSP | BID | ALGHELPVLAPQWEGyDELQtDGNRssHsRLGRIEADsEsQ |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60174 | T214 | Sugiyama | TPI1 TPI | KsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLVGG |
| P60174 | T217 | Sugiyama | TPI1 TPI | VsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLVGGAsL |
| P60660 | S30 | Sugiyama | MYL6 | AEFKEAFQLFDRtGDGKILysQCGDVMRALGQNPtNAEVLK |
| P60709 | S199 | Sugiyama | ACTB | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P60709 | S368 | Sugiyama | ACTB | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60709 | T202 | Sugiyama | ACTB | GRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVALD |
| P60709 | T249 | Sugiyama | ACTB | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P60709 | T318 | Sugiyama | ACTB | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P60709 | T89 | Sugiyama | ACTB | YPIEHGIVTNWDDMEKIWHHtFyNELRVAPEEHPVLLtEAP |
| P60709 | Y240 | Sugiyama | ACTB | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P60709 | Y362 | Sugiyama | ACTB | GGsILAsLstFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P60709 | Y91 | Sugiyama | ACTB | IEHGIVTNWDDMEKIWHHtFyNELRVAPEEHPVLLtEAPLN |
| P60866 | T6 | Sugiyama | RPS20 | _______________MAFKDtGKtPVEPEVAIHRIRITLTS |
| P61247 | S237 | Sugiyama | RPS3A FTE1 MFTL | MLKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGyE |
| P61247 | S263 | Sugiyama | RPS3A FTE1 MFTL | GDEtGAKVERADGyEPPVQEsV___________________ |
| P61254 | S32 | Sugiyama | RPL26 | sKNRKRHFNAPsHIRRKIMssPLSKELRQKYNVRSMPIRKD |
| P61604 | S64 | Sugiyama | HSPE1 | AtVVAVGsGsKGKGGEIQPVsVKVGDKVLLPEyGGtKVVLD |
| P61916 | S40 | Sugiyama | NPC2 HE1 | EPVQFKDCGsVDGVIKEVNVsPCPtQPCQLSKGQSYSVNVT |
| P61978 | S216 | SIGNOR|EPSD|PSP | HNRNPK HNRPK | GGKPDRVVECIKIILDLIsEsPIKGRAQPyDPNFyDETyDy |
| P61978 | S284 | Sugiyama | HNRNPK HNRPK | MPPGRGGRPMPPSRRDyDDMsPRRGPPPPPPGRGGRGGsRA |
| P61978 | S353 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | HNRNPK HNRPK | YDGMVGFSADETWDSAIDtWsPSEWQMAYEPQGGSGYDYSY |
| P61978 | S77 | Sugiyama | HNRNPK HNRPK | VIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIETI |
| P62195 | T109 | Sugiyama | PSMC5 SUG1 | VHPEGKFVVDVDKNIDINDVtPNCRVALRNDsytLHKILPN |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | T208 | Sugiyama | YWHAE | PDRACRLAKAAFDDAIAELDtLsEEsyKDstLIMQLLRDNL |
| P62263 | S137 | Sugiyama | RPS14 PRO2640 | RALARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL______ |
| P62263 | T133 | Sugiyama | RPS14 PRO2640 | QsALRALARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL__ |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P62714 | S212 | Sugiyama | PPP2CB | EGPMCDLLWSDPDDRGGWGIsPRGAGYTFGQDISETFNHAN |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62736 | T251 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P62736 | T320 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P62736 | Y242 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P62750 | S43 | Sugiyama | RPL23A | KAKKAVLKGVHSHKKKKIRtsPTFRRPKTLRLRRQPKYPRK |
| P62829 | S115 | Sugiyama | RPL23 | FLYFEDNAGVIVNNKGEMKGsAItGPVAKECADLWPRIASN |
| P62829 | T118 | Sugiyama | RPL23 | FEDNAGVIVNNKGEMKGsAItGPVAKECADLWPRIASNAGs |
| P62899 | T119 | Sugiyama | RPL31 | PNKLytLVtyVPVttFKNLQtVNVDEN______________ |
| P62942 | S9 | Sugiyama | FKBP1A FKBP1 FKBP12 | ____________MGVQVEtIsPGDGRtFPKRGQtCVVHytG |
| P63104 | S184 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | YWHAZ | HPIRLGLALNFSVFYYEILNsPEKACSLAKtAFDEAIAELD |
| P63104 | S28 | Sugiyama | YWHAZ | QKAKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAy |
| P63261 | S199 | Sugiyama | ACTG1 ACTG | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P63261 | S368 | Sugiyama | ACTG1 ACTG | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63261 | T202 | Sugiyama | ACTG1 ACTG | GRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVALD |
| P63261 | T249 | Sugiyama | ACTG1 ACTG | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P63261 | T318 | Sugiyama | ACTG1 ACTG | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P63261 | T89 | Sugiyama | ACTG1 ACTG | YPIEHGIVTNWDDMEKIWHHtFyNELRVAPEEHPVLLtEAP |
| P63261 | Y240 | Sugiyama | ACTG1 ACTG | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P63261 | Y362 | Sugiyama | ACTG1 ACTG | GGsILAsLstFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P63261 | Y91 | Sugiyama | ACTG1 ACTG | IEHGIVTNWDDMEKIWHHtFyNELRVAPEEHPVLLtEAPLN |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P63267 | T250 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P63267 | T319 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P63267 | Y241 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P67775 | S212 | Sugiyama | PPP2CA | EGPMCDLLWSDPDDRGGWGIsPRGAGYTFGQDISETFNHAN |
| P67809 | S102 | Sugiyama | YBX1 NSEP1 YB1 | EDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEA |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68032 | T251 | Sugiyama | ACTC1 ACTC | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68032 | T320 | Sugiyama | ACTC1 ACTC | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68032 | T91 | Sugiyama | ACTC1 ACTC | yPIEHGIItNWDDMEKIWHHtFyNELRVAPEEHPtLLTEAP |
| P68032 | Y242 | Sugiyama | ACTC1 ACTC | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68032 | Y93 | Sugiyama | ACTC1 ACTC | IEHGIItNWDDMEKIWHHtFyNELRVAPEEHPtLLTEAPLN |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | T251 | Sugiyama | ACTA1 ACTA | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68133 | T320 | Sugiyama | ACTA1 ACTA | VMSGGTTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68133 | T91 | Sugiyama | ACTA1 ACTA | yPIEHGIItNWDDMEKIWHHtFyNELRVAPEEHPtLLTEAP |
| P68133 | Y242 | Sugiyama | ACTA1 ACTA | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68133 | Y93 | Sugiyama | ACTA1 ACTA | IEHGIItNWDDMEKIWHHtFyNELRVAPEEHPtLLTEAPLN |
| P68363 | S48 | Sugiyama | TUBA1B | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P68363 | T51 | Sugiyama | TUBA1B | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| P68363 | T73 | Sugiyama | TUBA1B | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| P68363 | T80 | Sugiyama | TUBA1B | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| P78316 | S96 | Sugiyama | NOP14 C4orf9 NOL14 RES4-25 | ERDKSNVFRDKRFGEyNsNMsPEEKMMKRFALEQQRHHEKK |
| P78371 | T474 | Sugiyama | CCT2 99D8.1 CCTB | AGYDSADLVAQLRAAHsEGNttAGLDMREGTIGDMAILGIT |
| P80723 | T36 | Sugiyama | BASP1 NAP22 | DEKAKEKDKKAEGAAtEEEGtPKEsEPQAAAEPAEAKEGKE |
| P85037 | T436 | Sugiyama | FOXK1 MNF | sAPAsPtHPGLMsPRsGGLQtPECLsREGsPIPHDPEFGsK |
| P85298 | S455 | SIGNOR|EPSD|PSP | ARHGAP8 | LQEAVPRTQATGLTKPTLPPsPLMAARRRL___________ |
| P98177 | S230 | SIGNOR|EPSD|PSP | FOXO4 AFX AFX1 MLLT7 | KAPKKKPSVLPAPPEGAtPtsPVGHFAKWSGSPCSRNREEA |
| P98177 | T227 | SIGNOR|EPSD|PSP | FOXO4 AFX AFX1 MLLT7 | GRSKAPKKKPSVLPAPPEGAtPtsPVGHFAKWSGSPCSRNR |
| P98177 | T451 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | FOXO4 AFX AFX1 MLLT7 | LSMIAPPPVMASAPIPKALGtPVLtPPTEAASQDRMPQDLD |
| P98177 | T455 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | FOXO4 AFX AFX1 MLLT7 | APPPVMASAPIPKALGtPVLtPPTEAASQDRMPQDLDLDMY |
| Q00610 | S886 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | IHEGCEEPAtHNALAKIyIDsNNNPERFLRENPyyDsRVVG |
| Q00613 | S363 | SIGNOR|ELM|iPTMNet | HSF1 HSTF1 | AsVTALtDARGHTDtEGRPPsPPPtstPEKCLsVACLDKNE |
| Q01082 | T2192 | Sugiyama | SPTBN1 SPTB2 | sDRKAKTALPAQsAAtLPARtQEtPsAQMEGFLNRKHEWEA |
| Q01082 | T2195 | Sugiyama | SPTBN1 SPTB2 | KAKTALPAQsAAtLPARtQEtPsAQMEGFLNRKHEWEAHNK |
| Q01130 | S212 | Sugiyama | SRSF2 SFRS2 | PPPVsKRESKSRSRsKsPPKsPEEEGAVss___________ |
| Q01814 | S1231 | Sugiyama | ATP2B2 PMCA2 | SAIDSGINLTTDtsKSATSSsPGsPIHSLEtsL________ |
| Q01814 | S1234 | Sugiyama | ATP2B2 PMCA2 | DSGINLTTDtsKSATSSsPGsPIHSLEtsL___________ |
| Q01844 | T79 | PSP | EWSR1 EWS | ATYGQTAYATSYGQPPTGYttPtAPQAYSQPVQGYGTGAYD |
| Q02952 | S483 | Sugiyama | AKAP12 AKAP250 | LVKLKEtCVsGEDPTQGADLsPDEKVLSKPPEGVVSEVEML |
| Q02952 | S569 | Sugiyama | AKAP12 AKAP250 | QVPADsPDsQEEQKGEssAssPEEPEEItCLEKGLAEVQQD |
| Q05639 | S205 | SIGNOR|EPSD|PSP | EEF1A2 EEF1AL STN | PATVPFVPISGWHGDNMLEPsPNMPWFKGWKVERKEGNASG |
| Q05639 | S358 | SIGNOR|EPSD|PSP | EEF1A2 EEF1AL STN | AQFTSQVIILNHPGQISAGYsPVIDCHTAHIACKFAELKEK |
| Q06481 | T736 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | APLP2 APPL2 | LRKRQYGtISHGIVEVDPMLtPEERHLNKMQNHGyENPtyK |
| Q07020 | S130 | Sugiyama | RPL18 | RSRILRAGGKILtFDQLALDsPKGCGtVLLsGPRKGREVYR |
| Q07020 | T122 | Sugiyama | RPL18 | ALRVTSRARSRILRAGGKILtFDQLALDsPKGCGtVLLsGP |
| Q07021 | T165 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | GEEEPSQGQKVEEQEPELtstPNFVVEVIKNDDGKKALVLD |
| Q07157 | S1619 | Sugiyama | TJP1 ZO1 | KPKyQINNISTVPKAIPVsPsAVEEDEDEDGHTVVATARGI |
| Q07157 | S912 | Sugiyama | TJP1 ZO1 | NQtyPPYsPQAQPQPIHRIDsPGFKPAsQQKAEAssPVPyL |
| Q07817 | S62 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | BCL2L1 BCL2L BCLX | ESEMEtPsAINGNPSWHLADsPAVNGATGHSSSLDAREVIP |
| Q07817 | T115 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | BCL2L1 BCL2L BCLX | DEFELRYRRAFSDLTSQLHItPGTAYQSFEQVVNELFRDGV |
| Q07817 | T47 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | BCL2L1 BCL2L BCLX | FSDVEENRTEAPEGTESEMEtPsAINGNPSWHLADsPAVNG |
| Q07820 | S121 | EPSD|PSP | MCL1 BCL2L3 | PTRRAAPLEEMEAPAADAIMsPEEELDGYEPEPLGKRPAVL |
| Q07820 | S64 | GPS6|EPSD|PSP | MCL1 BCL2L3 | ARREIGGGEAGAVIGGSAGAsPPstLtPDSRRVARPPPIGA |
| Q07820 | T163 | SIGNOR|EPSD|PSP | MCL1 BCL2L3 | LLELVGEsGNNtstDGsLPstPPPAEEEEDELYRQSLEIIS |
| Q07866 | S460 | Sugiyama | KLC1 KLC KNS2 | QKDGTsFGEyGGWyKACKVDsPtVTTtLKNLGALyRRQGKF |
| Q07960 | S51 | Sugiyama | ARHGAP1 CDC42GAP RHOGAP1 | KNWPsDEMPDFPKsDDsKsssPELVtHLKWDDPyyDIARHQ |
| Q08AD1 | S673 | Sugiyama | CAMSAP2 CAMSAP1L1 KIAA1078 | DASKFLQDyDIRTGNTREALsPCPsTVsTKSQPGSSAssss |
| Q08J23 | S743 | Sugiyama | NSUN2 SAKI TRM4 | AstGQPDNDVtEGQRAGEPNsPDAEEANsPDVtAGCDPAGV |
| Q08J23 | S751 | Sugiyama | NSUN2 SAKI TRM4 | DVtEGQRAGEPNsPDAEEANsPDVtAGCDPAGVHPPR____ |
| Q09666 | T3716 | Sugiyama | AHNAK PM227 | VEGDLKGPEVDIKGPKVDIDtPDINIEGsEGKFKGPKFKIP |
| Q09666 | T4100 | Sugiyama | AHNAK PM227 | VDVNLPKADIDVsGPKVDIDtPDIDIHGPEGKLKGPKFKMP |
| Q12765 | S322 | Sugiyama | SCRN1 KIAA0193 | RSIFKPFIFVDDVKLVPKtQsPCFGDDDPAKKEPRFQEKPD |
| Q12765 | T320 | Sugiyama | SCRN1 KIAA0193 | PSRSIFKPFIFVDDVKLVPKtQsPCFGDDDPAKKEPRFQEK |
| Q12774 | S445 | Sugiyama | ARHGEF5 TIM | ASYLMTQIPGTQTESRAEELsPAALsPsLEPIRCSHQPISL |
| Q12774 | S450 | Sugiyama | ARHGEF5 TIM | TQIPGTQTESRAEELsPAALsPsLEPIRCSHQPISLLGsFL |
| Q12792 | S143 | Sugiyama | TWF1 PTK9 | GTVKEDVSLHGYKKyLLsQssPAPLtAAEEELRQIKINEVQ |
| Q12888 | S380 | Sugiyama | TP53BP1 | sDLVAPsPDAFRstPFIVPssPtEQEGRQDKPMDtsVLsEE |
| Q12904 | S140 | SIGNOR|EPSD|PSP | AIMP1 EMAP2 SCYE1 | EKKAKEKIEKKGEKKEKKQQsIAGsADSKPIDVSRLDLRIG |
| Q12931 | S568 | Sugiyama | TRAP1 HSP75 HSPC5 | ISVETDIVVDHYKEEKFEDRsPAAECLSEKETEELMAWMRN |
| Q12965 | T1011 | Sugiyama | MYO1E MYO1C | sMARPPLPRQQstssDRVsQtPEsLDFLKVPDQGAAGVRRQ |
| Q13043 | S82 | SIGNOR|EPSD|PSP | STK4 KRS2 MST1 | PVEsDLQEIIKEIsIMQQCDsPHVVKYYGSYFKNTDLWIVM |
| Q13200 | S16 | Sugiyama | PSMD2 TRAP2 | _____MEEGGRDKAPVQPQQsPAAAPGGtDEKPsGKERRDA |
| Q13263 | S512 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | RLDLDLtADsQPPVFKVFPGsttEDyNLIVIERGAAAAATG |
| Q13263 | T513 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | LDLDLtADsQPPVFKVFPGsttEDyNLIVIERGAAAAATGQ |
| Q13263 | T514 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | DLDLtADsQPPVFKVFPGsttEDyNLIVIERGAAAAATGQP |
| Q13283 | S230 | Sugiyama | G3BP1 G3BP | IQEEKPEPVLEETAPEDAQKsssPAPADIAQtVQEDLRtFs |
| Q13283 | S231 | Sugiyama | G3BP1 G3BP | QEEKPEPVLEETAPEDAQKsssPAPADIAQtVQEDLRtFsW |
| Q13283 | S232 | Sugiyama | G3BP1 G3BP | EEKPEPVLEETAPEDAQKsssPAPADIAQtVQEDLRtFsWA |
| Q13283 | T241 | Sugiyama | G3BP1 G3BP | ETAPEDAQKsssPAPADIAQtVQEDLRtFsWAsVtsKNLPP |
| Q13363 | S422 | SIGNOR|EPSD|PSP | CTBP1 CTBP | PSAMSLSHGLPPVAHPPHAPsPGQTVKPEADRDHASDQL__ |
| Q13409 | S92 | Sugiyama | DYNC1I2 DNCI2 DNCIC2 | ESPIVFSEYWVPPPMsPSSKsVStPsEAGsQDsGDGAVGsR |
| Q13409 | S97 | Sugiyama | DYNC1I2 DNCI2 DNCIC2 | FSEYWVPPPMsPSSKsVStPsEAGsQDsGDGAVGsRTLHWD |
| Q13438 | S653 | Sugiyama | OS9 | AQKERQRQKELESNYRRVWGsPGGEGTGDLDEFDF______ |
| Q13442 | S19 | Sugiyama | PDAP1 HASPP28 | __MPKGGRKGGHKGRARQytsPEEIDAQLQAEKQKAREEEE |
| Q13443 | S758 | Sugiyama | ADAM9 KIAA0021 MCMP MDC9 MLTNG | SDGKNQANPSRQPGsVPRHVsPVtPPREVPIyANRFAVPty |
| Q13443 | T761 | Sugiyama | ADAM9 KIAA0021 MCMP MDC9 MLTNG | KNQANPSRQPGsVPRHVsPVtPPREVPIyANRFAVPtyAAK |
| Q13451 | S13 | Sugiyama | FKBP5 AIG6 FKBP51 | ________MttDEGAKNNEEsPtAtVAEQGEDITsKKDRGV |
| Q13451 | T46 | Sugiyama | FKBP5 AIG6 FKBP51 | TsKKDRGVLKIVKRVGNGEEtPMIGDKVyVHYKGKLSNGKK |
| Q13459 | S1290 | Sugiyama | MYO9B MYR5 | EtPEDKsKPCGsPRVQEKPDsPGGstQIQRYLDAERLAsAV |
| Q13501 | S266 | Sugiyama | SQSTM1 ORCA OSIL | AALsPLGIEVDIDVEHGGKRsRLtPVsPEssstEEKsssQP |
| Q13501 | S272 | Sugiyama | SQSTM1 ORCA OSIL | GIEVDIDVEHGGKRsRLtPVsPEssstEEKsssQPssCCsD |
| Q13501 | T269 | Sugiyama | SQSTM1 ORCA OSIL | sPLGIEVDIDVEHGGKRsRLtPVsPEssstEEKsssQPssC |
| Q13509 | S75 | Sugiyama | TUBB3 TUBB4 | SSHKYVPRAILVDLEPGtMDsVRSGAFGHLFRPDNFIFGQS |
| Q13509 | T72 | Sugiyama | TUBB3 TUBB4 | NEASSHKYVPRAILVDLEPGtMDsVRSGAFGHLFRPDNFIF |
| Q13526 | S115 | SIGNOR|PSP | PIN1 | KIKSGEEDFEsLAsQFSDCSsAKARGDLGAFsRGQMQKPFE |
| Q13541 | S83 | Sugiyama | EIF4EBP1 | RNsPVtKtPPRDLPtIPGVtsPssDEPPMEAsQsHLRNsPE |
| Q13573 | S224 | Sugiyama | SNW1 SKIIP SKIP | KDPMEPPRFKINKKIPRGPPsPPAPVMHsPsRKMTVKEQQE |
| Q13573 | S234 | Sugiyama | SNW1 SKIIP SKIP | INKKIPRGPPsPPAPVMHsPsRKMTVKEQQEWKIPPCISNW |
| Q13610 | S57 | Sugiyama | PWP1 | AEAKEKLQEEGGGsDEEEtGsPsEDGMQsARTQARPREPLE |
| Q13884 | S87 | Sugiyama | SNTB1 SNT2B1 | SFCRGAGAGHPGAGGAQPPDsPAGVRTAFTDLPEQVPESIS |
| Q13885 | S75 | Sugiyama | TUBB2A TUBB2 | AGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q13885 | T72 | Sugiyama | TUBB2A TUBB2 | NEAAGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVF |
| Q13950 | S118 | EPSD|PSP | RUNX2 AML3 CBFA1 OSF2 PEBP2A | DNRTMVEIIADHPAELVRTDsPNFLCSVLPSHWRCNKTLPV |
| Q14103 | S190 | Sugiyama | HNRNPD AUF1 HNRPD | KRAKAMKTKEPVKKIFVGGLsPDtPEEKIREYFGGFGEVES |
| Q14103 | T193 | Sugiyama | HNRNPD AUF1 HNRPD | KAMKTKEPVKKIFVGGLsPDtPEEKIREYFGGFGEVESIEL |
| Q14135 | S149 | Sugiyama | VGLL4 KIAA0121 | LEQPLALTKNsLDAsRPAGLsPtLtPGERQQNRPSVITCAS |
| Q14135 | T153 | Sugiyama | VGLL4 KIAA0121 | LALTKNsLDAsRPAGLsPtLtPGERQQNRPSVITCASAGAR |
| Q14137 | T106 | Sugiyama | BOP1 KIAA0124 | LDDEGHSGIKKTTEEQVQAstPCPRTEMASARIGDEyAEDs |
| Q14157 | S416 | Sugiyama | UBAP2L KIAA0144 NICE4 | tQsPsLVQYDLKNPsDsAVHsPFtKRQAFtPsstMMEVFLQ |
| Q14157 | S470 | Sugiyama | UBAP2L KIAA0144 NICE4 | PPPssPLPsKstsAPQMsPGssDNQsssPQPAQQKLKQQKK |
| Q14160 | S1232 | Sugiyama | SCRIB CRIB1 KIAA0147 LAP4 SCRB1 VARTUL | AAGIGHRNsLEsIssIDRELsPEGPGKEKELPGQTLHWGPE |
| Q14160 | S1486 | Sugiyama | SCRIB CRIB1 KIAA0147 LAP4 SCRB1 VARTUL | RHQERLRVQsPEPPAPERALsPAELRALEAEKRALWRAARM |
| Q14160 | S504 | Sugiyama | SCRIB CRIB1 KIAA0147 LAP4 SCRB1 VARTUL | MKRSIEGRRsEACPCQPDsGsPLPAEEEKRLsAESGLSEDS |
| Q14204 | S2410 | Sugiyama | DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325 | GEDEAQRRRKGKEDEGEEAAsPMLQIQRDAATIMQPYFTSN |
| Q14204 | T1882 | Sugiyama | DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325 | ANAKFNyGFEyLGVQDKLVQtPLTDRCyLTMTQALEARLGG |
| Q14247 | S405 | Sugiyama | CTTN EMS1 | EEARRKLEEQARAKtQtPPVsPAPQPtEERLPssPVyEDAA |
| Q14247 | S418 | Sugiyama | CTTN EMS1 | KtQtPPVsPAPQPtEERLPssPVyEDAAsFKAELsyRGPVs |
| Q14451 | S194 | SIGNOR|EPSD|PSP | GRB7 | GGDSRFVFRKNFAKyELFKssPHSLFPEKMVSSCLDAHTGI |
| Q14568 | S50 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | MSLIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKL |
| Q14653 | S173 | SIGNOR|EPSD|PSP | IRF3 | PDPGPPSLAVAPEPCPQPLRsPsLDNPtPFPNLGPsENPLK |
| Q14677 | S164 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | RLREERKKAKKNKDKyVGVssDsVGGFRysERYDPEPKSKW |
| Q14749 | S10 | PSP | GNMT | ___________MVDSVYRtRsLGVAAEGLPDQYADGEAARV |
| Q14847 | T104 | Sugiyama | LASP1 MLN50 | VRYKEEFEKNKGKGFsVVADtPELQRIKKTQDQIsNIKyHE |
| Q14934 | S213 | GPS6|EPSD|PSP | NFATC4 NFAT3 | AACDEVESELNEAASRFGLGsPLPsPRASPRPWtPEDPWSL |
| Q14934 | S217 | GPS6|EPSD|PSP | NFATC4 NFAT3 | EVESELNEAASRFGLGsPLPsPRASPRPWtPEDPWSLYGPS |
| Q14974 | S12 | Sugiyama | KPNB1 NTF97 | _________MELITILEKtVsPDRLELEAAQKFLERAAVEN |
| Q14980 | S1757 | Sugiyama | NUMA1 NMP22 NUMA | ITSKLPRtQPDGtsVPGEPAsPIsQRLPPKVEsLEsLyFtP |
| Q14980 | T2000 | Sugiyama | NUMA1 NMP22 NUMA | GITTRQQRKRVsLEPHQGPGtPEsKKATSCFPRPMtPRDRH |
| Q15181 | S250 | Sugiyama | PPA1 IOPPP PP | LVTKKTNGKGIsCMNttLsEsPFKCDPDAARAIVDALPPPC |
| Q15181 | T245 | Sugiyama | PPA1 IOPPP PP | DHWKALVTKKTNGKGIsCMNttLsEsPFKCDPDAARAIVDA |
| Q15185 | S113 | Sugiyama | PTGES3 P23 TEBP | RAKLNWLsVDFNNWKDWEDDsDEDMsNFDRFSEMMNNMGGD |
| Q15293 | T211 | Sugiyama | RCN1 RCN | FTAFLHPEEFEHMKEIVVLEtLEDIDKNGDGFVDQDEyIAD |
| Q15293 | T71 | Sugiyama | RCN1 RCN | EDNQsFQYDHEAFLGKEDsKtFDQLtPDEsKERLGKIVDRI |
| Q15293 | T76 | Sugiyama | RCN1 RCN | FQYDHEAFLGKEDsKtFDQLtPDEsKERLGKIVDRIDNDGD |
| Q15393 | T1200 | Sugiyama | SF3B3 KIAA0017 SAP130 | EQFNsMEPNKQKNVSEELDRtPPEVSKKLEDIRTRYAF___ |
| Q15599 | S43 | Sugiyama | NHERF2 SLC9A3R2 | FHLHGEKGRRGQFIRRVEPGsPAEAAALRAGDRLVEVNGVN |
| Q15599 | T102 | Sugiyama | NHERF2 SLC9A3R2 | QTRLLVVDQETDEELRRRQLtCTEEMAQRGLPPAHDPWEPK |
| Q15637 | S80 | Sugiyama | SF1 ZFM1 ZNF162 | DLTRKLRtGDLGIPPNPEDRsPsPEPIyNsEGKRLNTREFR |
| Q15637 | S82 | Sugiyama | SF1 ZFM1 ZNF162 | TRKLRtGDLGIPPNPEDRsPsPEPIyNsEGKRLNTREFRTR |
| Q15637 | T232 | Sugiyama | SF1 ZFM1 ZNF162 | MENVKKAVEQIRNILKQGIEtPEDQNDLRKMQLRELARLNG |
| Q15642 | S298 | Sugiyama | TRIP10 CIP4 STOT STP | RPGDVEFEDFsQPMNRAPsDssLGtPsDGRPELRGPGRSRT |
| Q15642 | T302 | Sugiyama | TRIP10 CIP4 STOT STP | VEFEDFsQPMNRAPsDssLGtPsDGRPELRGPGRSRTKRWP |
| Q15654 | T27 | Sugiyama | TRIP6 OIP1 | LPPKQPEPARAPQGRAIPRGtPGPPPAHGAALQPHPRVNFC |
| Q15672 | S68 | SIGNOR|EPSD|PSP | TWIST1 BHLHA38 TWIST | GGAGPGGAAGGGVGGGDEPGsPAQGKRGKKSAGCGGGGGAG |
| Q15717 | S221 | PSP | ELAVL1 HUR | HsPARRFGGPVHHQAQRFRFsPMGVDHMSGLSGVNVPGNAS |
| Q15750 | S438 | PSP | TAB1 MAP3K7IP1 | VNGAHsASTLDEAtPTLTNQsPTLTLQSTNTHTQssSSssD |
| Q15773 | S238 | Sugiyama | MLF2 | GAGGRRAEGPPRLAIQGPEDsPsRQsRRYDW__________ |
| Q15814 | S330 | Sugiyama | TBCC | RSKNNWNDVDDFNWLARDMAsPNWsILPEEERNIQWD____ |
| Q16204 | S244 | Sugiyama | CCDC6 D10S170 TST1 | LEAEKRILQEKLDQPVsAPPsPRDIsMEIDsPENMMRHIRF |
| Q16236 | S215 | PSP | NFE2L2 NRF2 | PELQCLNIENDKLVETtMVPsPEAKLTEVDNYHFYSSIPSM |
| Q16236 | S408 | PSP | NFE2L2 NRF2 | VKQNGPKtPVHSSGDMVQPLsPSQGQSTHVHDAQCENTPEK |
| Q16236 | S577 | PSP | NFE2L2 NRF2 | LstLYLEVFSMLRDEDGKPysPSEYSLQQTRDGNVFLVPKS |
| Q16513 | T121 | Sugiyama | PKN2 PRK2 PRKCL2 | QELNAHIVVsDPEDItDCPRtPDtPNNDPRCSTSNNRLKAL |
| Q16513 | T124 | Sugiyama | PKN2 PRK2 PRKCL2 | NAHIVVsDPEDItDCPRtPDtPNNDPRCSTSNNRLKALQKQ |
| Q16621 | S157 | SIGNOR|EPSD|PSP | NFE2 | KPQEDPESDSGLSLNYSDAEsLELEGTEAGRRRSEYVEMYP |
| Q16621 | S346 | PSP | NFE2 | LTELYRDIFQHLRDESGNSYsPEEYALQQAADGTIFLVPRG |
| Q16630 | T157 | Sugiyama | CPSF6 CFIM68 | SKKLMDLLPKRELHGQNPVVtPCNKQFLsQFEMQSRKTTQS |
| Q16643 | T346 | Sugiyama | DBN1 D0S117E | RRMAPtPIPtRsPsDsstAstPVAEQIERALDEVTsSQPPP |
| Q16658 | S127 | Sugiyama | FSCN1 FAN1 HSN SNL | AHRRYFGGtEDRLsCFAQtVsPAEKWSVHIAMHPQVNIYSV |
| Q16719 | S443 | Sugiyama | KYNU | VVCDKRNPNGIRVAPVPLyNsFHDVyKFTNLLtsILDsAET |
| Q16719 | Y448 | Sugiyama | KYNU | RNPNGIRVAPVPLyNsFHDVyKFTNLLtsILDsAETKN___ |
| Q16881 | T413 | Sugiyama | TXNRD1 GRIM12 KDRF | HGIKFIRQFVPIKVEQIEAGtPGRLRVVAQSTNSEEIIEGE |
| Q4KMP7 | T150 | Sugiyama | TBC1D10B FP2461 | ADsPKtEEARPsPAPGPGtPtGtPtRtPsRtAPGALTAKPP |
| Q4V328 | S655 | Sugiyama | GRIPAP1 KIAA1167 | ILTNSKSRSGLEELVLsEMNsPSRtQtGDsssIssFsYREI |
| Q53EZ4 | S425 | Sugiyama | CEP55 C10orf3 URCC6 | ITEPLVTFQGETENREKVAAsPKsPtAALNEsLVECPKCNI |
| Q53EZ4 | T430 | Sugiyama | CEP55 C10orf3 URCC6 | VTFQGETENREKVAAsPKsPtAALNEsLVECPKCNIQYPAT |
| Q53GS7 | S88 | PSP | GLE1 GLE1L | ETSPSSTSASALDQPSFVPKsPDAssAFsPAsPAtPNGTKG |
| Q53GS7 | S92 | PSP | GLE1 GLE1L | SSTSASALDQPSFVPKsPDAssAFsPAsPAtPNGTKGKDES |
| Q53GS7 | S93 | PSP | GLE1 GLE1L | STSASALDQPSFVPKsPDAssAFsPAsPAtPNGTKGKDESQ |
| Q53GS7 | S99 | PSP | GLE1 GLE1L | LDQPSFVPKsPDAssAFsPAsPAtPNGTKGKDESQHTESMV |
| Q53GS7 | T102 | PSP | GLE1 GLE1L | PSFVPKsPDAssAFsPAsPAtPNGTKGKDESQHTESMVLQS |
| Q562R1 | T107 | Sugiyama | ACTBL2 | WYHTFYNELRVAPDEHPILLtEAPLNPKINREKMTQIMFEA |
| Q562R1 | T250 | Sugiyama | ACTBL2 | RAAAssSPERsyELPDGQVItIGNERFRCPEAIFQPSFLGI |
| Q562R1 | Y241 | Sugiyama | ACTBL2 | ALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPEA |
| Q58FF7 | S370 | Sugiyama | HSP90AB3P HSP90BC | KETQKSTYYITGESKEQVANsAFVERVRKQGFEVVYMTEPI |
| Q5JR12 | S93 | SIGNOR | PPM1J PPP2CZ | LQLsPGGLRRADDHAGRAVQsPPDTGRRLPWSTGYAEVINA |
| Q5JSH3 | S50 | Sugiyama | WDR44 RPH11 | KVGLSTFKETENTAYKVGNEsPVQELKQDVSKKIIEsIIEE |
| Q5JSH3 | S96 | Sugiyama | WDR44 RPH11 | QLEDDsLDSKGKELsDQAtAsPIVARTDLSNIPGLLAIDQV |
| Q5JSH3 | T364 | Sugiyama | WDR44 RPH11 | sGRELtDEEILASVMIKNLDtGEEIPLsLAEEKLPTGINPL |
| Q5JTZ9 | T670 | Sugiyama | AARS2 AARSL KIAA1270 | TEQQGSHLNPEQLRLDVTTQtPLtPEQLRAVENTVQEAVGQ |
| Q5JTZ9 | T673 | Sugiyama | AARS2 AARSL KIAA1270 | QGSHLNPEQLRLDVTTQtPLtPEQLRAVENTVQEAVGQDEA |
| Q5R3I4 | S362 | Sugiyama | TTC38 | GAHDPQTTQELLTTLRDASEsPGENCQHLLARDVGLPLCQA |
| Q5T4S7 | S178 | Sugiyama | UBR4 KIAA0462 KIAA1307 RBAF600 | AKLPQTVKTLSDVEDQKELAsPVsPELRQKEVQMNFLNQLT |
| Q5VT52 | T723 | Sugiyama | RPRD2 KIAA0460 HSPC099 | SHPSDFQRGPtstsIDNIDGtPVRDERsGtPtQDEMMDKPt |
| Q66K74 | S759 | Sugiyama | MAP1S BPY2IP1 C19orf5 MAP8 VCY2IP1 | LVsPCEFEHRKAVPMAPAPAsPGssNDssARsQERAGGLGA |
| Q68CZ2 | S660 | Sugiyama | TNS3 TEM6 TENS1 TPP | RVAVQRGVGsGPHPPDTQQPsPsKAFKPRFPGDQVVNGAGP |
| Q6EMK4 | S322 | Sugiyama | VASN SLITL2 UNQ314/PRO357/PRO1282 | CVCPLSWFGPWVRESHVTLAsPEETRCHFPPKNAGRLLLEL |
| Q6FI81 | T136 | Sugiyama | CIAPIN1 CUA001 PRO0915 | CSALTLSGLVEVKELQREPLtPEEVQSVREHLGHESDNLLF |
| Q6JBY9 | S216 | GPS6|SIGNOR | RCSD1 CAPZIP | NGAKEEDGDEVLPSKsKAPGsPLssEGAAGEGVRTLGPAEK |
| Q6JBY9 | S68 | GPS6|SIGNOR | RCSD1 CAPZIP | PCSLPLFPPKVDLGQNGEEKsPPNAsHPPKFKVKssPLIEK |
| Q6JBY9 | S83 | GPS6|SIGNOR | RCSD1 CAPZIP | NGEEKsPPNAsHPPKFKVKssPLIEKLQANLTFDPAALLPG |
| Q6PEY2 | S48 | Sugiyama | TUBA3E | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q6PEY2 | T51 | Sugiyama | TUBA3E | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q6PKG0 | S627 | Sugiyama | LARP1 KIAA0731 LARP | FLFDEEMEQMDGRKNtFtAWsDEEsDyEIDDRDVNKILIVt |
| Q6PKG0 | S631 | Sugiyama | LARP1 KIAA0731 LARP | EEMEQMDGRKNtFtAWsDEEsDyEIDDRDVNKILIVtQtPH |
| Q6S8J3 | S1068 | Sugiyama | POTEE A26C1A POTE2 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q6S8J3 | T789 | Sugiyama | POTEE A26C1A POTE2 | YPMEHGIITNWDDMEKIWHHtFyNELRVAPEEHPILLTEAP |
| Q6S8J3 | T949 | Sugiyama | POTEE A26C1A POTE2 | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q6S8J3 | Y1062 | Sugiyama | POTEE A26C1A POTE2 | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| Q6S8J3 | Y791 | Sugiyama | POTEE A26C1A POTE2 | MEHGIITNWDDMEKIWHHtFyNELRVAPEEHPILLTEAPLN |
| Q6S8J3 | Y940 | Sugiyama | POTEE A26C1A POTE2 | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| Q6SZW1 | S548 | SIGNOR|PSP | SARM1 KIAA0524 SAMD2 SARM | GIHLGVHRARILTAAREMLHsPLPCTGGKPSGDTPDVFISY |
| Q6WCQ1 | S326 | Sugiyama | MPRIP KIAA0864 MRIP RHOIP3 | KFEALDIEKAEHMETNAVGPsPssDTRQGRSEKRAFPRKRD |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q71U36 | S48 | Sugiyama | TUBA1A TUBA3 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q71U36 | T51 | Sugiyama | TUBA1A TUBA3 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q71U36 | T73 | Sugiyama | TUBA1A TUBA3 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q71U36 | T80 | Sugiyama | TUBA1A TUBA3 | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| Q7KZF4 | T103 | EPSD|PSP | SND1 TDRD11 | REFLRKKLIGKEVCFtIENKtPQGREyGMIyLGKDTNGENI |
| Q7L2J0 | S217 | Sugiyama | MEPCE BCDIN3 | LNSLLDEEVSRtLNAEtPKssPLPAKGRDPVEILIPKDItD |
| Q7L2J0 | T213 | Sugiyama | MEPCE BCDIN3 | DPLNLNSLLDEEVSRtLNAEtPKssPLPAKGRDPVEILIPK |
| Q7Z2W4 | S275 | Sugiyama | ZC3HAV1 ZC3HDC2 PRO1677 | QGsQEFLASASAsAERsCtPsPDQIsHRAsLEDAPVDDLtR |
| Q7Z2W4 | T273 | Sugiyama | ZC3HAV1 ZC3HDC2 PRO1677 | FFQGsQEFLASASAsAERsCtPsPDQIsHRAsLEDAPVDDL |
| Q7Z3J3 | T1475 | Sugiyama | RGPD4 RGP4 | DSFKKIFDEAKTAQEKDsLItPHVsRsstPREsPCGKIAVA |
| Q7Z417 | S692 | Sugiyama | NUFIP2 KIAA1321 PIG1 | IWNLQKQDPKRIItyNEAMDsPDQ_________________ |
| Q7Z4H7 | T858 | Sugiyama | HAUS6 DGT6 FAM29A KIAA1574 | EALKKSLSKKREESyLSNsQtPERHKPELsPtPQNVQtDDt |
| Q7Z4V5 | S183 | Sugiyama | HDGFL2 HDGF2 HDGFRP2 HRP2 UNQ785/PRO1604 | KMsVSKRARKASSDLDQAsVsPSEEENSESSsESEKTsDQD |
| Q7Z6Z7 | T2889 | Sugiyama | HUWE1 KIAA0312 KIAA1578 UREB1 HSPC272 | EAVGDTSAAGSSEQPRAGsstPGDAPPAVAEVQGRSDGsGE |
| Q86TX2 | S298 | Sugiyama | ACOT1 CTE1 | NRNRIKVTKDGyADIVDVLNsPLEGPDQKSFIPVERAESTF |
| Q86UE4 | T143 | Sugiyama | MTDH AEG1 LYRIC | SEKPKPNGRTVEVAEGEAVRtPQsVtAKQPPEIDKKNEKSK |
| Q86UY5 | S353 | Sugiyama | FAM83A TSGP | NPFSGRSAGSHPGTRsVsAssGPCsPAAPHPPPPPRFQPHQ |
| Q86UY5 | S357 | Sugiyama | FAM83A TSGP | GRSAGSHPGTRsVsAssGPCsPAAPHPPPPPRFQPHQGPWG |
| Q86VQ1 | T350 | Sugiyama | GLCCI1 | RRAPLPAHYRssstRsIDTQtPsVQERSSSCSSHSPCVSPF |
| Q86X29 | T501 | Sugiyama | LSR ILDR3 LISCH | GGGWRARRPRARsVDALDDLtPPstAEsGsRsPtsNGGRSR |
| Q8IWW6 | S240 | Sugiyama | ARHGAP12 | SSSsTEQIRAttPPNQGRPDsPVyANLQELKISQSALPPLP |
| Q8IWW6 | T231 | Sugiyama | ARHGAP12 | QDSEsGDELSSSsTEQIRAttPPNQGRPDsPVyANLQELKI |
| Q8N122 | S696 | EPSD|PSP | RPTOR KIAA1303 RAPTOR | SNFCTVALQFIEEEKNYALPsPATTEGGSLtPVRDsPCtPR |
| Q8N122 | S863 | EPSD|PSP | RPTOR KIAA1303 RAPTOR | VNARPQRVLDtssLtQsAPAsPtNKGVHIHQAGGsPPAsst |
| Q8N122 | T706 | EPSD|PSP | RPTOR KIAA1303 RAPTOR | IEEEKNYALPsPATTEGGSLtPVRDsPCtPRLRsVssYGNI |
| Q8N1F7 | S430 | Sugiyama | NUP93 KIAA0095 | TEDYLWLKLNQVCFDDDGTssPQDRLTLsQFQKQLLEDYGE |
| Q8N684 | T203 | Sugiyama | CPSF7 | GGIPPRAHsRDssDsADGRAtPsENLVPSSARVDKPPSVLP |
| Q8N6T7 | S10 | EPSD|PSP | SIRT6 SIR2L6 | ___________MSVNYAAGLsPYADKGKCGLPEIFDPPEEL |
| Q8NBJ5 | S612 | Sugiyama | COLGALT1 GLT25D1 PSEC0241 | QKMREQQALSREAKNsDVLQsPLDsAARDEL__________ |
| Q8NBJ5 | S616 | Sugiyama | COLGALT1 GLT25D1 PSEC0241 | EQQALSREAKNsDVLQsPLDsAARDEL______________ |
| Q8NBJ7 | S44 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | NGQATSMVQLQGGRFLMGtNsPDSRDGDGPVREATVKPFAI |
| Q8NBJ7 | T278 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | IDtADGsANHRARVttRMGNtPDsAsDNLGFRCAADAGRPP |
| Q8NEY1 | S1000 | Sugiyama | NAV1 KIAA1151 KIAA1213 POMFIL3 STEERIN1 | PsPPALPMSLSAKGQLTNIVsPtAAttPRITRsNsIPTHEA |
| Q8NEY1 | S1377 | Sugiyama | NAV1 KIAA1151 KIAA1213 POMFIL3 STEERIN1 | DRLKVAPGPSSGstPGQVPGssALssPRRSLGLALTHSFGP |
| Q8NEY1 | T1006 | Sugiyama | NAV1 KIAA1151 KIAA1213 POMFIL3 STEERIN1 | PMSLSAKGQLTNIVsPtAAttPRITRsNsIPTHEAAFELYS |
| Q8NEY1 | T1370 | Sugiyama | NAV1 KIAA1151 KIAA1213 POMFIL3 STEERIN1 | DLLKAENDRLKVAPGPSSGstPGQVPGssALssPRRSLGLA |
| Q8NG08 | S1021 | Sugiyama | HELB | SEASSPDERTLTFAERWQLssPDGVDtDDDLPKSRASKRTC |
| Q8TAQ2 | S283 | Sugiyama | SMARCC2 BAF170 | KNPVSRRKKISAKtLtDEVNsPDsDRRDKKGGNYKKRKRsP |
| Q8TAQ2 | S286 | Sugiyama | SMARCC2 BAF170 | VSRRKKISAKtLtDEVNsPDsDRRDKKGGNYKKRKRsPsPs |
| Q8TC07 | S675 | Sugiyama | TBC1D15 | TSAFQSNALPTLSASGARNDsPtQIPVssDVCRLtPA____ |
| Q8TCS8 | S754 | Sugiyama | PNPT1 PNPASE | KYFGRDPADGRMRLSRKVLQsPAtTVVRTLNDRssIVMGEP |
| Q8TD19 | S29 | Sugiyama | NEK9 KIAA1995 NEK8 NERCC | RHCDsINSDFGSEsGGCGDssPGPSASQGPRAGGGAAEQEE |
| Q8WUF5 | S567 | Sugiyama | PPP1R13L IASPP NKIP1 PPP1R13BL RAI | ISRLFHRHGGPGPGGPEPELsPItEGSEARAGPPAPAPPAP |
| Q8WUI4 | S109 | Sugiyama | HDAC7 HDAC7A | LAEVILKKQQAALERtVHPNsPGIPYRTLEPLETEGATRSM |
| Q8WUM4 | S730 | Sugiyama | PDCD6IP AIP1 ALIX KIAA1375 | QQsIAREPsAPsIPtPAyQssPAGGHAPtPPtPAPRTMPPT |
| Q8WUM4 | T738 | Sugiyama | PDCD6IP AIP1 ALIX KIAA1375 | sAPsIPtPAyQssPAGGHAPtPPtPAPRTMPPTKPQPPARP |
| Q8WUM4 | T741 | Sugiyama | PDCD6IP AIP1 ALIX KIAA1375 | sIPtPAyQssPAGGHAPtPPtPAPRTMPPTKPQPPARPPPP |
| Q8WW01 | T10 | Sugiyama | TSEN15 C1orf19 SEN15 | ___________MEERGDsEPtPGCSGLGPGGVRGFGDGGGA |
| Q8WW12 | T139 | Sugiyama | PCNP | sEPEEMPPEAKMRMKNIGRDtPtsAGPNsFNKGKHGFsDNQ |
| Q8WWM7 | S111 | Sugiyama | ATXN2L A2D A2LG A2LP A2RP | PGAAAIGsARGQstGKGPPQsPVFEGVyNNSRMLHFLTAVV |
| Q8WWM7 | S589 | Sugiyama | ATXN2L A2D A2LG A2LP A2RP | PRILKEEPKGKEKEVDGLLtsEPMGsPVssKtEsVsDKEDK |
| Q8WWM7 | S594 | Sugiyama | ATXN2L A2D A2LG A2LP A2RP | EEPKGKEKEVDGLLtsEPMGsPVssKtEsVsDKEDKPPLAP |
| Q8WXI9 | S122 | Sugiyama | GATAD2B KIAA1150 | DEPVDMSARRsEPERGRLtPsPDIIVLsDNEAssPRsSsRM |
| Q8WXI9 | S135 | Sugiyama | GATAD2B KIAA1150 | ERGRLtPsPDIIVLsDNEAssPRsSsRMEERLKAANLEMFK |
| Q8WYK2 | T148 | GPS6|iPTMNet | JDP2 | LILMLNRHRPTCIVRTDsVKtPEsEGNPLLEQLEKK_____ |
| Q8WYQ5 | S153 | EPSD|PSP | DGCR8 C22orf12 DGCRK6 LP4941 | RKVLYTGAERDVRAECGLLLsPVSGDVHACPFGGSVGDGVG |
| Q92530 | S152 | Sugiyama | PSMF1 | SRIVSGIITPIHEQWEKANVssPHREFPPAtAREVDPLRIP |
| Q92530 | S153 | Sugiyama | PSMF1 | RIVSGIITPIHEQWEKANVssPHREFPPAtAREVDPLRIPP |
| Q92609 | S539 | Sugiyama | TBC1D5 KIAA0210 | KsEsMPVQLNKGLSSKNIsssPsVEsLPGGREFtGsPPssA |
| Q92614 | S164 | Sugiyama | MYO18A CD245 KIAA0216 MYSPDZ TIAF1 | RsRDEsAsEtstPsEHsAAPsPQVEVRTLEGQLVQHPGPGI |
| Q92871 | S242 | Sugiyama | PMM1 PMMH22 | PGGNDFEIFADPRTVGHSVVsPQDtVQRCREIFFPETAHEA |
| Q92879 | S179 | Sugiyama | CELF1 BRUNOL2 CUGBP CUGBP1 NAB50 | AMAQTAIKAMHQAQtMEGCssPMVVKFADTQKDKEQKRMAQ |
| Q92922 | T335 | Sugiyama | SMARCC1 BAF155 | DRKASANARKRKHsPsPPPPtPtEsRKKSGKKGQASLYGKR |
| Q92945 | S181 | Sugiyama | KHSRP FUBP2 | GRGGEQINKIQQDSGCKVQIsPDsGGLPERsVsLtGAPEsV |
| Q92945 | S184 | Sugiyama | KHSRP FUBP2 | GEQINKIQQDSGCKVQIsPDsGGLPERsVsLtGAPEsVQKA |
| Q93045 | S73 | PSP | STMN2 SCG10 SCGN10 | AFELILKPPsPISEAPRTLAsPKKKDLsLEEIQKKLEAAEE |
| Q969R2 | S762 | PSP | OSBP2 KIAA1664 ORP4 OSBPL4 | AHYVLSGSWDEQMECSKVMHssPssPsSDGKQKTVYQTLSA |
| Q969R2 | S763 | PSP | OSBP2 KIAA1664 ORP4 OSBPL4 | HYVLSGSWDEQMECSKVMHssPssPsSDGKQKTVYQTLSAK |
| Q969R2 | S766 | PSP | OSBP2 KIAA1664 ORP4 OSBPL4 | LSGSWDEQMECSKVMHssPssPsSDGKQKTVYQTLSAKLLW |
| Q969R2 | S768 | PSP | OSBP2 KIAA1664 ORP4 OSBPL4 | GSWDEQMECSKVMHssPssPsSDGKQKTVYQTLSAKLLWKK |
| Q96AE4 | S630 | Sugiyama | FUBP1 | DYSAAWAEYYRQQAAyyAQtsPQGMPQHPPAPQGQ______ |
| Q96B36 | S212 | Sugiyama | AKT1S1 PRAS40 | GFKEKRtEARssDEENGPPssPDLDRIAAsMRALVLREAED |
| Q96C19 | S74 | Sugiyama | EFHD2 SWS1 | ELSAKLLRRADLNQGIGEPQsPsRRVFNPytEFKEFSRKQI |
| Q96D15 | T72 | Sugiyama | RCN3 UNQ239/PRO272 | FQYDHEAFLGREVAKEFDQLtPEEsQARLGRIVDRMDRAGD |
| Q96EB6 | S27 | GPS6|SIGNOR|EPSD|PSP | SIRT1 SIR2L1 | LALQPGGsPsAAGADREAAssPAGEPLRKRPRRDGPGLERs |
| Q96EB6 | S47 | GPS6|SIGNOR|EPSD|PSP | SIRT1 SIR2L1 | sPAGEPLRKRPRRDGPGLERsPGEPGGAAPEREVPAAARGC |
| Q96EB6 | T530 | GPS6|SIGNOR|EPSD|PSP | SIRT1 SIR2L1 | ITEKPPRTQKELAYLSELPPtPLHVsEDsssPERtsPPDss |
| Q96EK9 | S184 | Sugiyama | KTI12 SBBI81 | GSAQADVPKELEREEsGAAEsPALVtPDSEKSAKHGsGAFy |
| Q96EK9 | T189 | Sugiyama | KTI12 SBBI81 | DVPKELEREEsGAAEsPALVtPDSEKSAKHGsGAFysPELL |
| Q96EN8 | S530 | Sugiyama | MOCOS | APSADSQADVIPAVMGRRsLsPQEDALTGSRVWNNSSTVNA |
| Q96FI4 | S207 | EPSD|PSP | NEIL1 | KIPPFEKARSVLEALQQHRPsPELTLSQKIRTKLQNPDLLE |
| Q96FI4 | S306 | EPSD|PSP | NEIL1 | GPLAPKGRKSRKKKSKATQLsPEDRVEDALPPSKAPSRTRR |
| Q96FI4 | S61 | EPSD|PSP | NEIL1 | ESSAYRISASARGKELRLILsPLPGAQPQQEPLALVFRFGM |
| Q96GM8 | S425 | Sugiyama | TOE1 | MGIKAARPEIADRATsEVPGsQAsPNPVPGDGLHRAGFDAF |
| Q96GM8 | S428 | Sugiyama | TOE1 | KAARPEIADRATsEVPGsQAsPNPVPGDGLHRAGFDAFMTG |
| Q96HN2 | S107 | Sugiyama | AHCYL2 KIAA0828 | KRSDPHHQHQRHRDGGEALVsPDGTVTEAPRTVKKQIQFAD |
| Q96I25 | S222 | PSP | RBM17 SPF45 | sQsSKAAIPPPVyEEQDRPRsPtGPsNsFLANMGGTVAHKI |
| Q96I25 | T71 | PSP | RBM17 SPF45 | LAPVIDLKRGGssDDRQIVDtPPHVAAGLKDPVPSGFSAGE |
| Q96J02 | S240 | SIGNOR | ITCH | GsDDPEDAGAGENRRVsGNNsPsLSNGGFKPSRPPRPsRPP |
| Q96J02 | S273 | SIGNOR | ITCH | PPRPsRPPPPtPRRPASVNGsPSATSESDGSSTGSLPPTNT |
| Q96J02 | T263 | SIGNOR | ITCH | LSNGGFKPSRPPRPsRPPPPtPRRPASVNGsPSATSESDGS |
| Q96K76 | S910 | Sugiyama | USP47 | DGDNGDssKstEtsDFENIEsPLNERDsSAsVDNRELEQHI |
| Q96LC9 | S74 | iPTMNet|EPSD|PSP | BMF | HCCGPGLRPTSQEDKATQTLsPAsPsQGVMLPCGVTEEPQR |
| Q96LC9 | S77 | iPTMNet | BMF | GPGLRPTSQEDKATQTLsPAsPsQGVMLPCGVTEEPQRLFY |
| Q96MH2 | S29 | Sugiyama | HEXIM2 L3 | ACNAEsPVALEEAKtsGAPGsPQtPPERHDsGGsLPLtPRM |
| Q96MH2 | S39 | Sugiyama | HEXIM2 L3 | EEAKtsGAPGsPQtPPERHDsGGsLPLtPRMEsHsEDEDLA |
| Q96MH2 | S76 | Sugiyama | HEXIM2 L3 | EDLAGAVGGLGWNsRsPRtQsPGGCsAEAVLARKKHRRRPS |
| Q96MH2 | T32 | Sugiyama | HEXIM2 L3 | AEsPVALEEAKtsGAPGsPQtPPERHDsGGsLPLtPRMEsH |
| Q96N67 | S241 | Sugiyama | DOCK7 KIAA1771 | RQNDDQRKSNRHKELFALHPsPDEEEPIERLSVPDIPKEHF |
| Q96P20 | S198 | SIGNOR|EPSD|PSP | NLRP3 C1orf7 CIAS1 NALP3 PYPAF1 | RSQQEREQELLAIGKTKTCEsPVSPIKMELLFDPDDEHSEP |
| Q96QK1 | S783 | Sugiyama | VPS35 MEM3 TCCCTA00141 | tEQINKHFHNtLEHLRLRREsPEsEGPIyEGLIL_______ |
| Q96S44 | T8 | Sugiyama | TP53RK C20orf64 PRPK | _____________MAAARAttPADGEEPAPEAEALAAARER |
| Q96S55 | T116 | Sugiyama | WRNIP1 WHIP | GEEGDDGGETESREsyDAPPtPsGARLIPDFPVARsssPGR |
| Q96SB4 | S311 | Sugiyama | SRPK1 | EMEKESGPGQKRPNKQEEsEsPVERPLKENPPNKMtQEKLE |
| Q96ST3 | T161 | Sugiyama | SIN3A | PQVYNDFLDIMKEFKSQsIDtPGVISRVSQLFKGHPDLIMG |
| Q99460 | S315 | Sugiyama | PSMD1 | DsMEtEEKTSsAFVGKtPEAsPEPKDQTLKMIKILSGEMAI |
| Q99460 | T311 | Sugiyama | PSMD1 | EKDsDsMEtEEKTSsAFVGKtPEAsPEPKDQTLKMIKILSG |
| Q99543 | T539 | Sugiyama | DNAJC2 MPHOSPH11 MPP11 ZRF1 | KKAFDKFKKEHGVVPQADNAtPsERFEGPytDFTPWTtEEQ |
| Q99607 | S641 | EPSD|PSP | ELF4 ELFR MEF | SGSLLMAEPSVTTSGSLLTRsPtPAPFsPFNPTSLIKMEPH |
| Q99613 | S865 | Sugiyama | EIF3C EIF3S8 | HRTEPTAQQNLALQLAEKLGsLVENNERVFDHKQGtyGGyF |
| Q99666 | T1474 | Sugiyama | RGPD5 RANBP2L1 RGP5 RGP7 RGPD7; RGPD6 RANBP2L2 RGP6 | DSFKKIFDEAKTAQEKDsLItPHVsRsstPREsPCGKIAVA |
| Q9BPU6 | T509 | Sugiyama | DPYSL5 CRMP5 ULIP6 | RTPYLGDVAVVVHPGKKEMGtPLADtPtRPVTRHGGMRDLH |
| Q9BPU6 | T514 | Sugiyama | DPYSL5 CRMP5 ULIP6 | GDVAVVVHPGKKEMGtPLADtPtRPVTRHGGMRDLHEssFs |
| Q9BQ52 | S618 | Sugiyama | ELAC2 HPC2 | VLHHISMIPAKCLQEGAEIssPAVERLISSLLRTCDLEEFQ |
| Q9BQE3 | S439 | Sugiyama | TUBA1C TUBA6 | SEAREDMAALEKDyEEVGADsADGEDEGEEy__________ |
| Q9BQE3 | S48 | Sugiyama | TUBA1C TUBA6 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q9BQE3 | T51 | Sugiyama | TUBA1C TUBA6 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q9BQE3 | T73 | Sugiyama | TUBA1C TUBA6 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q9BQE3 | T80 | Sugiyama | TUBA1C TUBA6 | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| Q9BQG0 | S11 | Sugiyama | MYBBP1A P160 | __________MEsRDPAQPMsPGEAtQsGARPADRYGLLKH |
| Q9BQG0 | S1163 | Sugiyama | MYBBP1A P160 | GVQRPKLEKKDAKEIPsAtQsPIsKKRKKKGFLPETKKRKK |
| Q9BTC0 | S1471 | Sugiyama | DIDO1 C20orf158 DATF1 KIAA0333 | DVRRNsVERPAEPVAGAAtPsLVEQQKMLEELNKQIEEQKR |
| Q9BTC0 | T1469 | Sugiyama | DIDO1 C20orf158 DATF1 KIAA0333 | CADVRRNsVERPAEPVAGAAtPsLVEQQKMLEELNKQIEEQ |
| Q9BVA1 | S75 | Sugiyama | TUBB2B | tGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q9BVA1 | T72 | Sugiyama | TUBB2B | NEAtGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVF |
| Q9BX68 | T47 | Sugiyama | HINT2 | QVRGAAGVTDGNEVAKAQQAtPGGAAPtIFsRILDKsLPAD |
| Q9BXJ9 | T652 | Sugiyama | NAA15 GA19 NARG1 NATH TBDN100 | DEEIGGPKEELIPEKLAKVEtPLEEAIKFLTPLKNLVKNKI |
| Q9BXP5 | S493 | Sugiyama | SRRT ARS2 ASR2 | VNIKEICWNLQNIRLRECELsPGVNRDLTRRVRNINGITQH |
| Q9BY44 | S503 | Sugiyama | EIF2A CDA02 MSTP004 MSTP089 | TALKNQRKHEAKKAAKQEARsDKsPDLAPtPAPQstPRNtV |
| Q9BY44 | T512 | Sugiyama | EIF2A CDA02 MSTP004 MSTP089 | EAKKAAKQEARsDKsPDLAPtPAPQstPRNtVsQsIsGDPE |
| Q9BYG3 | T234 | Sugiyama | NIFK MKI67IP NOPP34 | KKKVsGtLDtPEKtVDsQGPtPVCtPtFLERRKsQVAELND |
| Q9BYG3 | T238 | Sugiyama | NIFK MKI67IP NOPP34 | sGtLDtPEKtVDsQGPtPVCtPtFLERRKsQVAELNDDDKD |
| Q9BYX7 | S368 | Sugiyama | POTEKP ACTBL3 FKSG30 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q9BYX7 | T249 | Sugiyama | POTEKP ACTBL3 FKSG30 | MAASSSSVEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q9BYX7 | T89 | Sugiyama | POTEKP ACTBL3 FKSG30 | YPMEHGIITNWDDMEKIWHHtFyNELRVAPEEHPILLTEAP |
| Q9BYX7 | Y240 | Sugiyama | POTEKP ACTBL3 FKSG30 | ALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPEA |
| Q9BYX7 | Y362 | Sugiyama | POTEKP ACTBL3 FKSG30 | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| Q9BYX7 | Y91 | Sugiyama | POTEKP ACTBL3 FKSG30 | MEHGIITNWDDMEKIWHHtFyNELRVAPEEHPILLTEAPLN |
| Q9BZH6 | S1216 | Sugiyama | WDR11 BRWD2 KIAA1351 WDR15 | AVLFASKAGAAGKDLLNELEsPKEEPIEE____________ |
| Q9C0C2 | S1103 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | KRGWVGEFSLSVGPQREAAFsPGQQDWsRDFCIEASERsyQ |
| Q9C0C2 | S1297 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | GQADWtPDLGLRNMAPGAVCsPGEsKELGVGQMDWGNNLGL |
| Q9C0C2 | S435 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | DAHLRPtsLVQRRFsEGVLQsPsQDQEKLGGsLAALPQGQG |
| Q9C0C2 | S494 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | QSFEWTFPTRPSGLGVWRLDsPPPsPItEAsEAAEAAEAGN |
| Q9C0C2 | S498 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | WTFPTRPSGLGVWRLDsPPPsPItEAsEAAEAAEAGNLAVS |
| Q9C0C2 | S601 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | LPLQQAEERyEsQEPLAGQEsPLPLATREAALPILEPVLGQ |
| Q9C0C2 | S672 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | TLARAETtQARtEAQDLCRAsPEPPGPEsSSRWLDDLLAsP |
| Q9C0C2 | S712 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | PPPsGGGARRGAGAELKDtQsPstCsEGLLGWsQKDLQSEF |
| Q9C0C7 | S639 | Sugiyama | AMBRA1 DCAF3 KIAA1736 | LERTEGQTPsSsRLELsssAsPQEERTVGVAFNQETGHWER |
| Q9C0E2 | S521 | Sugiyama | XPO4 KIAA1721 | EERVTRLHGQLQRHQQQLLAsPGssTVDNKMLDDLYEDIHW |
| Q9H078 | S668 | Sugiyama | CLPB SKD3 | TLRITVEDSDKQLLKsPELPsPQAEKRLPKLRLEIIDKDSK |
| Q9H0B6 | S445 | Sugiyama | KLC2 | RRDsAPyGEyGsWYKACKVDsPtVNTTLRSLGALYRRQGKL |
| Q9H0D6 | T433 | Sugiyama | XRN2 | SFRRRQKEKRKRMKRDQPAFtPsGILtPHALGsRNsPGsQV |
| Q9H0D6 | T439 | Sugiyama | XRN2 | KEKRKRMKRDQPAFtPsGILtPHALGsRNsPGsQVAsNPRQ |
| Q9H1A4 | S313 | Sugiyama | ANAPC1 TSG24 | QNVAtsssLTAHLRsLsKGDsPVtsPFQNysSIHSQSRSTs |
| Q9H1A4 | S317 | Sugiyama | ANAPC1 TSG24 | tsssLTAHLRsLsKGDsPVtsPFQNysSIHSQSRSTssPsL |
| Q9H1A4 | T316 | Sugiyama | ANAPC1 TSG24 | AtsssLTAHLRsLsKGDsPVtsPFQNysSIHSQSRSTssPs |
| Q9H211 | S391 | SIGNOR|PSP | CDT1 | IsPRMEKALsQLALRsAAPssPGsPRPALPAtPPAtPPAAs |
| Q9H211 | S411 | PSP | CDT1 | sPGsPRPALPAtPPAtPPAAsPSALKGVSQDLLERIRAKEA |
| Q9H211 | S491 | SIGNOR|PSP | CDT1 | PALSMEVACARMVGSCCTIMsPGEMEKHLLLLSELLPDWLS |
| Q9H211 | T29 | GPS6|EPSD|PSP | CDT1 | FFARRRPGPPRIAPPKLACRtPsPARPALRAPASATSGSRK |
| Q9H211 | T402 | PSP | CDT1 | LALRsAAPssPGsPRPALPAtPPAtPPAAsPSALKGVSQDL |
| Q9H211 | T406 | PSP | CDT1 | sAAPssPGsPRPALPAtPPAtPPAAsPSALKGVSQDLLERI |
| Q9H2B2 | S135 | SIGNOR|EPSD|PSP | SYT4 KIAA1342 | PSDLENATPKLFLEGEKESVsPESLKSSTSLTSEEKQEKLG |
| Q9H2U2 | S317 | Sugiyama | PPA2 HSPC124 | DSPFRCtQEEARsLVEsVsssPNKEsNEEEQVWHFLGK___ |
| Q9H3D4 | S51 | PSP | TP63 KET P63 P73H P73L TP73L | WKESYYRSTMSQsTQtNEFLsPEVFQHIWDFLEQPICsVQP |
| Q9H4A5 | S112 | Sugiyama | GOLPH3L GPP34R | EPPTMRKKRLLDRKVLLKsDsPTGDVLLDETLKHIKATEPT |
| Q9HAP6 | S115 | Sugiyama | LIN7B MALS2 VELI2 UNQ3116/PRO10200 | ELPKTDEGLGFNIMGGKEQNsPIyIsRVIPGGVADRHGGLK |
| Q9HC38 | T242 | Sugiyama | GLOD4 C17orf25 CGI-150 My027 | PQKELPDLEDLMKRENQKILtPLVsLDtPGKATVQVVILAD |
| Q9HC38 | T249 | Sugiyama | GLOD4 C17orf25 CGI-150 My027 | LEDLMKRENQKILtPLVsLDtPGKATVQVVILADPDGHEIC |
| Q9HDC5 | S413 | Sugiyama | JPH1 JP1 | QAALAARQECDIARAVARELsPDFyQPGPDyVKQRFQEGVD |
| Q9HDC9 | T190 | Sugiyama | APMAP C20orf3 UNQ1869/PRO4305 | KGLFEVNPWKREVKLLLSsEtPIEGKNMSFVNDLTVTQDGR |
| Q9NPI6 | S315 | EPSD|PSP | DCP1A SMIF | TPASITQSNEKHAPtYtIPLsPVLsPtLPAEAPTAQVPPsL |
| Q9NPI6 | T531 | Sugiyama | DCP1A SMIF | VTRSSDLERKAssPsPLtIGtPEsQRKPSIILSKsQLQDTL |
| Q9NQ39 | S157 | Sugiyama | RPS10P5 RPS10L | TYRRCSVPPGADKKAEAGAGsAtEFQFRGRCGRGRGQPPQ_ |
| Q9NQR4 | S133 | Sugiyama | NIT2 CUA002 | IHLFDIDVPGKITFQESKTLsPGDsFSTFDTPyCRVGLGIC |
| Q9NR28 | S6 | EPSD|PSP | DIABLO SMAC | _______________MAALKsWLsRSVTSFFRYRQCLCVPV |
| Q9NR28 | S9 | EPSD|PSP | DIABLO SMAC | ____________MAALKsWLsRSVTSFFRYRQCLCVPVVAN |
| Q9NRA8 | S301 | SIGNOR|EPSD|PSP | EIF4ENIF1 | LAQEPAADQEVPRDAVLPEQsPGDFDFNEFFNLDKVPCLAS |
| Q9NRA8 | S374 | SIGNOR|EPSD|PSP | EIF4ENIF1 | LGstPHEELERLAGLEQAILsPGQNsGNyFAPIPLEDHAEN |
| Q9NRA8 | S513 | SIGNOR|EPSD|PSP | EIF4ENIF1 | ASGTLPsQPKVSRNLESHLMsPAEIPGQPVPKNILQELLGQ |
| Q9NRA8 | S587 | SIGNOR|EPSD|PSP | EIF4ENIF1 | LsQVFQTRAAsADYLRPRIPsPIGFtPGPQQLLGDPFQGMR |
| Q9NRA8 | S693 | SIGNOR|EPSD|PSP | EIF4ENIF1 | PVHRGNsssPAPAAsItsMLsPSFtPTSVIRKMYESKEKSK |
| Q9NRA8 | S752 | SIGNOR|EPSD|PSP | EIF4ENIF1 | KASEENLLSsssVPsADRDssPttNsKLSALQRSsCstPLS |
| Q9NSK0 | S460 | Sugiyama | KLC4 KNSL8 | HEGGtPYAEYGGWYKACKVssPTVNTTLRNLGALyRRQGKL |
| Q9NTJ3 | S22 | Sugiyama | SMC4 CAPC SMC4L1 | PRKGTQPSTARRREEGPPPPsPDGAssDAEPEPPsGRtEsP |
| Q9NUP9 | S115 | Sugiyama | LIN7C MALS3 VELI3 | ELPKTEEGLGFNIMGGKEQNsPIyIsRIIPGGIADRHGGLK |
| Q9NUQ3 | S97 | Sugiyama | TXLNG CXorf15 ELRG LSR5 | KHSLEEDEGsDFItENRNLVsPAyCtQEsREEIPGGEARTD |
| Q9NWS0 | T195 | Sugiyama | PIH1D1 NOP17 | sQQNIRSEQRPRIQELGDLytPAPGRAESGPEKPHLNLWLE |
| Q9NYD6 | S189 | Sugiyama | HOXC10 HOX3I | DFEAPFEQRASLNPRAEHLEsPQLGGKVSFPEtPKsDsQtP |
| Q9NYF3 | S254 | Sugiyama | FAM53C C5orf6 | sPsLGPQASRFLPSARssPAssPELPWRPRGLRNLPRsRsQ |
| Q9NYF8 | S290 | Sugiyama | BCLAF1 BTF KIAA0164 | ERsGsGsVGNGssRysPsQNsPIHHIPsRRsPAKtIAPQNA |
| Q9NZ72 | S60 | PSP | STMN3 SCLIP | MEVKQLDKRAsGQsFEVILKsPSDLsPEsPMLssPPKKKDt |
| Q9NZB2 | T991 | Sugiyama | FAM120A C9orf10 KIAA0183 OSSA | PLQVVSVGGPARGRPRGVIstPVIRTFGRGGRYYGRGYKNQ |
| Q9NZN8 | S242 | Sugiyama | CNOT2 CDC36 NOT2 HSPC131 MSTP046 | VTGLDLSDFPALADRNRREGsGNPtPLINPLAGRAPYVGMV |
| Q9NZN8 | T246 | Sugiyama | CNOT2 CDC36 NOT2 HSPC131 MSTP046 | DLSDFPALADRNRREGsGNPtPLINPLAGRAPYVGMVTKPA |
| Q9NZT2 | S315 | Sugiyama | OGFR | FKPSSLPHPLEGSRKVEEEGsPGDPDHEAstQGRTCGPEHS |
| Q9NZT2 | S378 | Sugiyama | OGFR | LERsQGDEAGGHGEDRPEPLsPKEsKKRKLELSRREQPPTE |
| Q9P2E9 | S615 | Sugiyama | RRBP1 KIAA1398 | NQGKKTEsAsVQGRNTDVAQsPEAPKQEAPAKKKSGSKKKG |
| Q9UEY8 | S673 | Sugiyama | ADD3 ADDL | ttIENIEITIKsPEKIEEVLsPEGsPsKsPsKKKKKFRTPs |
| Q9UGP4 | S272 | PSP | LIMD1 | GGRssEKPtGLWstASSQRVsPGLPsPNLENGAPAVGPVQP |
| Q9UGP4 | S277 | PSP | LIMD1 | EKPtGLWstASSQRVsPGLPsPNLENGAPAVGPVQPRtPsV |
| Q9UGP4 | S421 | PSP | LIMD1 | CKEGPLGWSSDGsLGsVLLDsPssPRVRLPCQPLVPGPELR |
| Q9UGP4 | S424 | PSP | LIMD1 | GPLGWSSDGsLGsVLLDsPssPRVRLPCQPLVPGPELRPSA |
| Q9UGV2 | S341 | Sugiyama | NDRG3 | MTRLARsRtHstsssLGsGEsPFsRsVtsNQsDGtQESCEs |
| Q9UGV2 | S361 | Sugiyama | NDRG3 | sPFsRsVtsNQsDGtQESCEsPDVLDRHQTMEVsC______ |
| Q9UHB6 | S490 | Sugiyama | LIMA1 EPLIN SREBP3 PP624 | ENEEILERPAQLANAREtPHsPGVEDAPIAKVGVLAAsMEA |
| Q9UI10 | S130 | Sugiyama | EIF2B4 EIF2BD | AERALKQARKGEQGGPPPKAsPstAGEtPsGVKRLPEYPQV |
| Q9UI10 | S132 | Sugiyama | EIF2B4 EIF2BD | RALKQARKGEQGGPPPKAsPstAGEtPsGVKRLPEYPQVDD |
| Q9UI10 | T137 | Sugiyama | EIF2B4 EIF2BD | ARKGEQGGPPPKAsPstAGEtPsGVKRLPEYPQVDDLLLRR |
| Q9UI10 | T86 | Sugiyama | EIF2B4 EIF2BD | AAQCQVGPTRELPESGIQLGtPREKVPAGRSKAELRAERRA |
| Q9UKG1 | T399 | Sugiyama | APPL1 APPL DIP13A KIAA1428 | LSENPEETAARVNQsALEAVtPsPsFQQRHEsLRPAAGQSR |
| Q9UKS6 | S341 | Sugiyama | PACSIN3 | DEVtLtsIVPTRDGTAPPPQsPGsPGtGQDEEWsDEEsPRK |
| Q9UKS6 | S344 | Sugiyama | PACSIN3 | tLtsIVPTRDGTAPPPQsPGsPGtGQDEEWsDEEsPRKAAT |
| Q9UKV3 | S365 | Sugiyama | ACIN1 ACINUS KIAA0670 | EEARKSHLARQQQEKEMKttsPLEEEEREIKssQGLKEKsK |
| Q9UKX7 | S221 | Sugiyama | NUP50 NPAP60L PRO1146 | HGNsGRNsESEsNKVAAEtQsPsLFGstKLQQEStFLFHGN |
| Q9UNE7 | S23 | Sugiyama | STUB1 CHIP PP1131 | GKEEKEGGARLGAGGGsPEKsPsAQELKEQGNRLFVGRKYP |
| Q9UNE7 | S25 | Sugiyama | STUB1 CHIP PP1131 | EEKEGGARLGAGGGsPEKsPsAQELKEQGNRLFVGRKYPEA |
| Q9UNX3 | S32 | Sugiyama | RPL26L1 RPL26P1 | sKNRKRHFNAPSHVRRKIMssPLSKELRQKYNVRSMPIRKD |
| Q9UPQ0 | S973 | Sugiyama | LIMCH1 KIAA1102 | SEDVKPKTLPLDKsINHQIEsPsERRKKSPREHFQAGPFsP |
| Q9UPT6 | T265 | SIGNOR|iPTMNet | MAPK8IP3 JIP3 KIAA1066 | SSYQCPQDEMSESGQSSAAAtPSTTGTKsNtPtssVPSAAV |
| Q9UPT6 | T275 | SIGNOR|iPTMNet | MAPK8IP3 JIP3 KIAA1066 | SESGQSSAAAtPSTTGTKsNtPtssVPSAAVtPLNESLQPL |
| Q9UPT6 | T286 | SIGNOR|iPTMNet | MAPK8IP3 JIP3 KIAA1066 | PSTTGTKsNtPtssVPSAAVtPLNESLQPLGDYGVGSKNSK |
| Q9UQ35 | S1103 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sPsLQSKSQTsPKGGRsRsssPVtELAsRsPIRQDRGEFsA |
| Q9UQ35 | S1112 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | TsPKGGRsRsssPVtELAsRsPIRQDRGEFsAsPMLKsGMs |
| Q9UQ35 | S1320 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sMASSWGGPHFsPEHKELsNsPLRENsFGsPLEFRNsGPLG |
| Q9UQ35 | S1329 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | HFsPEHKELsNsPLRENsFGsPLEFRNsGPLGTEMNtGFss |
| Q9UQ35 | S1387 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | PsLDMKEQstRssGHsssELsPDAVEKAGMssNQsIssPVL |
| Q9UQ35 | S1404 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sELsPDAVEKAGMssNQsIssPVLDAVPRtPsRERsssAss |
| Q9UQ35 | S2272 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | tAVNLADsRtPAAAAAMNLAsPRtAVAPsAVNLADPRtPtA |
| Q9UQ35 | S857 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sssPHPKVKsGtPPRQGsItsPQANEQsVtPQRRsCFEssP |
| Q9UQ35 | S994 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sPDtKVKPEtPPRQsHsGsIsPyPKVKAQtPPGPsLsGsKs |
| Q9UQ35 | T1413 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | KAGMssNQsIssPVLDAVPRtPsRERsssAssPEMKDGLPR |
| Q9UQ35 | T384 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | PAPtPLLAERHGGsPQPLAttPLsQEPVNPPsEAsPtRDRs |
| Q9UQ80 | T386 | Sugiyama | PA2G4 EBP1 | tQKKKKKKAsKtAENAtsGEtLEENEAGD____________ |
| Q9UQF2 | S15 | SIGNOR|ELM|iPTMNet | MAPK8IP1 IB1 JIP1 PRKM8IP | ______MAERESGGLGGGAAsPPAASPFLGLHIAsPPNFRL |
| Q9UQF2 | S197 | SIGNOR|ELM|iPTMNet | MAPK8IP1 IB1 JIP1 PRKM8IP | LNNNSLGKKHSWQDRVSRSSsPLKTGEQtPPHEHICLSDEL |
| Q9UQF2 | S29 | SIGNOR|ELM|iPTMNet | MAPK8IP1 IB1 JIP1 PRKM8IP | LGGGAAsPPAASPFLGLHIAsPPNFRLTHDISLEEFEDEDL |
| Q9UQF2 | S341 | ELM|iPTMNet|EPSD | MAPK8IP1 IB1 JIP1 PRKM8IP | TAGRPHPSISEEEEGFDCLSsPERAEPPGGGWRGSLGEPPP |
| Q9UQF2 | S421 | SIGNOR|ELM|iPTMNet | MAPK8IP1 IB1 JIP1 PRKM8IP | GDYSDESDSATVYDNCASVSsPYESAIGEEYEEAPRPQPPA |
| Q9UQF2 | T103 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | MAPK8IP1 IB1 JIP1 PRKM8IP | AGSRLQAEMLQMDLIDATGDtPGAEDDEEDDDEERAARRPG |
| Q9UQF2 | T205 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | MAPK8IP1 IB1 JIP1 PRKM8IP | KHSWQDRVSRSSsPLKTGEQtPPHEHICLSDELPPQSGPAP |
| Q9UQF2 | T284 | ELM|iPTMNet | MAPK8IP1 IB1 JIP1 PRKM8IP | RDRIHYQADVRLEATEEIYLtPVQRPPDAAEPTSAFLPPTE |
| Q9Y266 | T303 | Sugiyama | NUDC | tRsMVEKMMYDQRQKsMGLPtsDEQKKQEILKKFMDQHPEM |
| Q9Y2T7 | S137 | Sugiyama | YBX2 CSDA3 MSY2 | EDVFVHQtAIKRNNPRKFLRsVGDGEtVEFDVVEGEKGAEA |
| Q9Y2V2 | S41 | Sugiyama | CARHSP1 | LDtPRsRERsPsPLRGNVVPsPLPtRRtRtFsAtVRASQGP |
| Q9Y2W2 | S237 | Sugiyama | WBP11 NPWBP SIPP1 SNP70 | RKVGFALDLPPRRRDEDMLysPELAQRGHDDDVSSTSEDDG |
| Q9Y2X7 | S362 | Sugiyama | GIT1 | TLIIDILSEAKRRQQGKsLssPtDNLELsLRSQSDLDDQHD |
| Q9Y4E8 | S229 | Sugiyama | USP15 KIAA0529 | LVIEQKNEDGtWPRGPstPKsPGAsNFstLPKIsPssLsNN |
| Q9Y4E8 | T226 | Sugiyama | USP15 KIAA0529 | GQVLVIEQKNEDGtWPRGPstPKsPGAsNFstLPKIsPssL |
| Q9Y5U2 | S143 | Sugiyama | TSSC4 | KRPLAPsGRsPVEGLGRAHRsPAsPRVPPVPDYVAHPERWT |
| Q9Y5U2 | S146 | Sugiyama | TSSC4 | LAPsGRsPVEGLGRAHRsPAsPRVPPVPDYVAHPERWTKYS |
| Q9Y6G9 | S516 | Sugiyama | DYNC1LI1 DNCLI1 | HAELDRITRKPVtVsPttPtsPtEGEAs_____________ |
| Q9Y6G9 | T515 | Sugiyama | DYNC1LI1 DNCLI1 | VHAELDRITRKPVtVsPttPtsPtEGEAs____________ |
| Q9Y6Q9 | S505 | EPSD|PSP | NCOA3 AIB1 BHLHE42 RAC3 TRAM1 | RNRGSPKIASHQFSPVAGVHsPMAsSGNTGNHSFSSSSLSA |
| Q9Y6Q9 | S543 | EPSD|PSP | NCOA3 AIB1 BHLHE42 RAC3 TRAM1 | LSALQAISEGVGTSLLSTLSsPGPKLDNsPNMNITQPSKVs |
| Q9Y6Q9 | S860 | EPSD|PSP | NCOA3 AIB1 BHLHE42 RAC3 TRAM1 | KSSQSVQSIRPPYNRAVsLDsPVsVGssPPVKNISAFPMLP |
| Q9Y6Q9 | S867 | EPSD|PSP | NCOA3 AIB1 BHLHE42 RAC3 TRAM1 | SIRPPYNRAVsLDsPVsVGssPPVKNISAFPMLPKQPMLGG |
| Q9Y6Q9 | T24 | EPSD|PSP | NCOA3 AIB1 BHLHE42 RAC3 TRAM1 | LGENLDPLAsDSRKRKLPCDtPGQGLtCsGEKRRREQESKY |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Chromatin organization | R-HSA-4839726 | 1.606060e-08 | 7.794 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 9.818043e-08 | 7.008 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.187807e-06 | 5.925 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 3.832390e-06 | 5.417 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 4.806870e-06 | 5.318 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 5.153433e-06 | 5.288 | 1 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 7.774097e-06 | 5.109 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.071194e-05 | 4.970 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.178928e-05 | 4.929 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.266034e-05 | 4.898 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.835719e-05 | 4.736 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.987687e-05 | 4.702 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 2.466649e-05 | 4.608 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 2.635396e-05 | 4.579 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.595378e-05 | 4.586 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 2.222186e-05 | 4.653 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 3.648567e-05 | 4.438 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 4.494501e-05 | 4.347 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 4.355102e-05 | 4.361 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 5.812860e-05 | 4.236 | 1 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 6.331863e-05 | 4.198 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 6.875051e-05 | 4.163 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 7.745937e-05 | 4.111 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 8.666859e-05 | 4.062 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.039350e-04 | 3.983 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 1.315899e-04 | 3.881 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.606731e-04 | 3.794 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.754921e-04 | 3.756 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 1.948629e-04 | 3.710 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 2.061830e-04 | 3.686 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 2.780785e-04 | 3.556 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 2.732715e-04 | 3.563 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 2.948338e-04 | 3.530 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 3.019767e-04 | 3.520 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 3.222684e-04 | 3.492 | 0 | 0 |
| M Phase | R-HSA-68886 | 3.571549e-04 | 3.447 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 4.873314e-04 | 3.312 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 4.873314e-04 | 3.312 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 5.965764e-04 | 3.224 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 6.009391e-04 | 3.221 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 5.873205e-04 | 3.231 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 6.158404e-04 | 3.211 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 6.637921e-04 | 3.178 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 6.585667e-04 | 3.181 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 7.251542e-04 | 3.140 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 6.979832e-04 | 3.156 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 7.320720e-04 | 3.135 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 7.675693e-04 | 3.115 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 8.315668e-04 | 3.080 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 8.736924e-04 | 3.059 | 1 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 8.440137e-04 | 3.074 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 8.906984e-04 | 3.050 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 1.244250e-03 | 2.905 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 1.108871e-03 | 2.955 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.102579e-03 | 2.958 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.102579e-03 | 2.958 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.291697e-03 | 2.889 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.124666e-03 | 2.949 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.102579e-03 | 2.958 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.054219e-03 | 2.977 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.243238e-03 | 2.905 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 1.321993e-03 | 2.879 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 1.128302e-03 | 2.948 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.387054e-03 | 2.858 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.458179e-03 | 2.836 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.416451e-03 | 2.849 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.476989e-03 | 2.831 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.588556e-03 | 2.799 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 1.588556e-03 | 2.799 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 1.588556e-03 | 2.799 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 1.588556e-03 | 2.799 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 1.588556e-03 | 2.799 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.585044e-03 | 2.800 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.673468e-03 | 2.776 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 1.715517e-03 | 2.766 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 1.747001e-03 | 2.758 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.910827e-03 | 2.719 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 2.017794e-03 | 2.695 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 2.363787e-03 | 2.626 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 2.670699e-03 | 2.573 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 2.721745e-03 | 2.565 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 2.971641e-03 | 2.527 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 3.032279e-03 | 2.518 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 3.088481e-03 | 2.510 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 3.310100e-03 | 2.480 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 3.446961e-03 | 2.463 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 3.446961e-03 | 2.463 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 3.588980e-03 | 2.445 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 3.892206e-03 | 2.410 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 3.903264e-03 | 2.409 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 3.697038e-03 | 2.432 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 3.903264e-03 | 2.409 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 4.366506e-03 | 2.360 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 4.366506e-03 | 2.360 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 4.568986e-03 | 2.340 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 4.900021e-03 | 2.310 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 4.955751e-03 | 2.305 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 4.900021e-03 | 2.310 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 4.698621e-03 | 2.328 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 5.024323e-03 | 2.299 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 5.223788e-03 | 2.282 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 5.286772e-03 | 2.277 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 5.911291e-03 | 2.228 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 5.911291e-03 | 2.228 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 5.775105e-03 | 2.238 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 6.082576e-03 | 2.216 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 6.082576e-03 | 2.216 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 5.803428e-03 | 2.236 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 5.911291e-03 | 2.228 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 5.786747e-03 | 2.238 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 5.946596e-03 | 2.226 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 6.128755e-03 | 2.213 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 6.130154e-03 | 2.213 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 6.212814e-03 | 2.207 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 6.292716e-03 | 2.201 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 6.741559e-03 | 2.171 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 7.288406e-03 | 2.137 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 7.288406e-03 | 2.137 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 7.612836e-03 | 2.118 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 7.992970e-03 | 2.097 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 8.554672e-03 | 2.068 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 8.554672e-03 | 2.068 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 8.651580e-03 | 2.063 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 8.895932e-03 | 2.051 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 8.895932e-03 | 2.051 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 8.159607e-03 | 2.088 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 8.564584e-03 | 2.067 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 9.974149e-03 | 2.001 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 1.018150e-02 | 1.992 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.033527e-02 | 1.986 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 9.855008e-03 | 2.006 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 9.304451e-03 | 2.031 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 1.033527e-02 | 1.986 | 1 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 9.974149e-03 | 2.001 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 9.600942e-03 | 2.018 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 9.236350e-03 | 2.034 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 1.040508e-02 | 1.983 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.040671e-02 | 1.983 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.043417e-02 | 1.982 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.043417e-02 | 1.982 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.043417e-02 | 1.982 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 1.188716e-02 | 1.925 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 1.188716e-02 | 1.925 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 1.173070e-02 | 1.931 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.120441e-02 | 1.951 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.110392e-02 | 1.955 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.194386e-02 | 1.923 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 1.128284e-02 | 1.948 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 1.155868e-02 | 1.937 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.173232e-02 | 1.931 | 1 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.072601e-02 | 1.970 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.194386e-02 | 1.923 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.194386e-02 | 1.923 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.072601e-02 | 1.970 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.218277e-02 | 1.914 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.221565e-02 | 1.913 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 1.221565e-02 | 1.913 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 1.221565e-02 | 1.913 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 1.221565e-02 | 1.913 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.256652e-02 | 1.901 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.256652e-02 | 1.901 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 1.325846e-02 | 1.878 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.325846e-02 | 1.878 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 1.363832e-02 | 1.865 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.377707e-02 | 1.861 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.467375e-02 | 1.833 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.475605e-02 | 1.831 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 1.477634e-02 | 1.830 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.491587e-02 | 1.826 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.491587e-02 | 1.826 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 1.549904e-02 | 1.810 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.549904e-02 | 1.810 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.784985e-02 | 1.748 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 1.784985e-02 | 1.748 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.593216e-02 | 1.798 | 1 | 1 |
| Signaling by FGFR2 | R-HSA-5654738 | 1.751493e-02 | 1.757 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.782155e-02 | 1.749 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 1.760712e-02 | 1.754 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 1.549904e-02 | 1.810 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.751493e-02 | 1.757 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 1.800247e-02 | 1.745 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.826902e-02 | 1.738 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 1.848810e-02 | 1.733 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.877102e-02 | 1.727 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.938686e-02 | 1.712 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.938686e-02 | 1.712 | 1 | 1 |
| Gap junction trafficking | R-HSA-190828 | 1.956139e-02 | 1.709 | 0 | 0 |
| RSK activation | R-HSA-444257 | 1.987180e-02 | 1.702 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 2.074379e-02 | 1.683 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 2.077890e-02 | 1.682 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 2.141653e-02 | 1.669 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 2.141653e-02 | 1.669 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 2.153756e-02 | 1.667 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 2.161666e-02 | 1.665 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 2.207277e-02 | 1.656 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 2.427973e-02 | 1.615 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 2.625056e-02 | 1.581 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 2.625056e-02 | 1.581 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 2.516653e-02 | 1.599 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 2.763342e-02 | 1.559 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 2.333086e-02 | 1.632 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 2.439807e-02 | 1.613 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 2.625056e-02 | 1.581 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 2.625056e-02 | 1.581 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 2.694688e-02 | 1.569 | 1 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 2.648138e-02 | 1.577 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 2.478184e-02 | 1.606 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 2.538657e-02 | 1.595 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 2.538657e-02 | 1.595 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 2.478184e-02 | 1.606 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 2.339031e-02 | 1.631 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 2.538657e-02 | 1.595 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 2.339031e-02 | 1.631 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 2.770634e-02 | 1.557 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 2.816426e-02 | 1.550 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 2.939365e-02 | 1.532 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 2.939365e-02 | 1.532 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 2.939365e-02 | 1.532 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 2.973442e-02 | 1.527 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 2.973442e-02 | 1.527 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 3.005447e-02 | 1.522 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 3.044645e-02 | 1.516 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 3.063086e-02 | 1.514 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 3.116331e-02 | 1.506 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 3.139428e-02 | 1.503 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 3.224462e-02 | 1.492 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 3.229335e-02 | 1.491 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 3.229335e-02 | 1.491 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 3.229335e-02 | 1.491 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 3.229335e-02 | 1.491 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 3.276442e-02 | 1.485 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 3.276442e-02 | 1.485 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 3.276442e-02 | 1.485 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 3.276442e-02 | 1.485 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 3.890242e-02 | 1.410 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 3.890242e-02 | 1.410 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 3.890242e-02 | 1.410 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 3.890242e-02 | 1.410 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 3.664247e-02 | 1.436 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 3.636647e-02 | 1.439 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 4.020277e-02 | 1.396 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 4.020277e-02 | 1.396 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 4.020277e-02 | 1.396 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 3.356843e-02 | 1.474 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 3.636647e-02 | 1.439 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 4.020277e-02 | 1.396 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 3.630974e-02 | 1.440 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 4.168131e-02 | 1.380 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 4.020277e-02 | 1.396 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 4.092130e-02 | 1.388 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 4.122917e-02 | 1.385 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 3.890242e-02 | 1.410 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 3.890242e-02 | 1.410 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 3.438193e-02 | 1.464 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 3.890242e-02 | 1.410 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 4.088053e-02 | 1.388 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 3.491158e-02 | 1.457 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 3.636647e-02 | 1.439 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 3.656933e-02 | 1.437 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 3.754976e-02 | 1.425 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 3.987308e-02 | 1.399 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 3.664247e-02 | 1.436 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 4.122917e-02 | 1.385 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 3.664247e-02 | 1.436 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 4.194701e-02 | 1.377 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 4.219980e-02 | 1.375 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 4.328824e-02 | 1.364 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 4.343258e-02 | 1.362 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 4.343258e-02 | 1.362 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 4.442165e-02 | 1.352 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 4.646326e-02 | 1.333 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 4.688129e-02 | 1.329 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 4.689424e-02 | 1.329 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 4.689424e-02 | 1.329 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 4.689424e-02 | 1.329 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 4.689424e-02 | 1.329 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 4.696108e-02 | 1.328 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 4.725765e-02 | 1.326 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 4.741418e-02 | 1.324 | 1 | 1 |
| Signaling by ALK in cancer | R-HSA-9700206 | 4.741418e-02 | 1.324 | 1 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 4.741418e-02 | 1.324 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 4.976241e-02 | 1.303 | 1 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 5.017991e-02 | 1.299 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 5.017991e-02 | 1.299 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 5.017991e-02 | 1.299 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 5.026702e-02 | 1.299 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 5.026702e-02 | 1.299 | 1 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 5.041423e-02 | 1.297 | 1 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 5.065376e-02 | 1.295 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 5.080315e-02 | 1.294 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 5.080315e-02 | 1.294 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 5.080315e-02 | 1.294 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 5.080315e-02 | 1.294 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 5.121760e-02 | 1.291 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 5.121760e-02 | 1.291 | 0 | 0 |
| IRS activation | R-HSA-74713 | 5.121760e-02 | 1.291 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 5.121760e-02 | 1.291 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 5.121760e-02 | 1.291 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 5.137466e-02 | 1.289 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 5.873736e-02 | 1.231 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 6.721567e-02 | 1.173 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 6.721567e-02 | 1.173 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 6.459160e-02 | 1.190 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 6.459160e-02 | 1.190 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 6.459160e-02 | 1.190 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 6.305786e-02 | 1.200 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 6.493529e-02 | 1.188 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 5.346153e-02 | 1.272 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 5.361209e-02 | 1.271 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 5.460685e-02 | 1.263 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 5.460685e-02 | 1.263 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 5.361209e-02 | 1.271 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 5.361209e-02 | 1.271 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 6.822061e-02 | 1.166 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 6.459160e-02 | 1.190 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 6.822061e-02 | 1.166 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 6.822061e-02 | 1.166 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 5.912454e-02 | 1.228 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 5.460685e-02 | 1.263 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 6.721567e-02 | 1.173 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 6.142451e-02 | 1.212 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 6.380911e-02 | 1.195 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 6.822061e-02 | 1.166 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 5.874139e-02 | 1.231 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 5.245212e-02 | 1.280 | 0 | 0 |
| Kinesins | R-HSA-983189 | 6.493529e-02 | 1.188 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 5.162724e-02 | 1.287 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 6.732928e-02 | 1.172 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 6.104993e-02 | 1.214 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 5.313648e-02 | 1.275 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 6.856085e-02 | 1.164 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 6.142451e-02 | 1.212 | 1 | 0 |
| MAP kinase activation | R-HSA-450294 | 6.896700e-02 | 1.161 | 1 | 0 |
| Autophagy | R-HSA-9612973 | 7.065626e-02 | 1.151 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 7.079365e-02 | 1.150 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 7.116458e-02 | 1.148 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 7.116458e-02 | 1.148 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 7.116458e-02 | 1.148 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 7.122429e-02 | 1.147 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 7.231197e-02 | 1.141 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 7.312454e-02 | 1.136 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 7.621632e-02 | 1.118 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 7.621632e-02 | 1.118 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 7.621632e-02 | 1.118 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 7.621632e-02 | 1.118 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 7.621632e-02 | 1.118 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 7.641336e-02 | 1.117 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 7.756108e-02 | 1.110 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 7.925095e-02 | 1.101 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 8.131494e-02 | 1.090 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 8.194056e-02 | 1.087 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.214037e-02 | 1.085 | 0 | 0 |
| Protein folding | R-HSA-391251 | 8.506543e-02 | 1.070 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 8.528714e-02 | 1.069 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 8.544724e-02 | 1.068 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 8.571571e-02 | 1.067 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 8.571571e-02 | 1.067 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 9.162784e-02 | 1.038 | 0 | 0 |
| S Phase | R-HSA-69242 | 9.261247e-02 | 1.033 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 9.276025e-02 | 1.033 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 9.282179e-02 | 1.032 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 9.293701e-02 | 1.032 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 9.468203e-02 | 1.024 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 9.468203e-02 | 1.024 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 9.468203e-02 | 1.024 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 9.468203e-02 | 1.024 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 9.568880e-02 | 1.019 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 9.568880e-02 | 1.019 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 9.568880e-02 | 1.019 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 9.568880e-02 | 1.019 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 9.591053e-02 | 1.018 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 9.784468e-02 | 1.009 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 9.784468e-02 | 1.009 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 9.784468e-02 | 1.009 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 9.784468e-02 | 1.009 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 9.784468e-02 | 1.009 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5619101 | 1.431202e-01 | 0.844 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5660686 | 1.431202e-01 | 0.844 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 1.431202e-01 | 0.844 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 1.108838e-01 | 0.955 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 1.277403e-01 | 0.894 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 1.277403e-01 | 0.894 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.451452e-01 | 0.838 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 1.061094e-01 | 0.974 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 1.169506e-01 | 0.932 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.397838e-01 | 0.855 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 1.087941e-01 | 0.963 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 9.805043e-02 | 1.009 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 1.440618e-01 | 0.841 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.215849e-01 | 0.915 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 9.805043e-02 | 1.009 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 1.087941e-01 | 0.963 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 9.805043e-02 | 1.009 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 1.440618e-01 | 0.841 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 1.172120e-01 | 0.931 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.277403e-01 | 0.894 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 1.117916e-01 | 0.952 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 1.108838e-01 | 0.955 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.451452e-01 | 0.838 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 1.451452e-01 | 0.838 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 1.223427e-01 | 0.912 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.353319e-01 | 0.869 | 1 | 1 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.172598e-01 | 0.931 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 1.169506e-01 | 0.932 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 1.259035e-01 | 0.900 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 1.046937e-01 | 0.980 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.172598e-01 | 0.931 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 1.420609e-01 | 0.848 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 1.420609e-01 | 0.848 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 1.420609e-01 | 0.848 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 1.420609e-01 | 0.848 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 1.277403e-01 | 0.894 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.337442e-01 | 0.874 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 1.023798e-01 | 0.990 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 1.440618e-01 | 0.841 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 9.784468e-02 | 1.009 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 1.431202e-01 | 0.844 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 1.108838e-01 | 0.955 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 1.281847e-01 | 0.892 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 1.064750e-01 | 0.973 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.064750e-01 | 0.973 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.440618e-01 | 0.841 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.228645e-01 | 0.911 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 1.133333e-01 | 0.946 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 1.397838e-01 | 0.855 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 1.172598e-01 | 0.931 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 1.239812e-01 | 0.907 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.273494e-01 | 0.895 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 1.431202e-01 | 0.844 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.061094e-01 | 0.974 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 1.021962e-01 | 0.991 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 1.420609e-01 | 0.848 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 1.277403e-01 | 0.894 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 1.117916e-01 | 0.952 | 1 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 1.277403e-01 | 0.894 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 1.172120e-01 | 0.931 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 1.410455e-01 | 0.851 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 1.108838e-01 | 0.955 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 1.397838e-01 | 0.855 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 1.146159e-01 | 0.941 | 1 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 1.146159e-01 | 0.941 | 1 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 1.146159e-01 | 0.941 | 1 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 1.295800e-01 | 0.887 | 1 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.254635e-01 | 0.901 | 1 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.058041e-01 | 0.975 | 1 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.451452e-01 | 0.838 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.192483e-01 | 0.924 | 1 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.454089e-01 | 0.837 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 1.486538e-01 | 0.828 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 1.489026e-01 | 0.827 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 1.489410e-01 | 0.827 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.489410e-01 | 0.827 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 1.489410e-01 | 0.827 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 1.517199e-01 | 0.819 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 1.535047e-01 | 0.814 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 1.535047e-01 | 0.814 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 1.559681e-01 | 0.807 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 1.569404e-01 | 0.804 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 1.630012e-01 | 0.788 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 1.631378e-01 | 0.787 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 1.639650e-01 | 0.785 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 1.639650e-01 | 0.785 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 1.651519e-01 | 0.782 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 1.709015e-01 | 0.767 | 1 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 1.723337e-01 | 0.764 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.861262e-01 | 0.730 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.861262e-01 | 0.730 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.861262e-01 | 0.730 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.861262e-01 | 0.730 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.861262e-01 | 0.730 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.861262e-01 | 0.730 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 1.861262e-01 | 0.730 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 1.861262e-01 | 0.730 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.861262e-01 | 0.730 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 1.861262e-01 | 0.730 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.861262e-01 | 0.730 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.861262e-01 | 0.730 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.861262e-01 | 0.730 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.861262e-01 | 0.730 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 2.269762e-01 | 0.644 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 2.269762e-01 | 0.644 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 2.269762e-01 | 0.644 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 2.269762e-01 | 0.644 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 2.657782e-01 | 0.575 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 2.657782e-01 | 0.575 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 2.657782e-01 | 0.575 | 0 | 0 |
| Signaling by LRP5 mutants | R-HSA-5339717 | 2.657782e-01 | 0.575 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 3.026348e-01 | 0.519 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 3.026348e-01 | 0.519 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 3.026348e-01 | 0.519 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 3.026348e-01 | 0.519 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.812194e-01 | 0.742 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 1.812194e-01 | 0.742 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 1.812194e-01 | 0.742 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 1.997186e-01 | 0.700 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 1.997186e-01 | 0.700 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 3.376433e-01 | 0.472 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 3.376433e-01 | 0.472 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 3.376433e-01 | 0.472 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 3.376433e-01 | 0.472 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 3.376433e-01 | 0.472 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 3.376433e-01 | 0.472 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 3.376433e-01 | 0.472 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 3.376433e-01 | 0.472 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 2.372707e-01 | 0.625 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 2.372707e-01 | 0.625 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 2.372707e-01 | 0.625 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 1.764913e-01 | 0.753 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 1.764913e-01 | 0.753 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 1.764913e-01 | 0.753 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 2.561954e-01 | 0.591 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 2.561954e-01 | 0.591 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 2.022782e-01 | 0.694 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 2.751435e-01 | 0.560 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.751435e-01 | 0.560 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 2.751435e-01 | 0.560 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 2.940652e-01 | 0.532 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 2.423984e-01 | 0.615 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 2.423984e-01 | 0.615 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 2.252076e-01 | 0.647 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 1.995892e-01 | 0.700 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 2.085584e-01 | 0.681 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 2.085584e-01 | 0.681 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 2.085584e-01 | 0.681 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 2.471034e-01 | 0.607 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 2.471034e-01 | 0.607 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 2.471034e-01 | 0.607 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 2.975461e-01 | 0.526 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 2.694348e-01 | 0.570 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 2.921010e-01 | 0.534 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 3.393743e-01 | 0.469 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 2.009639e-01 | 0.697 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 2.471034e-01 | 0.607 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 3.114781e-01 | 0.507 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 3.239192e-01 | 0.490 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 1.902966e-01 | 0.721 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 1.902966e-01 | 0.721 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 3.377393e-01 | 0.471 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 1.858848e-01 | 0.731 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 2.372707e-01 | 0.625 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 1.902966e-01 | 0.721 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 2.423984e-01 | 0.615 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 2.751435e-01 | 0.560 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 2.500406e-01 | 0.602 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 2.657782e-01 | 0.575 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 2.671076e-01 | 0.573 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 2.516371e-01 | 0.599 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 2.516371e-01 | 0.599 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 1.997186e-01 | 0.700 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 3.129153e-01 | 0.505 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 2.751435e-01 | 0.560 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 3.114781e-01 | 0.507 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 2.638327e-01 | 0.579 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 3.026348e-01 | 0.519 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 3.026348e-01 | 0.519 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 3.026348e-01 | 0.519 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 2.184247e-01 | 0.661 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 1.820672e-01 | 0.740 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 2.582211e-01 | 0.588 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 2.750084e-01 | 0.561 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 2.332983e-01 | 0.632 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 2.423984e-01 | 0.615 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.931511e-01 | 0.714 | 1 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 2.184247e-01 | 0.661 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 2.038507e-01 | 0.691 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 2.332983e-01 | 0.632 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 2.423984e-01 | 0.615 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 2.360947e-01 | 0.627 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 1.861262e-01 | 0.730 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 1.861262e-01 | 0.730 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 1.861262e-01 | 0.730 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 1.861262e-01 | 0.730 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 2.269762e-01 | 0.644 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 2.269762e-01 | 0.644 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 2.657782e-01 | 0.575 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.812194e-01 | 0.742 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 3.376433e-01 | 0.472 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 3.376433e-01 | 0.472 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 3.376433e-01 | 0.472 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 2.560550e-01 | 0.592 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 3.316535e-01 | 0.479 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 2.698133e-01 | 0.569 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 2.975461e-01 | 0.526 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 3.265165e-01 | 0.486 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 3.380532e-01 | 0.471 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 3.380532e-01 | 0.471 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 2.187824e-01 | 0.660 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 3.174601e-01 | 0.498 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 3.254271e-01 | 0.488 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 3.254271e-01 | 0.488 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 2.561954e-01 | 0.591 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 2.698133e-01 | 0.569 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 3.039926e-01 | 0.517 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 2.561954e-01 | 0.591 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 1.931511e-01 | 0.714 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.022782e-01 | 0.694 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.022782e-01 | 0.694 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 3.109056e-01 | 0.507 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 2.657782e-01 | 0.575 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 1.812194e-01 | 0.742 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.997186e-01 | 0.700 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.997186e-01 | 0.700 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.997186e-01 | 0.700 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 3.129153e-01 | 0.505 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 3.150048e-01 | 0.502 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 2.690308e-01 | 0.570 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.254271e-01 | 0.488 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.772433e-01 | 0.751 | 1 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 2.561954e-01 | 0.591 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 2.975461e-01 | 0.526 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 1.869132e-01 | 0.728 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 1.997186e-01 | 0.700 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 3.181216e-01 | 0.497 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 2.154854e-01 | 0.667 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 2.423984e-01 | 0.615 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 3.316535e-01 | 0.479 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 2.975461e-01 | 0.526 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 1.816904e-01 | 0.741 | 1 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 3.447750e-01 | 0.462 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 2.893961e-01 | 0.539 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 2.893961e-01 | 0.539 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 2.516619e-01 | 0.599 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 2.802308e-01 | 0.552 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 3.254271e-01 | 0.488 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 2.867825e-01 | 0.542 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 2.940652e-01 | 0.532 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 2.009639e-01 | 0.697 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 2.351600e-01 | 0.629 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 2.893961e-01 | 0.539 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 3.178179e-01 | 0.498 | 0 | 0 |
| The NLRP1 inflammasome | R-HSA-844455 | 2.269762e-01 | 0.644 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 2.184247e-01 | 0.661 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 2.022782e-01 | 0.694 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 2.751435e-01 | 0.560 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 2.751435e-01 | 0.560 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 2.751435e-01 | 0.560 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 2.154854e-01 | 0.667 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 2.144552e-01 | 0.669 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 1.902966e-01 | 0.721 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 1.740517e-01 | 0.759 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 2.142246e-01 | 0.669 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 2.561954e-01 | 0.591 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 2.288672e-01 | 0.640 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 2.932204e-01 | 0.533 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 2.561954e-01 | 0.591 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 3.254271e-01 | 0.488 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 2.516371e-01 | 0.599 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 2.505775e-01 | 0.601 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 3.316535e-01 | 0.479 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 1.934071e-01 | 0.714 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 3.254271e-01 | 0.488 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.793923e-01 | 0.746 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 3.376433e-01 | 0.472 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 3.376433e-01 | 0.472 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 2.561954e-01 | 0.591 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 2.561954e-01 | 0.591 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 2.147048e-01 | 0.668 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 2.772992e-01 | 0.557 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 2.268740e-01 | 0.644 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 2.250628e-01 | 0.648 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 1.765687e-01 | 0.753 | 1 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 2.038507e-01 | 0.691 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 2.505775e-01 | 0.601 | 1 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 2.505775e-01 | 0.601 | 1 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 2.705408e-01 | 0.568 | 1 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 2.705408e-01 | 0.568 | 1 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 2.950906e-01 | 0.530 | 1 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 2.362044e-01 | 0.627 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 2.694348e-01 | 0.570 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 2.950906e-01 | 0.530 | 1 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 2.000635e-01 | 0.699 | 1 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 2.587389e-01 | 0.587 | 1 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 3.026348e-01 | 0.519 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 3.376433e-01 | 0.472 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 3.254271e-01 | 0.488 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 3.099646e-01 | 0.509 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 3.287612e-01 | 0.483 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 3.248219e-01 | 0.488 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 3.130189e-01 | 0.504 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 3.231742e-01 | 0.491 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 2.932204e-01 | 0.533 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 3.393743e-01 | 0.469 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 3.316535e-01 | 0.479 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.762138e-01 | 0.559 | 1 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 2.009639e-01 | 0.697 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 3.477712e-01 | 0.459 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 3.502435e-01 | 0.456 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 3.502435e-01 | 0.456 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 3.502435e-01 | 0.456 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 3.502435e-01 | 0.456 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 3.533017e-01 | 0.452 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 3.533017e-01 | 0.452 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 3.533017e-01 | 0.452 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 3.533017e-01 | 0.452 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 3.542177e-01 | 0.451 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 3.611583e-01 | 0.442 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 3.630492e-01 | 0.440 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 3.686531e-01 | 0.433 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 3.686531e-01 | 0.433 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 3.686531e-01 | 0.433 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 3.708964e-01 | 0.431 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 3.708964e-01 | 0.431 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 3.708964e-01 | 0.431 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 3.708964e-01 | 0.431 | 0 | 0 |
| Defective CHST14 causes EDS, musculocontractural type | R-HSA-3595174 | 3.708964e-01 | 0.431 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 3.708964e-01 | 0.431 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 3.708964e-01 | 0.431 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 3.708964e-01 | 0.431 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 3.808553e-01 | 0.419 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 3.810304e-01 | 0.419 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 3.829240e-01 | 0.417 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 3.830121e-01 | 0.417 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 3.842373e-01 | 0.415 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 3.842373e-01 | 0.415 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 3.842832e-01 | 0.415 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 3.842832e-01 | 0.415 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 3.868536e-01 | 0.412 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 3.868536e-01 | 0.412 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 3.948005e-01 | 0.404 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 3.948005e-01 | 0.404 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 3.973664e-01 | 0.401 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 4.024820e-01 | 0.395 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 4.024820e-01 | 0.395 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 4.024820e-01 | 0.395 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 4.024820e-01 | 0.395 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 4.024820e-01 | 0.395 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 4.024820e-01 | 0.395 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 4.024820e-01 | 0.395 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 4.048196e-01 | 0.393 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 4.048196e-01 | 0.393 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 4.048196e-01 | 0.393 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 4.048196e-01 | 0.393 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 4.138080e-01 | 0.383 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 4.144506e-01 | 0.383 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 4.144506e-01 | 0.383 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 4.178138e-01 | 0.379 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 4.186401e-01 | 0.378 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 4.186401e-01 | 0.378 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 4.186401e-01 | 0.378 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 4.220813e-01 | 0.375 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 4.225289e-01 | 0.374 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 4.225289e-01 | 0.374 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 4.225289e-01 | 0.374 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 4.225289e-01 | 0.374 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 4.247841e-01 | 0.372 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 4.259988e-01 | 0.371 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 4.281428e-01 | 0.368 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 4.324835e-01 | 0.364 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 4.324835e-01 | 0.364 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 4.324835e-01 | 0.364 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 4.324835e-01 | 0.364 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 4.324835e-01 | 0.364 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 4.324835e-01 | 0.364 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 4.324835e-01 | 0.364 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 4.324835e-01 | 0.364 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 4.324835e-01 | 0.364 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 4.324835e-01 | 0.364 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 4.324835e-01 | 0.364 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 4.324835e-01 | 0.364 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 4.355662e-01 | 0.361 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 4.355662e-01 | 0.361 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 4.355662e-01 | 0.361 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 4.355662e-01 | 0.361 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 4.355662e-01 | 0.361 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 4.355662e-01 | 0.361 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 4.390679e-01 | 0.357 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 4.399618e-01 | 0.357 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 4.399618e-01 | 0.357 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 4.399618e-01 | 0.357 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 4.399618e-01 | 0.357 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 4.406569e-01 | 0.356 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 4.413299e-01 | 0.355 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 4.461094e-01 | 0.351 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 4.478494e-01 | 0.349 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 4.525773e-01 | 0.344 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 4.542768e-01 | 0.343 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 4.571016e-01 | 0.340 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 4.571016e-01 | 0.340 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 4.608716e-01 | 0.336 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 4.609804e-01 | 0.336 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 4.609804e-01 | 0.336 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 4.609804e-01 | 0.336 | 1 | 1 |
| Lipophagy | R-HSA-9613354 | 4.609804e-01 | 0.336 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 4.609804e-01 | 0.336 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 4.609804e-01 | 0.336 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 4.609804e-01 | 0.336 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 4.609804e-01 | 0.336 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 4.609804e-01 | 0.336 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 4.609804e-01 | 0.336 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 4.637500e-01 | 0.334 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 4.637500e-01 | 0.334 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 4.671577e-01 | 0.331 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 4.720208e-01 | 0.326 | 1 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 4.739338e-01 | 0.324 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 4.739338e-01 | 0.324 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 4.739338e-01 | 0.324 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 4.739338e-01 | 0.324 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 4.739338e-01 | 0.324 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 4.739338e-01 | 0.324 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 4.752630e-01 | 0.323 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 4.752630e-01 | 0.323 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 4.752630e-01 | 0.323 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 4.752630e-01 | 0.323 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 4.816502e-01 | 0.317 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 4.835801e-01 | 0.316 | 1 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 4.858440e-01 | 0.314 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 4.880480e-01 | 0.312 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 4.880480e-01 | 0.312 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 4.880480e-01 | 0.312 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 4.880480e-01 | 0.312 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 4.880480e-01 | 0.312 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 4.880480e-01 | 0.312 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 4.880480e-01 | 0.312 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 4.880480e-01 | 0.312 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 4.880480e-01 | 0.312 | 0 | 0 |
| Sperm Motility And Taxes | R-HSA-1300642 | 4.880480e-01 | 0.312 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 4.880480e-01 | 0.312 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 4.880480e-01 | 0.312 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 4.880480e-01 | 0.312 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 4.904461e-01 | 0.309 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 4.904461e-01 | 0.309 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 4.904461e-01 | 0.309 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 4.967527e-01 | 0.304 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 4.977250e-01 | 0.303 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 5.009985e-01 | 0.300 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 5.066281e-01 | 0.295 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 5.066281e-01 | 0.295 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 5.119628e-01 | 0.291 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 5.136224e-01 | 0.289 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 5.136224e-01 | 0.289 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 5.136224e-01 | 0.289 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 5.137580e-01 | 0.289 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 5.137580e-01 | 0.289 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 5.137580e-01 | 0.289 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 5.137580e-01 | 0.289 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 5.137580e-01 | 0.289 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 5.137580e-01 | 0.289 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 5.137580e-01 | 0.289 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 5.137580e-01 | 0.289 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 5.137580e-01 | 0.289 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 5.137580e-01 | 0.289 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 5.198971e-01 | 0.284 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 5.224714e-01 | 0.282 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 5.224714e-01 | 0.282 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 5.224714e-01 | 0.282 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 5.260742e-01 | 0.279 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 5.302795e-01 | 0.275 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 5.312495e-01 | 0.275 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 5.325814e-01 | 0.274 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 5.379692e-01 | 0.269 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 5.379692e-01 | 0.269 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 5.381782e-01 | 0.269 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 5.381782e-01 | 0.269 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 5.381782e-01 | 0.269 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 5.381782e-01 | 0.269 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 5.381782e-01 | 0.269 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 5.381782e-01 | 0.269 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 5.381782e-01 | 0.269 | 0 | 0 |
| DS-GAG biosynthesis | R-HSA-2022923 | 5.381782e-01 | 0.269 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 5.434049e-01 | 0.265 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 5.462840e-01 | 0.263 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 5.504372e-01 | 0.259 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 5.504372e-01 | 0.259 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 5.504372e-01 | 0.259 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 5.531162e-01 | 0.257 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 5.531162e-01 | 0.257 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 5.586508e-01 | 0.253 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 5.588079e-01 | 0.253 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 5.613735e-01 | 0.251 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 5.613735e-01 | 0.251 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 5.613735e-01 | 0.251 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 5.613735e-01 | 0.251 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 5.613735e-01 | 0.251 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 5.613735e-01 | 0.251 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 5.613735e-01 | 0.251 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 5.613735e-01 | 0.251 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 5.613735e-01 | 0.251 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 5.679087e-01 | 0.246 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 5.800138e-01 | 0.237 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 5.823440e-01 | 0.235 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 5.834050e-01 | 0.234 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 5.834050e-01 | 0.234 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 5.834050e-01 | 0.234 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 5.834050e-01 | 0.234 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 5.834050e-01 | 0.234 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 5.834050e-01 | 0.234 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 5.834050e-01 | 0.234 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 5.834050e-01 | 0.234 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 5.853997e-01 | 0.233 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 5.855544e-01 | 0.232 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 5.913244e-01 | 0.228 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 5.962539e-01 | 0.225 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 5.964206e-01 | 0.224 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 5.964206e-01 | 0.224 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 5.968636e-01 | 0.224 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 6.043313e-01 | 0.219 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 6.043313e-01 | 0.219 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 6.043313e-01 | 0.219 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 6.043313e-01 | 0.219 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 6.043313e-01 | 0.219 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 6.079693e-01 | 0.216 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 6.091300e-01 | 0.215 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 6.101382e-01 | 0.215 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 6.101382e-01 | 0.215 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 6.101382e-01 | 0.215 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 6.185554e-01 | 0.209 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 6.185554e-01 | 0.209 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 6.188693e-01 | 0.208 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 6.234973e-01 | 0.205 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 6.234973e-01 | 0.205 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 6.234973e-01 | 0.205 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 6.242075e-01 | 0.205 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 6.242075e-01 | 0.205 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 6.242075e-01 | 0.205 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 6.242075e-01 | 0.205 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 6.242075e-01 | 0.205 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 6.242075e-01 | 0.205 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 6.242075e-01 | 0.205 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 6.242075e-01 | 0.205 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 6.242075e-01 | 0.205 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 6.278373e-01 | 0.202 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 6.298627e-01 | 0.201 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 6.298627e-01 | 0.201 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 6.369737e-01 | 0.196 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 6.399689e-01 | 0.194 | 1 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 6.400450e-01 | 0.194 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 6.400450e-01 | 0.194 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 6.430865e-01 | 0.192 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 6.430865e-01 | 0.192 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 6.430865e-01 | 0.192 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 6.430865e-01 | 0.192 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 6.430865e-01 | 0.192 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 6.430865e-01 | 0.192 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 6.430865e-01 | 0.192 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 6.430865e-01 | 0.192 | 1 | 1 |
| Killing mechanisms | R-HSA-9664420 | 6.430865e-01 | 0.192 | 1 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 6.459633e-01 | 0.190 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 6.459633e-01 | 0.190 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 6.491464e-01 | 0.188 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 6.491464e-01 | 0.188 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 6.491464e-01 | 0.188 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 6.491464e-01 | 0.188 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 6.491464e-01 | 0.188 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 6.610181e-01 | 0.180 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 6.610181e-01 | 0.180 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 6.610181e-01 | 0.180 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 6.610181e-01 | 0.180 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 6.610181e-01 | 0.180 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 6.610181e-01 | 0.180 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 6.634967e-01 | 0.178 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 6.702317e-01 | 0.174 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 6.720387e-01 | 0.173 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 6.780498e-01 | 0.169 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 6.780498e-01 | 0.169 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 6.780498e-01 | 0.169 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 6.780498e-01 | 0.169 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 6.780498e-01 | 0.169 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 6.780498e-01 | 0.169 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 6.780498e-01 | 0.169 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 6.780498e-01 | 0.169 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 6.780498e-01 | 0.169 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 6.780498e-01 | 0.169 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 6.798720e-01 | 0.168 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 6.849894e-01 | 0.164 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 6.849894e-01 | 0.164 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 6.893015e-01 | 0.162 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 6.904067e-01 | 0.161 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 6.942268e-01 | 0.158 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 6.942268e-01 | 0.158 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 6.942268e-01 | 0.158 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 6.942268e-01 | 0.158 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 6.942268e-01 | 0.158 | 0 | 0 |
| PKA activation | R-HSA-163615 | 6.942268e-01 | 0.158 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 6.942268e-01 | 0.158 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 6.962509e-01 | 0.157 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 6.962509e-01 | 0.157 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 6.962509e-01 | 0.157 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 6.962509e-01 | 0.157 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 6.962509e-01 | 0.157 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 6.967583e-01 | 0.157 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 6.972185e-01 | 0.157 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 6.985210e-01 | 0.156 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 6.985210e-01 | 0.156 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 6.985210e-01 | 0.156 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 7.050829e-01 | 0.152 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 7.050829e-01 | 0.152 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 7.071771e-01 | 0.150 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 7.071771e-01 | 0.150 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 7.095918e-01 | 0.149 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 7.095918e-01 | 0.149 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 7.095918e-01 | 0.149 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 7.095918e-01 | 0.149 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 7.095918e-01 | 0.149 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 7.095918e-01 | 0.149 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 7.095918e-01 | 0.149 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 7.124807e-01 | 0.147 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 7.177731e-01 | 0.144 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 7.177731e-01 | 0.144 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 7.177731e-01 | 0.144 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 7.177731e-01 | 0.144 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 7.177731e-01 | 0.144 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 7.241857e-01 | 0.140 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 7.241857e-01 | 0.140 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 7.241857e-01 | 0.140 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 7.241857e-01 | 0.140 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 7.241857e-01 | 0.140 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 7.241857e-01 | 0.140 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 7.241857e-01 | 0.140 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 7.258225e-01 | 0.139 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 7.280447e-01 | 0.138 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 7.280447e-01 | 0.138 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 7.280447e-01 | 0.138 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 7.280447e-01 | 0.138 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 7.280447e-01 | 0.138 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 7.353213e-01 | 0.134 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 7.379977e-01 | 0.132 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 7.379977e-01 | 0.132 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 7.379977e-01 | 0.132 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 7.380470e-01 | 0.132 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 7.380470e-01 | 0.132 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 7.380470e-01 | 0.132 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 7.380470e-01 | 0.132 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 7.380470e-01 | 0.132 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 7.380470e-01 | 0.132 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 7.380470e-01 | 0.132 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 7.390547e-01 | 0.131 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 7.476380e-01 | 0.126 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 7.476380e-01 | 0.126 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 7.476380e-01 | 0.126 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 7.494948e-01 | 0.125 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 7.512125e-01 | 0.124 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 7.512125e-01 | 0.124 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 7.512125e-01 | 0.124 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 7.512125e-01 | 0.124 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 7.512125e-01 | 0.124 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 7.545393e-01 | 0.122 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 7.569720e-01 | 0.121 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 7.569720e-01 | 0.121 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 7.569720e-01 | 0.121 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 7.569720e-01 | 0.121 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 7.572826e-01 | 0.121 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 7.610251e-01 | 0.119 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 7.637170e-01 | 0.117 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 7.637170e-01 | 0.117 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 7.637170e-01 | 0.117 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 7.637170e-01 | 0.117 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 7.637170e-01 | 0.117 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 7.637170e-01 | 0.117 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 7.648738e-01 | 0.116 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 7.648738e-01 | 0.116 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 7.648738e-01 | 0.116 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 7.660062e-01 | 0.116 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 7.660062e-01 | 0.116 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 7.660062e-01 | 0.116 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 7.660062e-01 | 0.116 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 7.671907e-01 | 0.115 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 7.732885e-01 | 0.112 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 7.747470e-01 | 0.111 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 7.747470e-01 | 0.111 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 7.755938e-01 | 0.110 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 7.755938e-01 | 0.110 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 7.755938e-01 | 0.110 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 7.755938e-01 | 0.110 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 7.868743e-01 | 0.104 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 7.868743e-01 | 0.104 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 7.868743e-01 | 0.104 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 7.868743e-01 | 0.104 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 7.868743e-01 | 0.104 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 7.868743e-01 | 0.104 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 7.882916e-01 | 0.103 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 7.911698e-01 | 0.102 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 7.913752e-01 | 0.102 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 7.913752e-01 | 0.102 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 7.975884e-01 | 0.098 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 7.975884e-01 | 0.098 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 7.975884e-01 | 0.098 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 7.975884e-01 | 0.098 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 7.975884e-01 | 0.098 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 7.975884e-01 | 0.098 | 0 | 0 |
| Beta-oxidation of pristanoyl-CoA | R-HSA-389887 | 7.975884e-01 | 0.098 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 7.975884e-01 | 0.098 | 0 | 0 |
| Fertilization | R-HSA-1187000 | 7.975884e-01 | 0.098 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 7.975884e-01 | 0.098 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 7.992762e-01 | 0.097 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 7.999719e-01 | 0.097 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 8.069107e-01 | 0.093 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 8.069107e-01 | 0.093 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 8.077645e-01 | 0.093 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 8.077645e-01 | 0.093 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 8.077645e-01 | 0.093 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 8.077645e-01 | 0.093 | 0 | 0 |
| Attachment of bacteria to epithelial cells | R-HSA-9638630 | 8.077645e-01 | 0.093 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 8.077645e-01 | 0.093 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 8.077645e-01 | 0.093 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 8.115663e-01 | 0.091 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 8.142856e-01 | 0.089 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 8.142856e-01 | 0.089 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 8.142856e-01 | 0.089 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 8.142856e-01 | 0.089 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 8.174295e-01 | 0.088 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 8.174295e-01 | 0.088 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 8.174295e-01 | 0.088 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 8.174295e-01 | 0.088 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 8.214078e-01 | 0.085 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 8.264957e-01 | 0.083 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 8.266092e-01 | 0.083 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 8.266092e-01 | 0.083 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 8.266092e-01 | 0.083 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 8.266092e-01 | 0.083 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 8.266092e-01 | 0.083 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 8.282839e-01 | 0.082 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 8.282839e-01 | 0.082 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 8.327068e-01 | 0.080 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 8.349206e-01 | 0.078 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 8.353279e-01 | 0.078 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 8.353279e-01 | 0.078 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 8.353279e-01 | 0.078 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 8.353279e-01 | 0.078 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 8.353279e-01 | 0.078 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 8.413247e-01 | 0.075 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 8.425138e-01 | 0.074 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 8.436087e-01 | 0.074 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 8.436087e-01 | 0.074 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 8.436087e-01 | 0.074 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 8.475028e-01 | 0.072 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 8.513678e-01 | 0.070 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 8.514735e-01 | 0.070 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 8.514735e-01 | 0.070 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 8.514735e-01 | 0.070 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.514735e-01 | 0.070 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 8.534613e-01 | 0.069 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 8.563147e-01 | 0.067 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 8.570643e-01 | 0.067 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 8.589326e-01 | 0.066 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 8.589433e-01 | 0.066 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 8.589433e-01 | 0.066 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 8.589433e-01 | 0.066 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 8.589433e-01 | 0.066 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 8.592068e-01 | 0.066 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 8.606806e-01 | 0.065 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 8.647455e-01 | 0.063 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 8.660378e-01 | 0.062 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 8.660378e-01 | 0.062 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 8.660378e-01 | 0.062 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 8.700838e-01 | 0.060 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 8.700838e-01 | 0.060 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 8.700838e-01 | 0.060 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 8.727759e-01 | 0.059 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.727759e-01 | 0.059 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 8.727759e-01 | 0.059 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.727759e-01 | 0.059 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 8.727759e-01 | 0.059 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 8.752277e-01 | 0.058 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 8.791755e-01 | 0.056 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 8.791755e-01 | 0.056 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 8.791755e-01 | 0.056 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 8.791755e-01 | 0.056 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 8.791755e-01 | 0.056 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 8.791755e-01 | 0.056 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 8.791755e-01 | 0.056 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 8.791755e-01 | 0.056 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 8.791755e-01 | 0.056 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 8.801833e-01 | 0.055 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 8.808452e-01 | 0.055 | 1 | 1 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 8.810419e-01 | 0.055 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 8.852536e-01 | 0.053 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 8.852536e-01 | 0.053 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 8.852536e-01 | 0.053 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 8.852536e-01 | 0.053 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 8.852536e-01 | 0.053 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 8.852536e-01 | 0.053 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 8.852536e-01 | 0.053 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 8.852536e-01 | 0.053 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 8.892595e-01 | 0.051 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 8.895531e-01 | 0.051 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 8.910262e-01 | 0.050 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 8.910262e-01 | 0.050 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 8.910262e-01 | 0.050 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 8.910262e-01 | 0.050 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 8.939789e-01 | 0.049 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 8.957080e-01 | 0.048 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 8.965088e-01 | 0.047 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 8.965088e-01 | 0.047 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 8.965088e-01 | 0.047 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 8.965088e-01 | 0.047 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 8.965088e-01 | 0.047 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 8.965088e-01 | 0.047 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 8.965088e-01 | 0.047 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 8.965088e-01 | 0.047 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 8.982392e-01 | 0.047 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 8.982392e-01 | 0.047 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 8.982392e-01 | 0.047 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 8.984266e-01 | 0.047 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 8.993649e-01 | 0.046 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.001900e-01 | 0.046 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.017158e-01 | 0.045 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.017158e-01 | 0.045 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.017158e-01 | 0.045 | 0 | 0 |
| Biofilm formation | R-HSA-9931953 | 9.017158e-01 | 0.045 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.017158e-01 | 0.045 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 9.017158e-01 | 0.045 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.017158e-01 | 0.045 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.023396e-01 | 0.045 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.066612e-01 | 0.043 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.066612e-01 | 0.043 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.066612e-01 | 0.043 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.075646e-01 | 0.042 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.128633e-01 | 0.040 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.137336e-01 | 0.039 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.158187e-01 | 0.038 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.158187e-01 | 0.038 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.158187e-01 | 0.038 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 9.158187e-01 | 0.038 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 9.158187e-01 | 0.038 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.200552e-01 | 0.036 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.200552e-01 | 0.036 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.200552e-01 | 0.036 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 9.200552e-01 | 0.036 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 9.206237e-01 | 0.036 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 9.231826e-01 | 0.035 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.238713e-01 | 0.034 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.269933e-01 | 0.033 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.279001e-01 | 0.032 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.313800e-01 | 0.031 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.315292e-01 | 0.031 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.315292e-01 | 0.031 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.315292e-01 | 0.031 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.328783e-01 | 0.030 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 9.349759e-01 | 0.029 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 9.349759e-01 | 0.029 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.349759e-01 | 0.029 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.349759e-01 | 0.029 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.349759e-01 | 0.029 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.349759e-01 | 0.029 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.356496e-01 | 0.029 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 9.382493e-01 | 0.028 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 9.382493e-01 | 0.028 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 9.382493e-01 | 0.028 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 9.382493e-01 | 0.028 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 9.382493e-01 | 0.028 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.386341e-01 | 0.028 | 1 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 9.413581e-01 | 0.026 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.413581e-01 | 0.026 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.440578e-01 | 0.025 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.442136e-01 | 0.025 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.461235e-01 | 0.024 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.471146e-01 | 0.024 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.479509e-01 | 0.023 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.479527e-01 | 0.023 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 9.481181e-01 | 0.023 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.497776e-01 | 0.022 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.497776e-01 | 0.022 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 9.522170e-01 | 0.021 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.523066e-01 | 0.021 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 9.523066e-01 | 0.021 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.523066e-01 | 0.021 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 9.536970e-01 | 0.021 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 9.536970e-01 | 0.021 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.546839e-01 | 0.020 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 9.547084e-01 | 0.020 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 9.547084e-01 | 0.020 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 9.547084e-01 | 0.020 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 9.561463e-01 | 0.019 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.563574e-01 | 0.019 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.569894e-01 | 0.019 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.569894e-01 | 0.019 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.571260e-01 | 0.019 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.587113e-01 | 0.018 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 9.591557e-01 | 0.018 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.597654e-01 | 0.018 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.612130e-01 | 0.017 | 0 | 0 |
| Chondroitin sulfate/dermatan sulfate metabolism | R-HSA-1793185 | 9.612130e-01 | 0.017 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.614658e-01 | 0.017 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.617664e-01 | 0.017 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.630971e-01 | 0.016 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 9.631668e-01 | 0.016 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.645415e-01 | 0.016 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.646080e-01 | 0.016 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.646620e-01 | 0.016 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.650222e-01 | 0.015 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 9.661631e-01 | 0.015 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 9.661631e-01 | 0.015 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 9.667843e-01 | 0.015 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.667843e-01 | 0.015 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.670638e-01 | 0.015 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.676027e-01 | 0.014 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.684578e-01 | 0.014 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.684578e-01 | 0.014 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 9.689832e-01 | 0.014 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.700470e-01 | 0.013 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.703070e-01 | 0.013 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.711910e-01 | 0.013 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 9.711925e-01 | 0.013 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.715563e-01 | 0.013 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.715563e-01 | 0.013 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.715763e-01 | 0.013 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.727932e-01 | 0.012 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.727932e-01 | 0.012 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.727932e-01 | 0.012 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.739597e-01 | 0.011 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.743507e-01 | 0.011 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.745401e-01 | 0.011 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.752627e-01 | 0.011 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.752627e-01 | 0.011 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 9.752627e-01 | 0.011 | 1 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.756433e-01 | 0.011 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 9.756433e-01 | 0.011 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 9.761471e-01 | 0.010 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.761494e-01 | 0.010 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.771765e-01 | 0.010 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.781607e-01 | 0.010 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.791037e-01 | 0.009 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 9.791037e-01 | 0.009 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.808729e-01 | 0.008 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.821416e-01 | 0.008 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.821416e-01 | 0.008 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.830420e-01 | 0.007 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.830420e-01 | 0.007 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.838970e-01 | 0.007 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.844674e-01 | 0.007 | 1 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.847090e-01 | 0.007 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 9.853518e-01 | 0.006 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 9.853518e-01 | 0.006 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.863374e-01 | 0.006 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.866042e-01 | 0.006 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.866042e-01 | 0.006 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 9.868805e-01 | 0.006 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.881951e-01 | 0.005 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.881951e-01 | 0.005 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.887905e-01 | 0.005 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 9.906502e-01 | 0.004 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 9.906502e-01 | 0.004 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.913469e-01 | 0.004 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.925438e-01 | 0.003 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.927760e-01 | 0.003 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.934941e-01 | 0.003 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.939781e-01 | 0.003 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.939781e-01 | 0.003 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.943321e-01 | 0.002 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.945788e-01 | 0.002 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.947832e-01 | 0.002 | 1 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.951721e-01 | 0.002 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.955032e-01 | 0.002 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.958815e-01 | 0.002 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.960215e-01 | 0.002 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.963227e-01 | 0.002 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.967496e-01 | 0.001 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.968838e-01 | 0.001 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.977449e-01 | 0.001 | 1 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.978426e-01 | 0.001 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.981234e-01 | 0.001 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.985135e-01 | 0.001 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.985813e-01 | 0.001 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.987288e-01 | 0.001 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.988322e-01 | 0.001 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.989055e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.990934e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.991800e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.991998e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.993040e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.993182e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.994166e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.994715e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.994715e-01 | 0.000 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 9.994742e-01 | 0.000 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.994960e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.995830e-01 | 0.000 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.997031e-01 | 0.000 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.997031e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.997031e-01 | 0.000 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.997182e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.997958e-01 | 0.000 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.998720e-01 | 0.000 | 1 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.998720e-01 | 0.000 | 1 | 0 |
| Keratinization | R-HSA-6805567 | 9.998956e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.999308e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999509e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999729e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999750e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.999794e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999825e-01 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 9.999900e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999956e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999960e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.999974e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999975e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999983e-01 | 0.000 | 1 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.999985e-01 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.999995e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.999998e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999999e-01 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 1.000000e+00 | 0.000 | 1 | 1 |
| Activation of BMF and translocation to mitochondria | R-HSA-139910 | 1.000000e+00 | 0.000 | 1 | 1 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 1.000000e+00 | 0.000 | 1 | 1 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 1.000000e+00 | 0.000 | 1 | 1 |
| Interleukin-38 signaling | R-HSA-9007892 | 1.000000e+00 | 0.000 | 1 | 1 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Recycling pathway of L1 | R-HSA-437239 | 1.861973e-07 | 6.730 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 3.236283e-07 | 6.490 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 2.021787e-06 | 5.694 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 2.133130e-06 | 5.671 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 2.123565e-06 | 5.673 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 2.344354e-06 | 5.630 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 3.558916e-06 | 5.449 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 5.336444e-06 | 5.273 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 5.161004e-06 | 5.287 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 7.445219e-06 | 5.128 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.265092e-05 | 4.898 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.362867e-05 | 4.866 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 2.235755e-05 | 4.651 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 2.133783e-05 | 4.671 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 3.268497e-05 | 4.486 | 1 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 4.368284e-05 | 4.360 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 4.214470e-05 | 4.375 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 6.387806e-05 | 4.195 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 9.531496e-05 | 4.021 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.048873e-04 | 3.979 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.184267e-04 | 3.927 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.526179e-04 | 3.816 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.613900e-04 | 3.792 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.838538e-04 | 3.736 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.900718e-04 | 3.721 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 2.307377e-04 | 3.637 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 2.452817e-04 | 3.610 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 2.487119e-04 | 3.604 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 2.654294e-04 | 3.576 | 1 | 1 |
| Mitotic Prometaphase | R-HSA-68877 | 2.992314e-04 | 3.524 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 3.115918e-04 | 3.506 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 3.145673e-04 | 3.502 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 3.064070e-04 | 3.514 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 3.312887e-04 | 3.480 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 3.350700e-04 | 3.475 | 1 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 3.798781e-04 | 3.420 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 3.798781e-04 | 3.420 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 3.712680e-04 | 3.430 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 3.918844e-04 | 3.407 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 3.780967e-04 | 3.422 | 1 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 4.194129e-04 | 3.377 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 4.106826e-04 | 3.386 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 4.675947e-04 | 3.330 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 5.056170e-04 | 3.296 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 5.056170e-04 | 3.296 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 4.739097e-04 | 3.324 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 5.100767e-04 | 3.292 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 5.127781e-04 | 3.290 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 5.186416e-04 | 3.285 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 5.358286e-04 | 3.271 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 5.716501e-04 | 3.243 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 6.085498e-04 | 3.216 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 6.486735e-04 | 3.188 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 6.603187e-04 | 3.180 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 6.943372e-04 | 3.158 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 6.978723e-04 | 3.156 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 7.232005e-04 | 3.141 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 7.720979e-04 | 3.112 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 8.014286e-04 | 3.096 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 9.467658e-04 | 3.024 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 9.467658e-04 | 3.024 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 9.365218e-04 | 3.028 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 9.617759e-04 | 3.017 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 9.777142e-04 | 3.010 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.034848e-03 | 2.985 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.034926e-03 | 2.985 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.047038e-03 | 2.980 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.079524e-03 | 2.967 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.180648e-03 | 2.928 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.200226e-03 | 2.921 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.374321e-03 | 2.862 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 1.374321e-03 | 2.862 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.339222e-03 | 2.873 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.393494e-03 | 2.856 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.420909e-03 | 2.847 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 1.479671e-03 | 2.830 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 1.479671e-03 | 2.830 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.627094e-03 | 2.789 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.673844e-03 | 2.776 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.682088e-03 | 2.774 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.793132e-03 | 2.746 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.848024e-03 | 2.733 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.823847e-03 | 2.739 | 1 | 1 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.823847e-03 | 2.739 | 1 | 0 |
| Interferon Signaling | R-HSA-913531 | 1.873637e-03 | 2.727 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.998189e-03 | 2.699 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 2.118411e-03 | 2.674 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 2.292427e-03 | 2.640 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 2.371379e-03 | 2.625 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 2.575520e-03 | 2.589 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.684287e-03 | 2.571 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 2.675348e-03 | 2.573 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 2.810504e-03 | 2.551 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 2.967121e-03 | 2.528 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 3.198421e-03 | 2.495 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 3.401439e-03 | 2.468 | 1 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.285013e-03 | 2.483 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 3.425103e-03 | 2.465 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 3.285013e-03 | 2.483 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 3.339506e-03 | 2.476 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 3.557989e-03 | 2.449 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 3.896696e-03 | 2.409 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 3.896696e-03 | 2.409 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 3.929699e-03 | 2.406 | 1 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 3.962650e-03 | 2.402 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 3.979169e-03 | 2.400 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 4.239346e-03 | 2.373 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 4.128804e-03 | 2.384 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 4.381723e-03 | 2.358 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 4.204101e-03 | 2.376 | 0 | 0 |
| Protein folding | R-HSA-391251 | 4.169494e-03 | 2.380 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 4.458643e-03 | 2.351 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 4.458643e-03 | 2.351 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 4.607184e-03 | 2.337 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 4.692758e-03 | 2.329 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 4.753542e-03 | 2.323 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 5.026230e-03 | 2.299 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 5.052724e-03 | 2.296 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 5.157661e-03 | 2.288 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 5.333269e-03 | 2.273 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 5.409070e-03 | 2.267 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 5.939711e-03 | 2.226 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 6.095831e-03 | 2.215 | 1 | 0 |
| Signaling by EGFR | R-HSA-177929 | 6.175899e-03 | 2.209 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 6.203468e-03 | 2.207 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 6.978663e-03 | 2.156 | 1 | 0 |
| Activation of RAC1 | R-HSA-428540 | 7.562018e-03 | 2.121 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 7.778550e-03 | 2.109 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 7.809600e-03 | 2.107 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 7.953046e-03 | 2.099 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 8.669204e-03 | 2.062 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 8.669204e-03 | 2.062 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 9.794679e-03 | 2.009 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 9.794679e-03 | 2.009 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 9.177545e-03 | 2.037 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 9.115813e-03 | 2.040 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 9.794679e-03 | 2.009 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 9.819632e-03 | 2.008 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.057169e-02 | 1.976 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.097748e-02 | 1.959 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.132273e-02 | 1.946 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.140066e-02 | 1.943 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 1.273154e-02 | 1.895 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 1.273154e-02 | 1.895 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.226008e-02 | 1.912 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 1.226008e-02 | 1.912 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 1.244254e-02 | 1.905 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 1.244254e-02 | 1.905 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 1.244254e-02 | 1.905 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.274060e-02 | 1.895 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.274060e-02 | 1.895 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.274060e-02 | 1.895 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.274060e-02 | 1.895 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.244254e-02 | 1.905 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 1.188557e-02 | 1.925 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 1.226008e-02 | 1.912 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.274060e-02 | 1.895 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.277837e-02 | 1.894 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.285826e-02 | 1.891 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.322571e-02 | 1.879 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 1.379106e-02 | 1.860 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.450929e-02 | 1.838 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 1.545493e-02 | 1.811 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 1.545493e-02 | 1.811 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.553702e-02 | 1.809 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 1.597151e-02 | 1.797 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.632921e-02 | 1.787 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.632921e-02 | 1.787 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.635314e-02 | 1.786 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.907828e-02 | 1.719 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.839231e-02 | 1.735 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 1.912700e-02 | 1.718 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.839231e-02 | 1.735 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.734064e-02 | 1.761 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.793873e-02 | 1.746 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 2.015308e-02 | 1.696 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 2.048956e-02 | 1.688 | 1 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 2.069052e-02 | 1.684 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 2.137395e-02 | 1.670 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 2.155431e-02 | 1.666 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 2.247840e-02 | 1.648 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 2.344457e-02 | 1.630 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 2.403499e-02 | 1.619 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 2.421667e-02 | 1.616 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 2.434904e-02 | 1.614 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 2.478570e-02 | 1.606 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 2.493518e-02 | 1.603 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.529365e-02 | 1.597 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 2.666032e-02 | 1.574 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 2.683660e-02 | 1.571 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 2.686599e-02 | 1.571 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 2.688093e-02 | 1.571 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 2.701946e-02 | 1.568 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 2.776703e-02 | 1.556 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 3.483245e-02 | 1.458 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 3.435859e-02 | 1.464 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 3.150648e-02 | 1.502 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 3.213459e-02 | 1.493 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 3.329419e-02 | 1.478 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 3.031761e-02 | 1.518 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 3.483245e-02 | 1.458 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 3.483245e-02 | 1.458 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 3.613630e-02 | 1.442 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 3.793105e-02 | 1.421 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 3.802803e-02 | 1.420 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 3.802803e-02 | 1.420 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 3.808028e-02 | 1.419 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 3.858080e-02 | 1.414 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 3.865355e-02 | 1.413 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 3.888052e-02 | 1.410 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 3.969089e-02 | 1.401 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 3.971519e-02 | 1.401 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 3.975901e-02 | 1.401 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 4.004574e-02 | 1.397 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 4.044301e-02 | 1.393 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 4.044301e-02 | 1.393 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 4.044301e-02 | 1.393 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 4.681358e-02 | 1.330 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 4.681358e-02 | 1.330 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 4.851867e-02 | 1.314 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 4.347339e-02 | 1.362 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 4.434568e-02 | 1.353 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 4.452342e-02 | 1.351 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 4.626593e-02 | 1.335 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 4.681358e-02 | 1.330 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 4.510597e-02 | 1.346 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 4.147276e-02 | 1.382 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 4.605104e-02 | 1.337 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 4.077581e-02 | 1.390 | 1 | 1 |
| HCMV Infection | R-HSA-9609646 | 4.629012e-02 | 1.335 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 4.110408e-02 | 1.386 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 4.851867e-02 | 1.314 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 4.095885e-02 | 1.388 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 4.792930e-02 | 1.319 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 4.856835e-02 | 1.314 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 4.379277e-02 | 1.359 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 5.020764e-02 | 1.299 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 5.164370e-02 | 1.287 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 5.164370e-02 | 1.287 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 5.181891e-02 | 1.286 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 5.414946e-02 | 1.266 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 5.586028e-02 | 1.253 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 5.724018e-02 | 1.242 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 5.741727e-02 | 1.241 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 5.863298e-02 | 1.232 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 5.876382e-02 | 1.231 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 5.886009e-02 | 1.230 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 5.886009e-02 | 1.230 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 5.886009e-02 | 1.230 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 5.928816e-02 | 1.227 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 5.928816e-02 | 1.227 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 5.928816e-02 | 1.227 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 5.928816e-02 | 1.227 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 5.928816e-02 | 1.227 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 5.931978e-02 | 1.227 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 5.931978e-02 | 1.227 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 5.931978e-02 | 1.227 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 5.959557e-02 | 1.225 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 5.959557e-02 | 1.225 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 5.959557e-02 | 1.225 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 6.100819e-02 | 1.215 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 6.159557e-02 | 1.210 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 7.652815e-02 | 1.116 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 7.652815e-02 | 1.116 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 7.652815e-02 | 1.116 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 7.652815e-02 | 1.116 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 7.220615e-02 | 1.141 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 7.762915e-02 | 1.110 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 7.762915e-02 | 1.110 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 7.762915e-02 | 1.110 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 6.372597e-02 | 1.196 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 7.156511e-02 | 1.145 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 7.080102e-02 | 1.150 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 7.080102e-02 | 1.150 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 6.496856e-02 | 1.187 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 7.080102e-02 | 1.150 | 1 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 7.551577e-02 | 1.122 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 6.792347e-02 | 1.168 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 6.881630e-02 | 1.162 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 6.526236e-02 | 1.185 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 6.873057e-02 | 1.163 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 7.729249e-02 | 1.112 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 7.220615e-02 | 1.141 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 6.490357e-02 | 1.188 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 6.712698e-02 | 1.173 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 6.579098e-02 | 1.182 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 7.251163e-02 | 1.140 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 7.762915e-02 | 1.110 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 7.063227e-02 | 1.151 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 7.408675e-02 | 1.130 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 7.080102e-02 | 1.150 | 0 | 0 |
| S Phase | R-HSA-69242 | 7.768808e-02 | 1.110 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 7.946770e-02 | 1.100 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 7.969298e-02 | 1.099 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 8.348204e-02 | 1.078 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 8.348204e-02 | 1.078 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 8.348204e-02 | 1.078 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 8.348204e-02 | 1.078 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 8.348204e-02 | 1.078 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 8.624835e-02 | 1.064 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 8.676931e-02 | 1.062 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 8.676931e-02 | 1.062 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 8.676931e-02 | 1.062 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 8.695532e-02 | 1.061 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 8.889907e-02 | 1.051 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 8.889907e-02 | 1.051 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 8.893731e-02 | 1.051 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 8.937470e-02 | 1.049 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 9.004593e-02 | 1.046 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 9.133484e-02 | 1.039 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 9.165650e-02 | 1.038 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.165650e-02 | 1.038 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 9.259868e-02 | 1.033 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 9.259868e-02 | 1.033 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 9.422930e-02 | 1.026 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 9.461211e-02 | 1.024 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 9.461211e-02 | 1.024 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 9.461211e-02 | 1.024 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 9.580875e-02 | 1.019 | 1 | 0 |
| HIV Infection | R-HSA-162906 | 9.616049e-02 | 1.017 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 9.801269e-02 | 1.009 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 1.080164e-01 | 0.967 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.080164e-01 | 0.967 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 1.080164e-01 | 0.967 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 1.080164e-01 | 0.967 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 1.341648e-01 | 0.872 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 1.191737e-01 | 0.924 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 1.191737e-01 | 0.924 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 1.262508e-01 | 0.899 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 1.262508e-01 | 0.899 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.033939e-01 | 0.986 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.083408e-01 | 0.965 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 1.321532e-01 | 0.879 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 1.107232e-01 | 0.956 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 1.184061e-01 | 0.927 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.185597e-01 | 0.926 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.185597e-01 | 0.926 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 1.150730e-01 | 0.939 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.136175e-01 | 0.945 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 1.225129e-01 | 0.912 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.029062e-01 | 0.988 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 1.136175e-01 | 0.945 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 1.136175e-01 | 0.945 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.115359e-01 | 0.953 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.231819e-01 | 0.909 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.191737e-01 | 0.924 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.047577e-01 | 0.980 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.258320e-01 | 0.900 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 1.338846e-01 | 0.873 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 1.111260e-01 | 0.954 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 1.033939e-01 | 0.986 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.046168e-01 | 0.980 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.265857e-01 | 0.898 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 1.221755e-01 | 0.913 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 1.163196e-01 | 0.934 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.115381e-01 | 0.953 | 1 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 1.341648e-01 | 0.872 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 1.068482e-01 | 0.971 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.321532e-01 | 0.879 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.136175e-01 | 0.945 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.028107e-01 | 0.988 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.007685e-01 | 0.997 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 1.009067e-01 | 0.996 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 1.136175e-01 | 0.945 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.345957e-01 | 0.871 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.357267e-01 | 0.867 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.357267e-01 | 0.867 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 1.368151e-01 | 0.864 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.368151e-01 | 0.864 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.368151e-01 | 0.864 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 1.368151e-01 | 0.864 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.379053e-01 | 0.860 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.379053e-01 | 0.860 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.412632e-01 | 0.850 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 1.425053e-01 | 0.846 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.428637e-01 | 0.845 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.430909e-01 | 0.844 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.440363e-01 | 0.842 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.472040e-01 | 0.832 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 1.472040e-01 | 0.832 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.472040e-01 | 0.832 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.472040e-01 | 0.832 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 1.472040e-01 | 0.832 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.472040e-01 | 0.832 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.472040e-01 | 0.832 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 1.472040e-01 | 0.832 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 1.500133e-01 | 0.824 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.551432e-01 | 0.809 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.552786e-01 | 0.809 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 1.555694e-01 | 0.808 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 1.558252e-01 | 0.807 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 1.558252e-01 | 0.807 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 1.558252e-01 | 0.807 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 1.615370e-01 | 0.792 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 1.615505e-01 | 0.792 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.625503e-01 | 0.789 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.633046e-01 | 0.787 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 1.660070e-01 | 0.780 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 1.695471e-01 | 0.771 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 1.706800e-01 | 0.768 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.706800e-01 | 0.768 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 1.734011e-01 | 0.761 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 2.124747e-01 | 0.673 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 2.124747e-01 | 0.673 | 0 | 0 |
| Defective VWF binding to collagen type I | R-HSA-9845622 | 2.124747e-01 | 0.673 | 0 | 0 |
| Defective MMADHC causes MMAHCD | R-HSA-3359473 | 2.124747e-01 | 0.673 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.124747e-01 | 0.673 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 2.727533e-01 | 0.564 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 2.727533e-01 | 0.564 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 2.727533e-01 | 0.564 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 2.727533e-01 | 0.564 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 2.727533e-01 | 0.564 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 2.727533e-01 | 0.564 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 2.727533e-01 | 0.564 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 2.727533e-01 | 0.564 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 2.727533e-01 | 0.564 | 0 | 0 |
| Enhanced cleavage of VWF variant by ADAMTS13 | R-HSA-9845619 | 2.727533e-01 | 0.564 | 0 | 0 |
| Defective VWF cleavage by ADAMTS13 variant | R-HSA-9845621 | 2.727533e-01 | 0.564 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 2.727533e-01 | 0.564 | 0 | 0 |
| Glycogen storage disease type IV (GBE1) | R-HSA-3878781 | 2.727533e-01 | 0.564 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 2.727533e-01 | 0.564 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 2.727533e-01 | 0.564 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 2.727533e-01 | 0.564 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 2.727533e-01 | 0.564 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 2.727533e-01 | 0.564 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 1.897928e-01 | 0.722 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 1.897928e-01 | 0.722 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 1.897928e-01 | 0.722 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.897928e-01 | 0.722 | 0 | 0 |
| Defective MMACHC causes MAHCC | R-HSA-3359474 | 3.284214e-01 | 0.484 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 3.284214e-01 | 0.484 | 1 | 1 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 3.284214e-01 | 0.484 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 3.284214e-01 | 0.484 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 3.284214e-01 | 0.484 | 0 | 0 |
| Adrenaline signalling through Alpha-2 adrenergic receptor | R-HSA-392023 | 3.284214e-01 | 0.484 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 2.186372e-01 | 0.660 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 2.186372e-01 | 0.660 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 2.478147e-01 | 0.606 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 3.798314e-01 | 0.420 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 3.798314e-01 | 0.420 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 3.798314e-01 | 0.420 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 3.798314e-01 | 0.420 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.942595e-01 | 0.712 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 1.942595e-01 | 0.712 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 1.942595e-01 | 0.712 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 1.942595e-01 | 0.712 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 2.771057e-01 | 0.557 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.145752e-01 | 0.668 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 1.862762e-01 | 0.730 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 1.862762e-01 | 0.730 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 4.273088e-01 | 0.369 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 4.273088e-01 | 0.369 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 4.273088e-01 | 0.369 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 4.273088e-01 | 0.369 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 4.273088e-01 | 0.369 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 2.023097e-01 | 0.694 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.563775e-01 | 0.591 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 3.353036e-01 | 0.475 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 3.353036e-01 | 0.475 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.991510e-01 | 0.524 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 2.991510e-01 | 0.524 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 3.639154e-01 | 0.439 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 3.639154e-01 | 0.439 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 3.639154e-01 | 0.439 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 4.711541e-01 | 0.327 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 4.711541e-01 | 0.327 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 4.711541e-01 | 0.327 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 4.711541e-01 | 0.327 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 4.711541e-01 | 0.327 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 4.711541e-01 | 0.327 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 2.307245e-01 | 0.637 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 2.307245e-01 | 0.637 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 2.698474e-01 | 0.569 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 3.206994e-01 | 0.494 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 3.920444e-01 | 0.407 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 2.600197e-01 | 0.585 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 3.422578e-01 | 0.466 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 3.422578e-01 | 0.466 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 2.018980e-01 | 0.695 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 2.629877e-01 | 0.580 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 3.227546e-01 | 0.491 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 3.227546e-01 | 0.491 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 3.637601e-01 | 0.439 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 3.637601e-01 | 0.439 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 4.195968e-01 | 0.377 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 4.195968e-01 | 0.377 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 5.116450e-01 | 0.291 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 5.116450e-01 | 0.291 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 5.116450e-01 | 0.291 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 5.116450e-01 | 0.291 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 5.116450e-01 | 0.291 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 2.209572e-01 | 0.656 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 3.207880e-01 | 0.494 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 2.756504e-01 | 0.560 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 4.464962e-01 | 0.350 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 4.464962e-01 | 0.350 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 3.588052e-01 | 0.445 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 3.727846e-01 | 0.429 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 4.981033e-01 | 0.303 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 4.007718e-01 | 0.397 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 4.007718e-01 | 0.397 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 4.684759e-01 | 0.329 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 3.783917e-01 | 0.422 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 4.885408e-01 | 0.311 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 4.601156e-01 | 0.337 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 5.082285e-01 | 0.294 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 5.082285e-01 | 0.294 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 5.147581e-01 | 0.288 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 5.147581e-01 | 0.288 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 4.906291e-01 | 0.309 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 2.626962e-01 | 0.581 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 3.207880e-01 | 0.494 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 4.274327e-01 | 0.369 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 4.259429e-01 | 0.371 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 2.563775e-01 | 0.591 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.888062e-01 | 0.724 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 3.207880e-01 | 0.494 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 3.275383e-01 | 0.485 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 4.195968e-01 | 0.377 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.795775e-01 | 0.746 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 4.641521e-01 | 0.333 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 3.269384e-01 | 0.486 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 2.478147e-01 | 0.606 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 3.851451e-01 | 0.414 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 1.897928e-01 | 0.722 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 2.478147e-01 | 0.606 | 1 | 1 |
| PI3K/AKT activation | R-HSA-198203 | 2.771057e-01 | 0.557 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 3.353036e-01 | 0.475 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 3.053964e-01 | 0.515 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 3.851451e-01 | 0.414 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 3.207880e-01 | 0.494 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 4.885408e-01 | 0.311 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 2.307245e-01 | 0.637 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 2.763186e-01 | 0.559 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 3.512071e-01 | 0.454 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 2.354942e-01 | 0.628 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 3.637601e-01 | 0.439 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 2.776847e-01 | 0.556 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 2.991510e-01 | 0.524 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 3.639154e-01 | 0.439 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 3.639154e-01 | 0.439 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 3.639154e-01 | 0.439 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 2.878932e-01 | 0.541 | 1 | 1 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 1.862762e-01 | 0.730 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 3.063220e-01 | 0.514 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 4.684759e-01 | 0.329 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.942595e-01 | 0.712 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 2.353119e-01 | 0.628 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 4.273088e-01 | 0.369 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 4.273088e-01 | 0.369 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 2.563775e-01 | 0.591 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 2.116019e-01 | 0.674 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 3.422578e-01 | 0.466 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 4.752572e-01 | 0.323 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 4.752572e-01 | 0.323 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 2.776847e-01 | 0.556 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 3.920444e-01 | 0.407 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 1.795775e-01 | 0.746 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 1.795775e-01 | 0.746 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 1.795775e-01 | 0.746 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 1.795775e-01 | 0.746 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 4.425624e-01 | 0.354 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 3.890180e-01 | 0.410 | 1 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 5.116450e-01 | 0.291 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 4.726811e-01 | 0.325 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 3.195399e-01 | 0.495 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 4.885408e-01 | 0.311 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 5.227261e-01 | 0.282 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 2.241171e-01 | 0.650 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 3.518025e-01 | 0.454 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 2.917094e-01 | 0.535 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 1.756584e-01 | 0.755 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 3.353036e-01 | 0.475 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 3.206994e-01 | 0.494 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.956388e-01 | 0.709 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 4.684759e-01 | 0.329 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 4.731616e-01 | 0.325 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 5.223815e-01 | 0.282 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 2.478147e-01 | 0.606 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 2.923134e-01 | 0.534 | 1 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 2.113413e-01 | 0.675 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 4.274327e-01 | 0.369 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 2.353119e-01 | 0.628 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 2.187319e-01 | 0.660 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 2.776847e-01 | 0.556 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 4.528961e-01 | 0.344 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 3.053964e-01 | 0.515 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 2.316088e-01 | 0.635 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 2.124747e-01 | 0.673 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 2.727533e-01 | 0.564 | 0 | 0 |
| Signalling to ERK5 | R-HSA-198765 | 2.727533e-01 | 0.564 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 2.727533e-01 | 0.564 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 3.284214e-01 | 0.484 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 3.284214e-01 | 0.484 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 2.478147e-01 | 0.606 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 3.798314e-01 | 0.420 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 3.798314e-01 | 0.420 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 2.353119e-01 | 0.628 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 2.353119e-01 | 0.628 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 3.063220e-01 | 0.514 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 4.273088e-01 | 0.369 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 4.273088e-01 | 0.369 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 2.187319e-01 | 0.660 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 3.353036e-01 | 0.475 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 4.195968e-01 | 0.377 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 5.116450e-01 | 0.291 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 2.763186e-01 | 0.559 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 4.464962e-01 | 0.350 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 4.063572e-01 | 0.391 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 4.273458e-01 | 0.369 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 4.117958e-01 | 0.385 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 5.227261e-01 | 0.282 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 5.147581e-01 | 0.288 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 5.197658e-01 | 0.284 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 3.339796e-01 | 0.476 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 3.518025e-01 | 0.454 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 3.762815e-01 | 0.424 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 3.448596e-01 | 0.462 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 3.122285e-01 | 0.506 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 3.145609e-01 | 0.502 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 3.206994e-01 | 0.494 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 3.526651e-01 | 0.453 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 1.754903e-01 | 0.756 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.921971e-01 | 0.716 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 3.985526e-01 | 0.400 | 1 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 2.771057e-01 | 0.557 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 2.353119e-01 | 0.628 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.991510e-01 | 0.524 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 4.195968e-01 | 0.377 | 1 | 1 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 4.981033e-01 | 0.303 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 5.227261e-01 | 0.282 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.926352e-01 | 0.715 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 4.726811e-01 | 0.325 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.746825e-01 | 0.758 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 3.405821e-01 | 0.468 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 2.629877e-01 | 0.580 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 3.379484e-01 | 0.471 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 3.002596e-01 | 0.523 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 2.771057e-01 | 0.557 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 3.639154e-01 | 0.439 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 3.639154e-01 | 0.439 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 3.639154e-01 | 0.439 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 4.806140e-01 | 0.318 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 3.943726e-01 | 0.404 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 4.837413e-01 | 0.315 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 2.368665e-01 | 0.625 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 4.007718e-01 | 0.397 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 3.033172e-01 | 0.518 | 1 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 3.049948e-01 | 0.516 | 1 | 0 |
| Downstream signal transduction | R-HSA-186763 | 3.405821e-01 | 0.468 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 4.480656e-01 | 0.349 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 4.293998e-01 | 0.367 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 3.006529e-01 | 0.522 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 3.851451e-01 | 0.414 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 3.284214e-01 | 0.484 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 2.771057e-01 | 0.557 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 2.353119e-01 | 0.628 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 4.711541e-01 | 0.327 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 1.795775e-01 | 0.746 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 2.749834e-01 | 0.561 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 4.063572e-01 | 0.391 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 3.762815e-01 | 0.424 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 4.726811e-01 | 0.325 | 1 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 4.726811e-01 | 0.325 | 1 | 1 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 3.620793e-01 | 0.441 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 4.614233e-01 | 0.336 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 3.246530e-01 | 0.489 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 3.985071e-01 | 0.400 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 2.515965e-01 | 0.599 | 1 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 2.991510e-01 | 0.524 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 3.637601e-01 | 0.439 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 3.362658e-01 | 0.473 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 5.147581e-01 | 0.288 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 5.147581e-01 | 0.288 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 3.063220e-01 | 0.514 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 3.829482e-01 | 0.417 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 2.364144e-01 | 0.626 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 4.701077e-01 | 0.328 | 1 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 2.558815e-01 | 0.592 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 4.684759e-01 | 0.329 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 4.020264e-01 | 0.396 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 2.622645e-01 | 0.581 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 3.851451e-01 | 0.414 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 3.908761e-01 | 0.408 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 2.116019e-01 | 0.674 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 1.897928e-01 | 0.722 | 0 | 0 |
| The NLRP1 inflammasome | R-HSA-844455 | 3.284214e-01 | 0.484 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 2.478147e-01 | 0.606 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 4.711541e-01 | 0.327 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 3.920444e-01 | 0.407 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 3.053964e-01 | 0.515 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 1.807686e-01 | 0.743 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 4.464962e-01 | 0.350 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 4.726811e-01 | 0.325 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 4.726811e-01 | 0.325 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 3.715295e-01 | 0.430 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 3.686512e-01 | 0.433 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 3.596299e-01 | 0.444 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 3.980320e-01 | 0.400 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 4.480656e-01 | 0.349 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 4.684759e-01 | 0.329 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 5.227261e-01 | 0.282 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 2.478147e-01 | 0.606 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 4.972643e-01 | 0.303 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 4.972643e-01 | 0.303 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 2.563775e-01 | 0.591 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 3.422578e-01 | 0.466 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 4.195968e-01 | 0.377 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 5.116450e-01 | 0.291 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 3.471926e-01 | 0.459 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 4.630379e-01 | 0.334 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 4.140252e-01 | 0.383 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 3.762815e-01 | 0.424 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.921893e-01 | 0.716 | 1 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 2.771057e-01 | 0.557 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 3.920444e-01 | 0.407 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 4.367275e-01 | 0.360 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 3.063220e-01 | 0.514 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 3.063220e-01 | 0.514 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 4.273088e-01 | 0.369 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 4.711541e-01 | 0.327 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 5.116450e-01 | 0.291 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 5.116450e-01 | 0.291 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 4.464962e-01 | 0.350 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 3.639154e-01 | 0.439 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 2.743972e-01 | 0.562 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 4.981033e-01 | 0.303 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 3.512071e-01 | 0.454 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 4.707182e-01 | 0.327 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 4.480656e-01 | 0.349 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 4.063572e-01 | 0.391 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 5.239281e-01 | 0.281 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 5.239281e-01 | 0.281 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 5.275118e-01 | 0.278 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 5.275118e-01 | 0.278 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 5.275118e-01 | 0.278 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 5.342448e-01 | 0.272 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 5.463671e-01 | 0.263 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 5.463671e-01 | 0.263 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 5.463671e-01 | 0.263 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 5.465230e-01 | 0.262 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 5.465230e-01 | 0.262 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 5.465230e-01 | 0.262 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 5.465230e-01 | 0.262 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 5.465230e-01 | 0.262 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 5.465230e-01 | 0.262 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 5.465230e-01 | 0.262 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 5.465230e-01 | 0.262 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 5.465230e-01 | 0.262 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 5.472305e-01 | 0.262 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 5.472305e-01 | 0.262 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 5.472305e-01 | 0.262 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 5.490380e-01 | 0.260 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 5.490380e-01 | 0.260 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 5.490380e-01 | 0.260 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 5.490380e-01 | 0.260 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 5.490380e-01 | 0.260 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 5.490380e-01 | 0.260 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 5.490380e-01 | 0.260 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 5.490380e-01 | 0.260 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 5.490380e-01 | 0.260 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 5.490380e-01 | 0.260 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 5.490380e-01 | 0.260 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 5.490380e-01 | 0.260 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 5.490380e-01 | 0.260 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 5.515781e-01 | 0.258 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 5.526488e-01 | 0.258 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 5.647745e-01 | 0.248 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 5.694760e-01 | 0.245 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 5.751258e-01 | 0.240 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 5.754602e-01 | 0.240 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 5.754602e-01 | 0.240 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 5.754602e-01 | 0.240 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 5.756692e-01 | 0.240 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 5.766425e-01 | 0.239 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 5.782240e-01 | 0.238 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 5.785323e-01 | 0.238 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 5.827177e-01 | 0.235 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 5.827177e-01 | 0.235 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 5.827177e-01 | 0.235 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 5.835699e-01 | 0.234 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 5.835699e-01 | 0.234 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 5.835699e-01 | 0.234 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 5.835699e-01 | 0.234 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 5.835699e-01 | 0.234 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 5.835699e-01 | 0.234 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 5.835699e-01 | 0.234 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 5.835699e-01 | 0.234 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 5.835699e-01 | 0.234 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 5.835699e-01 | 0.234 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 5.835699e-01 | 0.234 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 5.835699e-01 | 0.234 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 5.835699e-01 | 0.234 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 5.878543e-01 | 0.231 | 1 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 5.915749e-01 | 0.228 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 5.915749e-01 | 0.228 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 5.915749e-01 | 0.228 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 5.937110e-01 | 0.226 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 5.949472e-01 | 0.226 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 5.949472e-01 | 0.226 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 5.949472e-01 | 0.226 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 5.966913e-01 | 0.224 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 5.979541e-01 | 0.223 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 6.000975e-01 | 0.222 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 6.000975e-01 | 0.222 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 6.001833e-01 | 0.222 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 6.001833e-01 | 0.222 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 6.001833e-01 | 0.222 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 6.033884e-01 | 0.219 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 6.085605e-01 | 0.216 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 6.128158e-01 | 0.213 | 1 | 1 |
| Signalling to RAS | R-HSA-167044 | 6.128158e-01 | 0.213 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 6.128158e-01 | 0.213 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 6.154595e-01 | 0.211 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 6.154595e-01 | 0.211 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 6.154595e-01 | 0.211 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 6.154595e-01 | 0.211 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 6.154595e-01 | 0.211 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 6.154595e-01 | 0.211 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 6.154595e-01 | 0.211 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 6.154595e-01 | 0.211 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 6.154595e-01 | 0.211 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 6.154595e-01 | 0.211 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 6.154595e-01 | 0.211 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 6.154595e-01 | 0.211 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 6.154595e-01 | 0.211 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 6.171611e-01 | 0.210 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 6.171611e-01 | 0.210 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 6.198156e-01 | 0.208 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 6.230721e-01 | 0.205 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 6.239824e-01 | 0.205 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 6.251380e-01 | 0.204 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 6.293466e-01 | 0.201 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 6.336435e-01 | 0.198 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 6.336435e-01 | 0.198 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 6.336435e-01 | 0.198 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 6.356124e-01 | 0.197 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 6.356124e-01 | 0.197 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 6.372386e-01 | 0.196 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 6.377542e-01 | 0.195 | 1 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 6.377542e-01 | 0.195 | 1 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 6.377542e-01 | 0.195 | 1 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 6.419317e-01 | 0.193 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 6.449087e-01 | 0.191 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 6.449087e-01 | 0.191 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 6.449087e-01 | 0.191 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 6.449087e-01 | 0.191 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 6.449087e-01 | 0.191 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 6.449087e-01 | 0.191 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 6.449087e-01 | 0.191 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 6.449087e-01 | 0.191 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 6.449087e-01 | 0.191 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 6.449087e-01 | 0.191 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 6.449087e-01 | 0.191 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 6.496253e-01 | 0.187 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 6.510542e-01 | 0.186 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 6.527358e-01 | 0.185 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 6.527358e-01 | 0.185 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 6.527358e-01 | 0.185 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 6.527358e-01 | 0.185 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 6.527358e-01 | 0.185 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 6.542471e-01 | 0.184 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 6.542471e-01 | 0.184 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 6.555892e-01 | 0.183 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 6.582229e-01 | 0.182 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 6.582229e-01 | 0.182 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 6.625648e-01 | 0.179 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 6.662884e-01 | 0.176 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 6.714320e-01 | 0.173 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 6.714320e-01 | 0.173 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 6.714320e-01 | 0.173 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 6.714320e-01 | 0.173 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 6.714320e-01 | 0.173 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 6.715727e-01 | 0.173 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 6.721043e-01 | 0.173 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 6.721043e-01 | 0.173 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 6.721043e-01 | 0.173 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 6.721043e-01 | 0.173 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 6.721043e-01 | 0.173 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 6.721043e-01 | 0.173 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 6.721043e-01 | 0.173 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 6.721043e-01 | 0.173 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 6.721043e-01 | 0.173 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 6.721043e-01 | 0.173 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 6.721043e-01 | 0.173 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 6.721146e-01 | 0.173 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 6.726860e-01 | 0.172 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 6.799415e-01 | 0.168 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 6.800779e-01 | 0.167 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 6.805466e-01 | 0.167 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 6.891525e-01 | 0.162 | 1 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 6.893030e-01 | 0.162 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 6.893030e-01 | 0.162 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 6.903564e-01 | 0.161 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 6.945488e-01 | 0.158 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 6.955859e-01 | 0.158 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 6.972185e-01 | 0.157 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 6.972185e-01 | 0.157 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 6.972185e-01 | 0.157 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 6.972185e-01 | 0.157 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 6.972185e-01 | 0.157 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 6.972185e-01 | 0.157 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 6.972185e-01 | 0.157 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 6.972185e-01 | 0.157 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 6.972185e-01 | 0.157 | 0 | 0 |
| Anchoring fibril formation | R-HSA-2214320 | 6.972185e-01 | 0.157 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 7.027353e-01 | 0.153 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 7.027353e-01 | 0.153 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 7.027353e-01 | 0.153 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 7.061385e-01 | 0.151 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 7.061385e-01 | 0.151 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 7.063656e-01 | 0.151 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 7.063656e-01 | 0.151 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 7.085192e-01 | 0.150 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 7.115973e-01 | 0.148 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 7.116563e-01 | 0.148 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 7.125651e-01 | 0.147 | 1 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 7.147525e-01 | 0.146 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 7.147525e-01 | 0.146 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 7.204106e-01 | 0.142 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 7.204106e-01 | 0.142 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 7.204106e-01 | 0.142 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 7.204106e-01 | 0.142 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 7.204106e-01 | 0.142 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 7.204106e-01 | 0.142 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 7.204106e-01 | 0.142 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 7.204106e-01 | 0.142 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 7.204106e-01 | 0.142 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 7.204106e-01 | 0.142 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 7.204106e-01 | 0.142 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 7.204106e-01 | 0.142 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 7.219934e-01 | 0.141 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 7.219934e-01 | 0.141 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 7.219934e-01 | 0.141 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 7.226387e-01 | 0.141 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 7.226387e-01 | 0.141 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 7.264089e-01 | 0.139 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 7.304792e-01 | 0.136 | 1 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 7.304792e-01 | 0.136 | 1 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 7.349768e-01 | 0.134 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 7.355694e-01 | 0.133 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 7.377063e-01 | 0.132 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 7.378229e-01 | 0.132 | 1 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 7.381432e-01 | 0.132 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 7.381432e-01 | 0.132 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 7.418275e-01 | 0.130 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 7.418275e-01 | 0.130 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 7.418275e-01 | 0.130 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 7.418275e-01 | 0.130 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 7.418275e-01 | 0.130 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 7.418275e-01 | 0.130 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 7.418275e-01 | 0.130 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 7.458941e-01 | 0.127 | 1 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 7.459369e-01 | 0.127 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 7.474763e-01 | 0.126 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 7.486474e-01 | 0.126 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 7.490090e-01 | 0.126 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 7.524957e-01 | 0.123 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 7.524957e-01 | 0.123 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 7.529012e-01 | 0.123 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 7.529012e-01 | 0.123 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 7.534334e-01 | 0.123 | 1 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 7.534334e-01 | 0.123 | 1 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 7.537907e-01 | 0.123 | 1 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 7.537907e-01 | 0.123 | 1 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 7.569131e-01 | 0.121 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 7.592354e-01 | 0.120 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 7.616050e-01 | 0.118 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 7.616050e-01 | 0.118 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 7.616050e-01 | 0.118 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 7.616050e-01 | 0.118 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 7.616050e-01 | 0.118 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 7.616050e-01 | 0.118 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 7.616050e-01 | 0.118 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 7.639407e-01 | 0.117 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 7.662137e-01 | 0.116 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 7.669361e-01 | 0.115 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 7.669361e-01 | 0.115 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 7.669361e-01 | 0.115 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 7.677358e-01 | 0.115 | 1 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 7.694743e-01 | 0.114 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 7.710551e-01 | 0.113 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 7.743055e-01 | 0.111 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 7.746348e-01 | 0.111 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 7.764351e-01 | 0.110 | 1 | 0 |
| Extension of Telomeres | R-HSA-180786 | 7.793686e-01 | 0.108 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 7.798686e-01 | 0.108 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 7.798686e-01 | 0.108 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 7.798686e-01 | 0.108 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 7.798686e-01 | 0.108 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 7.798686e-01 | 0.108 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 7.798686e-01 | 0.108 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 7.798686e-01 | 0.108 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 7.798686e-01 | 0.108 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 7.798686e-01 | 0.108 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 7.798686e-01 | 0.108 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 7.798686e-01 | 0.108 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 7.798686e-01 | 0.108 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 7.798686e-01 | 0.108 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 7.801808e-01 | 0.108 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 7.821525e-01 | 0.107 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 7.888602e-01 | 0.103 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 7.923893e-01 | 0.101 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 7.928018e-01 | 0.101 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 7.929338e-01 | 0.101 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 7.929338e-01 | 0.101 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 7.929338e-01 | 0.101 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 7.938356e-01 | 0.100 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 7.967339e-01 | 0.099 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 7.967339e-01 | 0.099 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 7.967339e-01 | 0.099 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 7.967339e-01 | 0.099 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 7.967339e-01 | 0.099 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 7.967339e-01 | 0.099 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 7.967339e-01 | 0.099 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 7.967339e-01 | 0.099 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 7.967339e-01 | 0.099 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 7.967339e-01 | 0.099 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 7.981134e-01 | 0.098 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 7.981443e-01 | 0.098 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 7.981443e-01 | 0.098 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 7.987076e-01 | 0.098 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 8.030136e-01 | 0.095 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 8.030136e-01 | 0.095 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 8.030136e-01 | 0.095 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 8.054147e-01 | 0.094 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 8.070371e-01 | 0.093 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 8.070371e-01 | 0.093 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 8.102166e-01 | 0.091 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 8.123081e-01 | 0.090 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 8.123081e-01 | 0.090 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 8.123081e-01 | 0.090 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 8.123081e-01 | 0.090 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 8.123081e-01 | 0.090 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 8.123081e-01 | 0.090 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 8.123081e-01 | 0.090 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 8.132974e-01 | 0.090 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 8.163347e-01 | 0.088 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 8.163347e-01 | 0.088 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 8.163347e-01 | 0.088 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 8.188417e-01 | 0.087 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 8.212307e-01 | 0.086 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 8.229510e-01 | 0.085 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 8.238641e-01 | 0.084 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 8.238641e-01 | 0.084 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 8.266898e-01 | 0.083 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 8.266898e-01 | 0.083 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 8.266898e-01 | 0.083 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 8.266898e-01 | 0.083 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 8.266898e-01 | 0.083 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 8.266898e-01 | 0.083 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 8.266898e-01 | 0.083 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 8.266898e-01 | 0.083 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 8.271241e-01 | 0.082 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 8.271241e-01 | 0.082 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 8.271241e-01 | 0.082 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.271241e-01 | 0.082 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 8.301008e-01 | 0.081 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 8.311368e-01 | 0.080 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 8.311368e-01 | 0.080 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 8.318118e-01 | 0.080 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 8.339368e-01 | 0.079 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 8.339368e-01 | 0.079 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 8.354184e-01 | 0.078 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 8.373393e-01 | 0.077 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 8.373393e-01 | 0.077 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 8.373393e-01 | 0.077 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 8.373393e-01 | 0.077 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.373393e-01 | 0.077 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 8.397127e-01 | 0.076 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 8.399704e-01 | 0.076 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 8.399704e-01 | 0.076 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 8.399704e-01 | 0.076 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 8.400937e-01 | 0.076 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 8.400937e-01 | 0.076 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 8.468111e-01 | 0.072 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 8.470050e-01 | 0.072 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 8.470050e-01 | 0.072 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 8.470050e-01 | 0.072 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 8.489400e-01 | 0.071 | 0 | 0 |
| Crosslinking of collagen fibrils | R-HSA-2243919 | 8.522340e-01 | 0.069 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 8.522340e-01 | 0.069 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 8.522340e-01 | 0.069 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 8.522340e-01 | 0.069 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 8.522340e-01 | 0.069 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 8.522340e-01 | 0.069 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 8.522340e-01 | 0.069 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 8.522340e-01 | 0.069 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 8.522340e-01 | 0.069 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 8.522340e-01 | 0.069 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 8.522340e-01 | 0.069 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 8.557391e-01 | 0.068 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 8.561453e-01 | 0.067 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 8.561453e-01 | 0.067 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 8.561453e-01 | 0.067 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 8.561453e-01 | 0.067 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 8.561453e-01 | 0.067 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 8.585121e-01 | 0.066 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 8.625666e-01 | 0.064 | 1 | 1 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 8.634969e-01 | 0.064 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 8.635584e-01 | 0.064 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 8.635584e-01 | 0.064 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 8.635584e-01 | 0.064 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 8.635584e-01 | 0.064 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 8.635584e-01 | 0.064 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 8.635584e-01 | 0.064 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 8.635584e-01 | 0.064 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 8.671810e-01 | 0.062 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 8.679811e-01 | 0.061 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 8.679811e-01 | 0.061 | 1 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 8.729444e-01 | 0.059 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 8.729444e-01 | 0.059 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 8.734337e-01 | 0.059 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 8.740157e-01 | 0.058 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 8.740157e-01 | 0.058 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 8.740157e-01 | 0.058 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 8.740157e-01 | 0.058 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 8.740157e-01 | 0.058 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 8.740157e-01 | 0.058 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 8.740157e-01 | 0.058 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 8.740157e-01 | 0.058 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 8.771473e-01 | 0.057 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 8.800099e-01 | 0.056 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 8.806489e-01 | 0.055 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 8.836720e-01 | 0.054 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 8.836720e-01 | 0.054 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 8.836720e-01 | 0.054 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 8.836720e-01 | 0.054 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 8.836720e-01 | 0.054 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 8.836720e-01 | 0.054 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 8.836720e-01 | 0.054 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 8.879194e-01 | 0.052 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 8.879194e-01 | 0.052 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 8.896654e-01 | 0.051 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 8.925087e-01 | 0.049 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 8.925887e-01 | 0.049 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 8.925887e-01 | 0.049 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 8.937763e-01 | 0.049 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 8.947772e-01 | 0.048 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 8.947772e-01 | 0.048 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 8.950411e-01 | 0.048 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 8.959628e-01 | 0.048 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.008225e-01 | 0.045 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.008225e-01 | 0.045 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 9.008225e-01 | 0.045 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 9.012428e-01 | 0.045 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.012428e-01 | 0.045 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.012428e-01 | 0.045 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.036400e-01 | 0.044 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.053459e-01 | 0.043 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.062871e-01 | 0.043 | 1 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 9.070570e-01 | 0.042 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.073361e-01 | 0.042 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.073361e-01 | 0.042 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 9.073361e-01 | 0.042 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.084255e-01 | 0.042 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 9.084255e-01 | 0.042 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 9.084255e-01 | 0.042 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 9.084255e-01 | 0.042 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 9.113220e-01 | 0.040 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 9.116710e-01 | 0.040 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.116710e-01 | 0.040 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 9.130760e-01 | 0.039 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 9.130760e-01 | 0.039 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.130760e-01 | 0.039 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 9.154461e-01 | 0.038 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 9.154461e-01 | 0.038 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.154461e-01 | 0.038 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.154461e-01 | 0.038 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 9.154461e-01 | 0.038 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.154461e-01 | 0.038 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.154461e-01 | 0.038 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 9.154461e-01 | 0.038 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.162118e-01 | 0.038 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.183741e-01 | 0.037 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.184810e-01 | 0.037 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 9.191106e-01 | 0.037 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 9.198511e-01 | 0.036 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 9.210556e-01 | 0.036 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.219288e-01 | 0.035 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 9.219288e-01 | 0.035 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 9.219288e-01 | 0.035 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 9.219288e-01 | 0.035 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.219288e-01 | 0.035 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.235685e-01 | 0.035 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.235685e-01 | 0.035 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 9.235685e-01 | 0.035 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 9.235685e-01 | 0.035 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 9.240825e-01 | 0.034 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 9.279149e-01 | 0.032 | 0 | 0 |
| Cobalamin (Cbl) metabolism | R-HSA-9759218 | 9.279149e-01 | 0.032 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 9.279149e-01 | 0.032 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 9.279149e-01 | 0.032 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 9.279149e-01 | 0.032 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.279149e-01 | 0.032 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.279149e-01 | 0.032 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 9.283556e-01 | 0.032 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 9.309835e-01 | 0.031 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.334318e-01 | 0.030 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 9.334423e-01 | 0.030 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.334423e-01 | 0.030 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 9.334423e-01 | 0.030 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 9.334423e-01 | 0.030 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.334423e-01 | 0.030 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.334423e-01 | 0.030 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 9.334423e-01 | 0.030 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.339154e-01 | 0.030 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.370923e-01 | 0.028 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 9.371425e-01 | 0.028 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 9.375342e-01 | 0.028 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 9.385462e-01 | 0.028 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 9.385462e-01 | 0.028 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 9.385462e-01 | 0.028 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 9.385462e-01 | 0.028 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.385462e-01 | 0.028 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 9.385462e-01 | 0.028 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 9.385462e-01 | 0.028 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.406613e-01 | 0.027 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.410720e-01 | 0.026 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.423955e-01 | 0.026 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.431610e-01 | 0.025 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 9.432590e-01 | 0.025 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.432590e-01 | 0.025 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.432590e-01 | 0.025 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 9.432590e-01 | 0.025 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.432590e-01 | 0.025 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 9.437696e-01 | 0.025 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.447233e-01 | 0.025 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.448116e-01 | 0.025 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.471574e-01 | 0.024 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.476106e-01 | 0.023 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.476106e-01 | 0.023 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.490832e-01 | 0.023 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 9.506285e-01 | 0.022 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 9.516235e-01 | 0.022 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.516288e-01 | 0.022 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.529534e-01 | 0.021 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.529867e-01 | 0.021 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 9.553389e-01 | 0.020 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 9.553389e-01 | 0.020 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 9.553389e-01 | 0.020 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 9.553389e-01 | 0.020 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 9.569486e-01 | 0.019 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 9.576277e-01 | 0.019 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.576277e-01 | 0.019 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.587647e-01 | 0.018 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.587647e-01 | 0.018 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 9.592156e-01 | 0.018 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.613717e-01 | 0.017 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.615846e-01 | 0.017 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.619279e-01 | 0.017 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.619279e-01 | 0.017 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.619279e-01 | 0.017 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.619279e-01 | 0.017 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 9.619279e-01 | 0.017 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.619279e-01 | 0.017 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 9.619279e-01 | 0.017 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 9.629142e-01 | 0.016 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 9.629142e-01 | 0.016 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 9.642384e-01 | 0.016 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.648487e-01 | 0.016 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.648487e-01 | 0.016 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.648487e-01 | 0.016 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.648487e-01 | 0.016 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.648487e-01 | 0.016 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.648487e-01 | 0.016 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.648487e-01 | 0.016 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.653050e-01 | 0.015 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 9.675455e-01 | 0.014 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.675455e-01 | 0.014 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 9.675455e-01 | 0.014 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.675455e-01 | 0.014 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.675455e-01 | 0.014 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 9.686908e-01 | 0.014 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 9.686908e-01 | 0.014 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.689860e-01 | 0.014 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.690519e-01 | 0.014 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.696729e-01 | 0.013 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.700356e-01 | 0.013 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 9.700356e-01 | 0.013 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.700356e-01 | 0.013 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.700356e-01 | 0.013 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.700356e-01 | 0.013 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.700356e-01 | 0.013 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.723347e-01 | 0.012 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 9.723347e-01 | 0.012 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.732019e-01 | 0.012 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 9.735015e-01 | 0.012 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 9.737431e-01 | 0.012 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.744576e-01 | 0.011 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.744576e-01 | 0.011 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.744576e-01 | 0.011 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.744576e-01 | 0.011 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.745642e-01 | 0.011 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 9.764177e-01 | 0.010 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 9.764177e-01 | 0.010 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 9.768611e-01 | 0.010 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 9.778131e-01 | 0.010 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.782275e-01 | 0.010 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.782275e-01 | 0.010 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.782275e-01 | 0.010 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.782275e-01 | 0.010 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 9.782275e-01 | 0.010 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 9.783824e-01 | 0.009 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.790747e-01 | 0.009 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.798985e-01 | 0.009 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.798985e-01 | 0.009 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.798985e-01 | 0.009 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.798985e-01 | 0.009 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.798985e-01 | 0.009 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.806942e-01 | 0.008 | 1 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.806942e-01 | 0.008 | 1 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.814413e-01 | 0.008 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.822545e-01 | 0.008 | 1 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.828658e-01 | 0.008 | 0 | 0 |
| Pyrimidine catabolism | R-HSA-73621 | 9.828658e-01 | 0.008 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.835545e-01 | 0.007 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.836302e-01 | 0.007 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.837275e-01 | 0.007 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.841811e-01 | 0.007 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.841811e-01 | 0.007 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.841811e-01 | 0.007 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.841811e-01 | 0.007 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 9.847520e-01 | 0.007 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.851289e-01 | 0.007 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 9.853954e-01 | 0.006 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 9.853954e-01 | 0.006 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.853954e-01 | 0.006 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.853954e-01 | 0.006 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 9.853954e-01 | 0.006 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 9.853954e-01 | 0.006 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 9.856677e-01 | 0.006 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.856677e-01 | 0.006 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 9.865130e-01 | 0.006 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.865166e-01 | 0.006 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.865166e-01 | 0.006 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.873114e-01 | 0.006 | 1 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 9.875518e-01 | 0.005 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.875518e-01 | 0.005 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.876720e-01 | 0.005 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.883505e-01 | 0.005 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.884226e-01 | 0.005 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 9.885076e-01 | 0.005 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.885076e-01 | 0.005 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.891307e-01 | 0.005 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.893730e-01 | 0.005 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 9.901001e-01 | 0.004 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 9.902048e-01 | 0.004 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.909570e-01 | 0.004 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.909570e-01 | 0.004 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.909570e-01 | 0.004 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.911778e-01 | 0.004 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.916515e-01 | 0.004 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 9.916515e-01 | 0.004 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.917724e-01 | 0.004 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.917724e-01 | 0.004 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.917724e-01 | 0.004 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.919370e-01 | 0.004 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.920826e-01 | 0.003 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.920826e-01 | 0.003 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.922927e-01 | 0.003 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.922927e-01 | 0.003 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 9.922927e-01 | 0.003 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.923277e-01 | 0.003 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.930835e-01 | 0.003 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.933306e-01 | 0.003 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.934849e-01 | 0.003 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.939358e-01 | 0.003 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.941593e-01 | 0.003 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.944017e-01 | 0.002 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.944017e-01 | 0.002 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 9.946120e-01 | 0.002 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 9.946120e-01 | 0.002 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.946924e-01 | 0.002 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.948318e-01 | 0.002 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.951612e-01 | 0.002 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.955954e-01 | 0.002 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.955954e-01 | 0.002 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.956025e-01 | 0.002 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.956295e-01 | 0.002 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.961039e-01 | 0.002 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.964665e-01 | 0.002 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.967188e-01 | 0.001 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 9.971454e-01 | 0.001 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.973418e-01 | 0.001 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.973418e-01 | 0.001 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.975249e-01 | 0.001 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.975372e-01 | 0.001 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.976769e-01 | 0.001 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.980029e-01 | 0.001 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.980029e-01 | 0.001 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.981097e-01 | 0.001 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.981411e-01 | 0.001 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.981411e-01 | 0.001 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.981726e-01 | 0.001 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.981726e-01 | 0.001 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.981726e-01 | 0.001 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.982817e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.985014e-01 | 0.001 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.986055e-01 | 0.001 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.986731e-01 | 0.001 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.987653e-01 | 0.001 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.989563e-01 | 0.000 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.989563e-01 | 0.000 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 9.991107e-01 | 0.000 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.991336e-01 | 0.000 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.991590e-01 | 0.000 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.992179e-01 | 0.000 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.993006e-01 | 0.000 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.993419e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.993710e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.994403e-01 | 0.000 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.994500e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.994702e-01 | 0.000 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.995674e-01 | 0.000 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.996315e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.996315e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.996470e-01 | 0.000 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.996598e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.996739e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.997416e-01 | 0.000 | 1 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.997531e-01 | 0.000 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.997558e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.997568e-01 | 0.000 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.997721e-01 | 0.000 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.997897e-01 | 0.000 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.998059e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.998202e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.998436e-01 | 0.000 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.998700e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.998747e-01 | 0.000 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.998756e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.998853e-01 | 0.000 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.998892e-01 | 0.000 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.998996e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.999338e-01 | 0.000 | 1 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.999445e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999462e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.999667e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999667e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.999671e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999790e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999838e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999909e-01 | 0.000 | 1 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999938e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999955e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999965e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999965e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999987e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.999990e-01 | 0.000 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.999995e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999998e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999999e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999999e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999999e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | -0.000 | 0 | 0 |
| Activation of BMF and translocation to mitochondria | R-HSA-139910 | 1.000000e+00 | 0.000 | 1 | 1 |
| Interleukin-38 signaling | R-HSA-9007892 | 1.000000e+00 | 0.000 | 1 | 1 |